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EXECUTIVE 
SUMMARY
The Merchant’s Quay Project was established in 1989 by the Franciscan Community in response to an
increase in the number of drug users seeking help within the locality. As a voluntary organisation the
Project is receptive to the needs of its service users and has the flexibility to respond accordingly. To
this end, a Health Promotion Unit was set up within the Merchant’s Quay Project in July 1992 to
provide a model for working with people who engage in both injecting and sexual risk behaviour. This
model concentrates on reducing or eliminating these risks in so far as possible. In 1997, it was decided
to undertake an evaluation of the Health Promotion Unit. This Report presents the findings of the
evaluative research undertaken from May 1st 1997 to October 31st 19981 .
RESEARCH OBJECTIVES
The objectives of this evaluation study are as follows;
½ to research the international information available on the evaluation of syringe exchanges
and outcome measures;
½ to fully define the services provided by the Merchant’s Quay Project’s Health Promotion
Unit;
½ to identify the indicators of positive effect for the Health Promotion Unit;
½ to collect information on clients’ self-reported behaviour at first visit and at a subsequent
three month follow-up visit;
½ to adjust the collection of information at first contact to include baseline data on these
indicators of positive effects;
½ to comparatively analyse clients’ behaviour according to these indicators and;
½ ultimately to evaluate the effectiveness of the service offered by the Health Promotion Unit
to the clients.
 
RESEARCH METHOD 
The evaluation was undertaken by means of collecting information on clients risk behaviour at both
First Intervention and at a Follow Up Visit. It entailed interviewing clients with the aid of a highly
structured questionnaire at the point of intake or as soon as possible thereafter, and asking the attendees
for the same pieces of core information, in the same way, at a three month follow-up time period and
comparing the results. The research instruments collect information on the following outcome domains;
drug use, injecting risk behaviour, sexual risk behaviour, contact with services and health and well-
being. Information is based on the self-reported risk behaviour of clients.  
                                                          
1 The evaluation of the Health Promotion Unit is ongoing, and consequently the relevant data is still being collected
from consenting attendees at the Unit.
MAKING CONTACT
A total of 1,337 new clients attended the Health Promotion Unit during the 18 months under
investigation. All consented to complete the First Visit Intervention Sheet, and the data collected
provides valuable information on the effectiveness of the Heath Promotion Unit in making contact with
various sub-groups of injecting drug users.
 The Health Promotion Unit proved highly successful in making initial contact with those injecting
drug users who were not attending any other drug treatment service. At the time of presenting at
the Unit a total of 48% of the new attendees at the Unit reported that they had never attended any
other drug treatment service. Moreover, only 21% of the sample reported that they were in contact
with a treatment service when they first presented at the Unit.
 The Unit was also effective in attracting female drug users; 23% of first visit clients were women
(n=313). International research illustrates that women are underrepresented in treatment services
(Anglin et al, 1987; Gossop et al, 1990).  This is most evident when the number of female first
visit clients at the Health Promotion Unit is compared with, for example, the number of female
first contacts presenting at the Manchester Syringe Exchange Schemes in 1997, where only 18%
of the clients were female (Drug Misuse Database, 1997).  
 International research illustrates that syringe-exchanges have not been successful in making
contact with young injectors (Paone et al, 1995). However, 28% of first visit clients at the Health
Promotion Unit were under 19 years of age, and 64% were under the age of 25. This suggests that
the service is particularly attractive to young injectors, who tend to be regarded as the ‘hard to
reach’ (Battjes et al, 1992).  In view of the fact that within Europe, Ireland is one of the countries
with the youngest population of drug users (EMCDDA, 1997) it is vital that services in Ireland
target young injectors. 
 The Health Promotion Unit was very successful in making initial contact with drug users who
have recently initiated intravenous drug use. Fifty five percent of the new presenters at the Health
Promotion Unit were injecting drugs for less than one year. Moreover, thirty percent of the above
clients reported injecting for less than 6 months. This is very encouraging, as the international
research indicates that Syringe Exchanges primarily appeal to those who have a long history of IV
drug use (Stimson et al, 1991).
 The Health Promotion Unit was also successful in attracting it’s target population, that is, those
who engage in risk behaviour. The high percentage of clients who reported injecting in excess of
four times a day (27%), recent sharing of injecting equipment (29%), and injecting paraphernalia
(55%), and inconsistent cleaning practices (60%) clearly illustrates the vulnerability of this group
in terms of personal risk, and risk of future transmission of HIV and hepatitis.
 The Unit has also been very successful in attracting a large number of drug users who are
potentially at greater risk if engaging in injecting and sexual risk behaviour due to their
circumstances, of engaging in unsafe injecting and sexual behaviour, such as homeless drug users
(19%) and poly-drug users (64%). 
OUTCOME MEASURES
The Health Promotion Unit proved successful in maintaining contact with a significant proportion of the
1337 first time attendees to the Unit. Twenty eight percent of all first visit clients who attended the
Health Promotion Unit during the 18-month period represented at the three month follow-up. This was
considered a reasonable follow-up rate in view of the time period and the chaotic life-style of the clients
attending the Health Promotion Unit. International research suggests that a one in four follow-up rate is
‘good’ (Dept. Health, 1996). In addition, the Unit was successful in delivering the most basic service
i.e. getting syringes out and getting them back. To this end, there was a 44% return rate on all injecting
equipment distributed by the Unit. The results of the evaluation show that the Health Promotion Unit
was effective in producing the following outcome measures at follow-up in relation to drug use,
injecting risk behaviour, sexual risk behaviour, and health and well-being. The data below relates only
to the 370 attendees who represented at the Unit. 
 Drug Use
 
 The Health Promotion Unit was effective in facilitating a significant change in reported heroin use.
12% of the attendees who reported using heroin as their primary drug at first visit (n=345),
reported using an ‘other’ primary drug by the three month follow-up period.
 There was a less dramatic, although statistically significant change in the number of clients who
reported using physeptone as their primary drug at the three-month follow-up period. At follow-up
visit, 8% (n=31) of follow-up clients reported the use of physeptone as their primary drug,
compared with 4% (n=15) of clients at first visit.
 The Health Promotion Unit was effective in not only producing the desired behaviour changes in
regard to the type of drug used but also in relation to the route of administrations. Follow-up
clients reported safer routes of administration in that there was a 11% reduction in IV drug use
among those who reported doing so at first visit (n=341).  
 There was also a reduction in the frequency of injecting for clients who reported injecting in
excess of 4 times a day (n=104). 67% of these respondents reported less frequent IV drug use at
their three month follow-up visit.
 Injecting Risk Behaviour
 Literature has shown that syringe exchanges have been effective in reducing injecting risk
behaviour among regular attenders (Keene et al 1993, Frischer and Elliott 1993). The evaluation
of the Health Promotion Unit has illustrated that there was a significant reduction in the number of
clients who reported both the lending and borrowing of used injecting equipment. Fifteen percent
of clients (n=56) reported lending their used injecting equipment at first visit compared with only
9% of clients (n=33) at follow-up. There was a similar reduction in the number of clients who
reported borrowing others injecting equipment, in that 23% of first visit clients (n=85) reported
such risk behaviour compared with 15% of follow-up clients (n=55). 
 Analysis revealed that unlike the sharing of injecting equipment, there were no significant changes
in the sharing of injecting paraphernalia. In that, there was only a 1% reduction in reported sharing
at follow-up. Fifty four percent of follow-up clients (n=197) at first visit reported this sharing
compared with 53% of clients (n=194) at follow-up. 
 The Merchant’s Quay Project is also concerned with health problems that emerge from unhygienic
and poor injecting techniques. Improvement in injecting hygiene is considered to be a positive
outcome measure in reducing the level of injecting risk behaviour. At follow-up, there was a 44%
increase in the number of clients who reported cleaning their injecting site. In addition, 64% of the
clients who reported not injecting self at first visit (n=87) had initiated the safer practice of self
injecting by follow-up.
 Sexual Risk Behaviour
 International research has indicated that there has been little or no change in the condom use of
injecting drug users as a result of attending syringe exchanges (Hart, 1989). The emphasis placed
on needle sharing and syringe sharing has led to the exclusion of other risk factors. The evaluation
of the Health Promotion Unit revealed that only 33% of those who reported never using condoms
at first visit (n=222), had initiated condom use by follow-up. Overall there was a 5% increase in
reported condom use in the time period under investigation. At first visit 38% of clients reported
always using condoms compared with 43% at follow-up.
Health and Well-Being
 Recognising the fact that 79% of new presenters at the Health Promotion Unit were not in contact
with any other drug treatment service,  there is a need to ensure that the Unit acts as an effective
source of referral thus maintaining and maximising treatment contacts. The evaluation of the
Health Promotion Unit has illustrated that although not statistically significant, there was an
increase in reported contact with drug treatment services in the three-month time period between
first visit and follow-up intervention. Twenty percent of clients (n=75) reported contact with other
treatment services at first visit, compared with 26% of clients (n=95) at follow-up. 
 Unlike treatment contact, there was only a 1% increase in the total number of reported medical
contacts by clients, in that, 56% of clients (n=206) reported contact at first visit compared with
57% (n=212) at follow-up. Although, this change was not statistically significant, 48% of the
clients who reported no medical contact at first visit (n=161) reported such contact at follow-up.
 Encouraging clients to engage in specialist contact such as having a HIV test, and receiving the
hepatitis B vaccination are also considered an integral part of the Health Promotion Unit. The
evaluation of the Health Promotion Unit reveals that 18% of the attendees who reported not
having had a HIV test at first visit (n=203), had done so by the three month follow-up period.
Although not statistically significant 31 clients or 10% of those who reported not having had a
vaccination against Hep B at first visit (n=301), reported having had one at follow-up.  
 The Health Promotion Unit also strives to maintain the health and well being of clients. Following
the three-month follow-up period, there were significant changes in mental health complaints, in
that, there was a reduction in the number of clients who reported experiencing all complaints. This
could be due to clients initiating contact with other drug treatment services and hence experiencing
less exclusion. With regard to physical health complaints, there was a significant change in the
number of clients reporting weight loss over the three-month follow-up period. 40% of the clients
who reported weight loss at first visit did not report this at follow-up (n=215). Other changes in
regard to physical health were less dramatic. Recognising the limited time frame of the follow-up
period there was however no overall deterioration in clients physical or mental health.
 The Health Promotion Unit recognises that to maintain satisfactory levels of medical contact, the
provision of medical card application forms to clients is therefore a necessary feature of the
service that is provided to clients. 37% of the attendees who reported having no medical card at
first visit (n=130 ) were in receipt of one by the three month follow-up visit. 
 The Health Promotion Unit was effective in providing clients with the necessary advice and
information to enable them to make the appropriate changes. At follow-up the majority of clients
reported that the Unit provided them with information on safer injecting techniques (70%), safer
drug use (71%) and safer sex (69%). 
RECOMMENDATIONS
This study has clearly demonstrated the effectiveness of needle exchanges as a public health initiative,
while at the same time highlighting a number of deficits in service provision and policy. To this end the
Report recommends the following;
 
 Improved access to sterile injecting equipment at a local and community level. To ensure 24 hour
availability of injecting equipment, a range of strategies supplementing existing services are
recommended. 
 Specific areas of service development to ensure the utilisation of more extensive harm reduction
strategies and ultimately a more holistic approach to the needs of injecting drug users.
 Innovative information and publicity campaigns to place HIV and hepatitis C at the forefront of
the public health agenda.
 Further research to advance and legitimise drug service provision.
 That harm reduction  be identified as a primary objective of the national drug policy.
CHAPTER 1
INTRODUCTION
Syringe exchange programmes are the cornerstone of HIV prevention strategies for people who inject
drugs. They are one of the most rapidly expanding and developing areas and have played a major role in
the development of new aims, working practices and ideologies for those who seek to help drug users
reduce the risks and harm associated with injecting drug use. This chapter provides a description of the
Merchant’s Quay Project’s syringe exchange. Thereafter, the aims and objectives of the service are
outlined. As will be seen the service is multidimensional in nature, in that it is not solely concerned with
the distribution of sterile injecting equipment. This is reflected by the fact that the Merchant’s Quay
Project refers to its syringe exchange as a Health Promotion Unit. This chapter concludes with an
outline of the Report. 
1.1 BACKGROUND TO THE STUDY
The Merchant’s Quay Project established its Health Promotion Unit in July 1992, to provide a model
for working with people engaging in intravenous drug use which concentrates on reducing or
eliminating the associated risks. Over the years the number of injecting drug users attending the Unit
has increased rapidly, and it is now the largest syringe exchange in Ireland. As the Health Promotion
Unit grew in size, the management of the Merchant’s Quay Project became acutely aware of the
increased difficulties in monitoring the efficacy of the Unit, that is, in producing the desired behaviour
changes among the attending clients. Moreover, they recognised the need to develop existing
mechanisms, to ensure adequate accountability to funders, service users and service providers. In order
to address these issues, the management decided that it was necessary to develop an outcome
monitoring system, to evaluate the effectiveness and efficiency of the Health Promotion Unit. 
It is essential from the outset to be clear about the correct definition of an outcome; an outcome is a
change within the client (Burns, 1994). This is usually taken to include changes in behaviour, such as
levels of drug use, injecting/sexual risk behaviour, and changes in health which encompass a range of
physical and psychological complaints. Collecting and analysing this information enables the Project to
determine if a significant proportion of clients are showing positive changes, or outcomes, over a period
of time, that are at least in part attributable to the service provided to the clients
2
. On the other hand, this
practice also enables the Project to report to funders and other interested bodies, which in turn
contributes positively to future planning and service development.
The Merchant’s Quay Project was well aware that by definition of the process involved, outcome
monitoring can have an impact on the service provided. This can present itself either as a problem or a
positive contribution. Some agencies express concern that outcome monitoring can be an intrusion into
the privacy of the clients, or too time-consuming, thus taking away from the time spent with the client.
The emphasis within the Project was on developing a system that located itself well within the needs of
the Health Promotion Unit and within the needs of the client group. The Merchant’s Quay Project found
that the research instrument employed proved to be a good therapeutic tool, and helped workers to get a
more in-depth understanding of the clients’ history and circumstances. Moreover at times, the questions
themselves worked as a motivational hook. 
The response of staff, to any new monitoring system is another important implication.  Research shows
that this can vary widely, and that the involvement of staff in developing the monitoring process, can
have positive results. However, a balance was needed between encouraging staff at the Project to
participate in the process of developing outcome measures, while acknowledging that this is outside
their usual priorities, but none the less essential. The staff at the Merchant’s Quay Project, were closely
involved in developing the outcome monitoring system and viewed the collection of outcome
information as a positive contribution to their work with clients.
                                                          
2  Theoretically there is a problem in attributing any change solely to the agency or particular intervention.  This
issue will be discussed in more detail in Chapter 3 Methodology.
1.2 OBJECTIVES OF THE STUDY
The objectives of the study are as follows;
½ to research the international information available on the evaluation of syringe exchanges
and outcome measures;
½ to fully define the services provided by the Merchant’s Quay Project’s Health Promotion
Unit;
½ to identify the indicators of positive effects for the Health Promotion Unit;
½ to collect information on clients’ self-reported behaviour at first visit and at a subsequent
three-month follow-up visit;
½ to adjust the collection of information at first contact to include baseline data on these
indicators of positive effects;
½ to comparatively analyse clients’ behaviour according to these indicators and;
½ ultimately to evaluate the effectiveness of the service offered by the Health Promotion Unit
to the clients.
1.3 MERCHANT’S QUAY HEALTH PROMOTION UNIT
This section provides a description of the service provided by the Merchant’s Quay Health Promotion
Unit. As the name of the Unit suggests it is not simply concerned with the distribution of needles and
syringes. Thereafter the aims and objectives of the Unit are identified.
½ The Health Promotion Unit is funded through the Merchant’s Quay Project’s mainstream
funding from the Eastern Health Board, the Probation and Welfare Service, F.A.S. and
from fund raising by the Merchant’s Quay Project.
½ The Health Promotion Unit is located within a Dublin Inner City drug service.
½ The Unit is open Monday to Friday, from 2.00pm until 4.30pm and operates on a drop in
basis. A minimum of five staff, all who have received training in syringe exchange
provision, operate the Health Promotion Unit; one worker for the reception area, one
Health Promotion Supervisor, and three workers to operate the three exchanges. A fourth
worker is required to operate an additional exchange on a busy day.
½ The Health Promotion Unit offers a range of needles and syringes plus sterile water, filters,
swabs, citric acid, and condoms. The equipment is sealed in brown paper bags, with a ‘one
works/one person’ sticker.
½ The Health Promotion Unit aims to ensure that all clients receive adequate supplies of
syringes and needles. However for first time clients the amount given out is normally
restricted to 2 barrels and 6 needles (or 6 microfines). Thereafter the quantity given to a
client depends on their return rates. 
½ The Health Promotion Team also provides a take-away service, for those who arrive
between 4.30pm and 5.00pm during the week, and to accommodate clients at weekends.
This takes the form of an emergency pack. A weekend emergency pack consists of 2
microfine barrels, 3 x 2ml barrels, 6 orange needles, 3 light brown needles, 2 bottles of
sterile water, 1 bag of citric acid, 3 filters, 10 swabs, and 1 box of 3 condoms. 
½ Limited exchanges are also offered in the mornings (similar to the emergency pack). This
was implemented as a means of facilitating women with children, drug users who are
working and individuals with other exceptional circumstances. People who are working
need to present proof of employment before they are eligible for the ‘limited exchange’.
½ The staff at the Unit offer advice on injecting behaviour, leaflets on safer injecting
practices, safer sex issues, HIV testing, hepatitis B and C testing, immunisation, and
internal and external referrals. 
½ The Health Promotion Unit is further enhanced by a first aid nursing service. This service
provides clients with basic wound care, and deals with other health issues e.g. scabies,
athletes foot, and any other conditions that clients present. When appropriate external
referrals are made. Clients may also get medical card application forms in the Health
Promotion Unit.
½ Staff monitor the Health Promotion Unit using a ‘card system’; which includes details of
clients initials, date of birth, gender, postal code, sharing behaviour in the previous month,
equipment provided and returned. At the time of writing the Report, the Health Promotion
Unit was in the process of being computerised.
½ The card system shows that an excess of 5,000 clients have attended the Health Promotion
Unit at some point since its inception.  However, no more than half of the clients attending
at any given time would be considered regular clients (attendance in excess of once a
week).  
½ In 1998, the Health Promotion Unit served an average of 67 clients a day. Mondays are the
busiest days, and numbers usually exceed 100 clients. In the same year a total of 16,509
syringe exchanges were dispensed.
½ The Health Promotion Unit is primarily publicised through word of mouth. Consequently,
most clients are self-referred.
½ The majority of clients using the service are from the Dublin Inner City.
½ The primary drug of choice used by the attending clients is heroin.
½ One quarter of the clients using the Health Promotion Unit are female.
½ The average age of the total population of the Unit’s clients is 25. Over the last year, the
staff of the Unit have been particularly concerned about the increasing number of under
eighteen year olds presenting  at the Health Promotion Unit.
½ It is impossible to estimate what percentage of the local injecting drug users are being
reached by the service, as there has been no research indicating the extent of intravenous
drug use in Dublin3.  However, the Health Promotion Unit at Merchant’s Quay serves the
largest number of injecting drug users in the city.
1.3.1 Aims of the Health Promotion Unit
The evaluation process requires that the aims and objectives of the service be clearly outlined. These
were clarified in agreement with staff at the Health Promotion Unit, thereby enabling an appropriate
research strategy to be adopted, including the specification of outcome measures. The aims of the Unit
are presented in Table 1.1.
Table 1.1 Aims of the Health Promotion Unit
• To enable clients to gain access to sterile injecting equipment, and condoms;
• To reduce the risk of contracting HIV, hepatitis B and C and other STDs;
                                                          
3 To the authors knowledge only one prevalence study has been carried out to date, by Comiskey (1998). This study
estimated that there were 13,460 opiate users in Dublin. However, it is not possible to extrapolate on the basis of
this data, as the results relate to 1996. Moreover, the estimate is not confined to injecting drug users, as a very broad
definition of opiate use was utilised, including both problematic and non-problematic drug use.  
• To increase knowledge of safer injecting and sexual practices;
• To improve health care and;
• To evaluate changes and trends in drug use.
 
 
Although a broad statement of intent of Merchant’s Quay Health Promotion Unit is to promote healthy
behaviour, it needs to be stated that risk behaviour does not occur in a vacuum. Healthy behaviour - and
risky behaviour - are located within particular social, economic, and cultural practices. As will be
discussed in detail in the next chapter, there are many good reasons why people engage in harmful
behaviour, even when they intend the opposite. All these behaviours take place well away from the
territory of the drug treatment agencies. While attempts can be made to tackle these behaviours on an
individual client-centered basis, what needs to be changed is the broader culture within which drug use
takes place. The Merchant’s Quay Project is aware that promoting healthy behaviour is thus a major
task of encouraging change.
1.3.2 Objectives of the Health Promotion Unit
The objectives of the Health Promotion Unit, which outline the desired outcomes, can be divided into
the broad categories illustrated in Table 1.2;
Table 1.2 Objectives of the Health Promotion Unit
Reduction in the quantity of drugs consumed
Reduction in the use of ‘risky combinations’ of drugs
Drug Use and Reduction in the frequency of injecting
Injecting Practices Reduction in the sharing of injecting equipment
Reduction in the sharing of spoons and filters
Eliminating the sharing of injecting equipment
Promoting safer injecting practices
Improvement in physical health
No deterioration in physical health
Health and Improvement in psychological health (well-being)
Well-Being No deterioration in psychological health (well-being)
Increase contact with medical services
Increase contact with drug treatment services
Reduction in sexual risk taking
Table 1.2 illustrates that the Health Promotion Unit operates according to a hierarchy of objectives.
Ideally the Unit strives to eliminate risky injecting drug use. If and when this is not possible the Unit
achieves its objectives by reducing the frequency of injecting, eliminating the sharing of injecting
equipment, reducing the incidence of sharing etc. This hierarchical approach places importance on what
others may perceive as relatively insignificant behaviour changes. However, it accommodates all
injecting drug users, by recognising the benefits of any positive behaviour change.    
 1.4  THE REPORT
This report is concerned with the evaluation of the Merchant’s Quay Health Promotion Unit. In
Chapter Two the key pieces of international research concerned with the effectiveness of syringe
exchanges are reviewed. It will be seen that syringe exchanges have proved very successful across
cultural divides, in attracting drug users, and in reducing the levels of injecting, and to a lesser degree
sexual risk behaviour among attendees. Overall, it is argued that syringe exchanges play an important
role in the prevention of HIV transmission and they operate as a potential access point to a wider
network of services. However, very little research has been carried out in Ireland, on the effectiveness
of syringe exchanges in producing the desired behaviour changes.  
Chapter Three outlines the research methods employed to achieve the objectives of the study. The
method chosen to measure clients outcomes or behaviour changes was to ask clients for the same pieces
of core information, in the same way, at different points in time and compare the results. A
questionnaire was designed and completed by consenting clients, at the point of first contact and again
at a three month interval. The highly structured questionnaires covered seven identified outcome
domains, which in turn were based on the aforementioned aims and objectives of the Health Promotion
Unit.
Chapter’s Four and Five contains analysis of the data collected from those clients who completed the
research instruments. Chapter Four includes a comprehensive profile of all new clients who attended
the Health Promotion Unit from May 1st 1997 to October 31st 1998. Data is presented on 1337 clients.
This chapter also contains a discussion of some of the areas of concern to emerge from the baseline data
collected by the First Visit Intervention Sheets. Chapter Five is concerned specifically with client
outcomes, or behaviour changes. In this chapter the follow-up data which was collected from those
clients who represented at the Health Promotion Unit three months after their first intervention is
analysed. Although there are some concerns around the follow-up rate, it will be seen that the Health
Promotion Unit has been effective in producing a number of positive changes in clients. These include
increasing client contact with drug treatment services, reducing injecting risk behaviour and drug use,
and improving the health of the clients.
The report concludes with Chapter Six and Seven, which offers a summary of the main findings, and
presents some conclusions and recommendations. 
CHAPTER 2
LITERATURE 
REVIEW
Both the AIDS epidemic and proliferation of hepatitis C infection among injecting drug users have
highlighted the importance of attracting drug users4 to services, so that those at risk of contracting and
transmitting the Human Immunodeficiency Virus (HIV) and/or hepatitis C may be advised on the best
measures to take, in order to protect both themselves and others from infection. Given that there are a
number of injecting drug users who are either unwilling or unable to stop injecting, syringe exchange
programmes have become an important harm reduction strategy. In this chapter the concept of harm
reduction in terms of policy and practice is discussed. Thereafter, international research which evaluates
one of the most publicised harm reduction strategies - syringe exchanges is reviewed. It will be seen
that most international research supports the effectiveness of such programmes, which have both
politically and scientifically survived the last two decades. The chapter concludes by contextualising
Irish drug policy within the harm reduction framework.
2.1  HARM REDUCTION  
A public health approach to problem drug use views its occurrence not as a phenomenon caused by an
individual’s pathology, but rather as one causing extensive social problems and threatening public
health. Harm reduction theory reflects this attitude and goes a step further, arguing that many of the
most destructive consequences of illicit drug use are not the result of drugs per se, but rather of drug
policy. Accordingly, within harm reduction there is as Strang (1999) argues, no predetermined position
on drug use being inherently ‘good’ or ‘bad’. As a policy response, harm reduction strategies are
determined solely by the extent of observed and/or anticipated harm which results from drug use.
The idea of harm reduction is not new and has been described as ‘old wine in new bottles’5 (Velleman,
and Rigby, 1992). However, over the past two decades harm reduction has gained increasing attention
and support from practitioners and policy makers. This resulted primarily from the recognition that HIV
can spread very rapidly among injecting drug users into the general population.  As an approach, harm
reduction has been described as having a bewildering variety of interpretations (Roche et al, 1997)
which Single (1995) maintains has contributed to its rapid uptake and widespread appeal6. This has lead
Mugford (1999) to argue that harm reduction has become a ‘sound bite’, in that everybody thinks they
know what it means, and it seems reasonable to all. Within the drugs field many have argued that to
concentrate on the philosophical and theoretical aspect of harm reduction distracts from the important
task of implementing such strategies (Strang, 1999). The resulting lack of clarity around theory and
definitions is likely to cause problems in terms of the development of policy and practice within this
area. Moreover, Newcombe (1992) argues that the importance of a precise theory for, and definition of,
the reduction of drug related harm is in the fact that it permits the measurement of the effectiveness of
harm reduction strategies through scientific evaluation.  
                                                          
4 It often appears that there is a bewildering vocabulary which surrounds the description of individuals who take
drugs and the consequences of their drug use. Many of the terms used, such as drug ‘abuser’ or ‘misuser’ have
ideological overtones. Furthermore, identifying drug use as a ‘problem’ is in itself dubious: drug use is not always,
nor even often, a problem. Hartnoll et al (1985) argue that it is essential to define the terms used, as any ambiguity
surrounding definitions has important implications for the interpretation and generalisation of results. Throughout
this Report the term ‘drug user’ and ‘drug use’ will be employed. In this context it refers to an individual who self
administers non-prescribed psychoactive drugs.
5 In the UK, harm reduction can be traced back to the old ‘British System’ of maintenance prescribing, which
emerged as a result of recommendations of the Rollestone Committee of 1924-1926 (Berridge and Edwards, 1987).
This provided a framework within which the reduction of harm to the individual drug user was paramount, even if it
was also implemented as a means of allowing the drug user to led a ‘useful life’ (Berridge, 1999).
6 In an attempt to develop a more theoretical framework surrounding harm reduction, Strang (1999) suggests
distinguishing between the terms harm reduction and harm minimisation. He states that harm reduction is
something that is operational (such as policies and programmes) whereas harm minimisation is the overall objective
to be aimed at. In other words, Strang (1999:7) argues that harm reduction strategies are the “means by which the
goals of harm minimisation might be achieved”. Thus, a harm minimisation approach to drug use will comprise of
various harm reduction strategies. However, the reality is that the terms are used synonymously. Throughout this
Report, the term harm reduction will be used, and will refer to both theoretical and practical issues.
Many of the principles of harm reduction have changed over time and now maintain a more precise
definition (Roche et al, 1997). Drucker (1995) argues that contemporary harm reduction approaches to
drug use aim at altering drug policies, not the drugs themselves - and certainly not human nature.
Current harm reduction practice can been seen as a response to a number of fundamental observations
about drug use. These form the central concepts in the harm reduction approach to psychoactive drug
use and are as follows;
1. The non-medical use of psychoactive drugs is inevitable in a society that has access to such
drugs. Consequently policies and programmes cannot be based on utopian ideals of a “drug
free society” (Nadelmann, 1998).
2. This non-medical use of drugs will ultimately produce significant social and individual
harms. The harms caused by drug use are many and highly varied and depend upon the
type of drug used, frequency and quantity of use, how it is administered, and the social and
physical circumstances of drug use (Strang, 1999).
3. Reducing drug related harms can be achieved without necessarily reducing drug use
(Roche et al, 1997), for example, by injecting with sterile injecting equipment. 
4. Drug policies must be pragmatic. They must be assessed on their actual consequences, and
not on whether they symbolically send the right, wrong or mixed messages (Des Jarlais,
1995). It is important to note the possibility that policies to reduce illicit drug use, may by
themselves increase the harm associated with drug use.
5. Drug users are an integral part of the larger community, and as such they must be treated
with dignity and integrated into society. Many of the harms coming from the use of drugs
are the result of social stigmatisation of drug users rather than of drug use itself (Paone et
al, 1995).
The principal feature of harm reduction is the acceptance of the fact that some drug users cannot be
expected to cease their drug use at the present time. Thus, the key component of harm reduction
programmes which distinguishes them from any other drug programme, is whether they attempt to
reduce the harmful consequences of drug use, while the user continues to use. To this end, harm
reduction emphasises practical rather than idealised goals (Single, 1995). Harm reduction is neutral
about the long term goals of interventions, while according a high priority to short term goals.
Today a range of services which target the ‘consequences of drug use’ (rather than use itself) operate
within a harm reduction framework. Although it has been argued that harm reduction has become ‘all
things to all people’, it seems more realistic to acknowledge that harm reduction does not mean
abstinence or use reduction (Roche, et al 1997). Conversely, use reduction need not lead to harm
reduction.
2.2 SYRINGE EXCHANGES: A HARM REDUCTION STRATEGY
Early in the AIDS epidemic the role of injecting equipment, specifically the sharing of needles and
syringes contaminated with HIV was clearly linked to the transmission of the virus. The pattern of
spread among injecting drug users was extended to their sexual partners (and potentially into the
heterosexual population as a whole) and to the foetus during pregnancy and delivery. Accordingly, the
introduction of syringe exchange programmes in the early years of the AIDS epidemic represented the
first explicit harm reduction intervention aiming to reduce HIV risk behaviour7 without necessarily
reducing illicit drug use per se (Berridge, 1998). It is not surprising that syringe exchange programmes
                                                          
7 Although the terms ‘harm’ and ‘risk’ are related, and are often used interchangeably, there are noteworthy
differences in meaning. Strang (1999) states that risk relates to the possibility that an event might occur - be it the
risk resulting from a single episode or the cumulative risk over time. On the other hand, harm is seen as the event
itself, or as relating to the event (Strang, 1999). Risk behaviour does not however inevitably result in harm. Thus,
risk behaviour, such as needle sharing, may result in individual, community and/or social harm. Harm reduction
strategies more often than not aim at reducing risk behaviour, primarily due to the possible harm which may be
incurred. As there are inherent difficulties with measuring harm, more often than not changes in risk behaviour are
used as an indication of the effectiveness of harm reduction strategies.   
have encountered conflict between drug prohibition policies and public health. By directly addressing
the most obvious linkage of injecting drug use and AIDS, syringe exchange programmes offer a way to
control new transmissions of HIV but they also provoke the wrath of the people who are committed to a
total abstinence and “Zero Tolerance” approach.
Syringe exchange programmes operate on the assumption that drug injectors share used equipment
because sterile injecting equipment is difficult to obtain (Stimson et al 1988; Ross et al 1994). For
example, it is likely that the non-availability of injecting equipment in Edinburgh was one of the key
factors which led to widespread needle sharing and the rapid spread of HIV infection in the 1980’s
(Pearson, 1991). Consequently, such programmes are designed to provide sterile injecting equipment to
drug users.  Used needles and syringes are returned for new ones and the supply of free and legal sterile
injecting equipment is constant. In principle, if non-sterile equipment is replaced with sterile equipment
it would be expected that the HIV incidence rates associated with shared needle use would decline, all
other things being equal (O’Hare et al 1992). 
The majority of syringe exchanges are not simply confined to the distribution of needles and syringes.
Most services also distribute other equipment to help ensure safer drug use; for example sterile water,
swabs and filters. As illustrated in the previous Chapter, Merchant’s Quay Health Promotion Unit is
also concerned with secondary health issues such as the prevention of infection and other health
problems related to poor injecting techniques. Poor injecting methods often lead to health problems
such as bruising, abscesses and thrombosis. To this end, advice is given on better injecting techniques,
better preparation procedures, and on the importance of utilising multiple injecting sites. In addition to
making sterile equipment available, many syringe exchanges also offer advice and information on safer
sex and condom use. Moreover, as programme staff`s contact with injecting drug users increases, the
goal is not only to establish trust and rapport but to facilitate safer drug use, and injecting practices and
also to facilitate entrance into drug treatment.
The public health argument for syringe exchanges is that the greater availability of needles and syringes
will result in a reduction in the spread of HIV and that it offsets any possible health/social costs in terms
of progression into injecting by novices, or the prolongation of injecting (Strang, 1990). As the
prevention of HIV infection among injecting drug users does not require that they completely stop
injecting drugs, syringe exchange schemes have generally been well accepted by drug injectors. This
has resulted in the vast majority of drug injectors in a given city reducing, although not necessarily
eliminating, their sharing of injecting equipment (Des Jarlais, 1992). Furthermore, syringe exchanges
attract users to agencies, and individuals who are in contact with drug services are more likely to be
amenable to health promotion than those who are not in contact (Paone et al, 1995). In short, contact
with services increases the opportunity for HIV/AIDS education and the prospect of reducing harmful
injecting procedures. However little is known about the extent of positive behaviour change that is a
direct result of such contact.
Although the aim of syringe exchange programmes is to increase the availability of injecting equipment,
two possible side effects of increased availability have been identified (Paone et al, 1995). Firstly, non-
compliance in terms of syringe exchanges could simply add to the pool of injecting equipment. If
syringes and needles are not returned to the exchanges, this in turn may lead to an increase in the
quantity of used injecting equipment in circulation. Secondly, increased availability may encourage
increased frequency of injecting. Consequently, the value of syringe exchanges are not universally
accepted and remain controversial. 
Nonetheless, syringe exchanges have been extensively documented, monitored and evaluated.
Moreover, there is a substantial body of research indicating that injecting drug users attending syringe
exchange programmes have changed their HIV risk behaviour. In the next section the key pieces of
research concerned with the effectiveness of syringe exchanges in reducing risk behaviour and in
producing other positive outcomes will be reviewed. It will be seen that although most research
worldwide supports the argument that syringe exchanges protect against HIV (and to a lesser extent
hepatitis) and help reduce risk behaviour, not all research studies concur (Elliott, 1998). This is due to a
combination of the methodological issues which must be considered when interpreting research results8
and individual programme differences. An important consideration when determining the effectiveness
of any syringe exchange is the programme structure and modus operandi. Thus a number of issues
including location, opening hours, attitudes towards clients and views on return rates will play an
important role in determining programme effectiveness (Hart, 1991).
                                                          
8 There are methodological difficulties inherent in evaluating social interventions such as syringe exchanges. These
constraints are examined in detail in Chapter Three.
2.3 REVIEW OF RESEARCH ON SYRINGE EXCHANGES
There is a large body of research indicating that syringe exchanges have succeeded in helping people to
make changes in their behaviour, in order to reduce their risk of HIV infection. Syringe exchanges
operate on a knowledge and means model of behaviour change, in that it is assumed that in order to
change behaviour people need to know the reasons why these changes are necessary and also need the
vehicle to make such changes (Homans and Aggleton, 1988). This approach presupposes that the
dynamics of everyday drug use are capable of modification and in turn that their success rests on small
behaviour changes in the everyday life of a drug user. This is primarily based on a model of health
intervention which is essentially individual centered, as opposed to dealing with groups or communities
of injecting drug users (Elliott, 1998).
As discussed previously the effectiveness of syringe exchanges in reducing the rates of HIV infection
has been very difficult to determine due to the methodological constraints. To this end the majority of
research concerned with evaluating syringe exchanges has concentrated on measuring the extent to
which they have succeeded in reducing HIV risk behaviour, as opposed to incidences of HIV infection.
This research will be reviewed below. However, some evidence has emerged to support the argument
that syringe exchanges have a protective effect against HIV. In Tacoma (USA) only 3 percent of
syringe exchange attendees were HIV positive compared with 8% of non-attendees (Hagan et al, 1993).
Lower rates of zero-conversion were also found among attendees of a London syringe exchange over a
one year period  (Hart et al, 1989). There is also some evidence supporting the ability of syringe
exchanges to control hepatitis (Buning, 1991). However, much of the evidence is anecdotal, and it is
possible that syringe exchanges may not have a significant impact on hepatitis infection. Rhodes et al
(1996) argues that this may be due to the relative efficiency of transmission of hepatitis compared with
HIV. Equally the widespread prevalence of hepatitis prior to the opening of syringe exchanges may
have had an impact (Elliott, 1998).
2.3.1 Evidence for Behaviour Change
Most injecting drug users are aware of the risks that are posed by continued injecting and needle sharing
and how to effectively protect themselves and others against infection (Magura et al, 1989). Hence, risk
behaviour cannot be attributed to ignorance about the consequences and this is so despite the fact that
few injecting drug users consider  themselves  at risk  of HIV infection (Stimson, et al 1988).
Nevertheless, the vast majority of studies have shown that injecting drug users have changed their
behaviour in order to reduce their chances of contracting HIV. For example, Stimson et al (1988)
reported on the HIV risk behaviour of clients interviewed during the first year of a needle exchange
programme in England. At the first interview 36% of the attendees at the exchange reported sharing
injecting equipment in the previous 4 weeks and only 7% of these attendees stated that they did not
clean the equipment. This rate of sharing is lower than the levels reported in most studies conducted
prior to the start of the syringe exchange schemes in the UK. For example, in a study of drug users
seeking treatment for the first time in London between 1984 and 1986, 59% of those who had injected
in the last 4 weeks reported having shared injecting equipment (Sheehan et al 1988). The evidence
points to attendees of syringe exchanges reducing levels of sharing.
Bath et al (1993) illustrated this by examining over a twelve year period, changes in injecting risk
behaviour of a group of injecting drug users. They found a reduction in the proportion of injectors using
needles and syringes that had been used previously. In 1992, one third of the sample group shared
injecting equipment, which was a considerable improvement on the 79% who had shared in 1980.
Hunter et al (1995) also found an overall reduction in sharing rates among injecting drug users in
London. This they argue, was no doubt partially due to the increase in the availability of injecting
equipment as a result of the growth in the number of syringe exchanges. However, Hunter et al (1995)
believe that it is also necessary to look beyond current interventions, in that, there is evidence to suggest
that a climate in which syringe sharing is no longer the norm is developing in the UK (Donoghoe, et al
1992; Burt and Stimson, 1993). Although it should be noted that within the UK there are important
regional differences in sharing rates, although this pattern may be limited to specific areas.
Some studies have shown a degree of risk reduction even in the absence of formal prevention
programmes (Des Jarlais, et al 1985). Such voluntary changes include personal marking of syringes;
being more selective about sharing partners, by for example sharing only with a sexual partner or close
friend; assessing the risk of sharing by considering the HIV antibody status of the prospective partner;
their appearance, or what is known of their drug using history; hiding syringes for use in an emergency;
and not sharing when blood is visible in the syringe (Burt and Simson, 1993). Based on the outlined
research there is evidence to suggest that syringe exchanges, by increasing the availability of sterile
injecting equipment have played an important role in reducing the overall incidences of sharing among
intravenous drug users. The next section will examine these changes in greater detail. 
2.3.2 Injecting Risk Behaviour
The primary aim of syringe exchanges is to reduce risky injecting behaviour. Consequently, the vast
majority of research on syringe exchanges have used a reduction  in risky  injecting practices as a
positive outcome. Keene et al (1993) carried out an evaluation of specialist (pharmacy-based) and
community based syringe exchanges in Wales. The evaluation covered both the  implementation of the
schemes and their impact on the behaviour of the clients. A comparison was made between syringe
exchange clients and drug users who did not attend an exchange. Although both attendees and non-
attendees were similar in terms of having shared syringes at some point in their history of drug
injecting, there were significant differences in recent HIV risk behaviour. Those attending the exchange
were less likely to have shared injecting equipment in the previous 12 months; only 20% of the
attendees compared to 53% of the non-attendees had done so. This difference was accentuated when
recent injecting behaviour was examined;  in the 4 weeks prior to interview, 41% of the non-attendees
had shared compared to only 9% of the attendees.
Frischer and Elliott’s (1993) study of Glasgow drug users revealed similar results. They concluded that
on the whole syringe exchange attendees manifested less risky injecting behaviour than non-attendees.
In short, attendees of syringe exchanges injected with and passed on used equipment less frequently
than non-attendees. Furthermore, syringe exchange attendees had a better knowledge of routes of HIV
infection, and made and maintained more harm reduction changes in their behaviour. However, despite
the reduction in injecting risk behaviour syringe exchange attendees were less likely to have received
treatment for drug use and reported fewer episodes of treatment than non-attendees. Hartgers et al
(1989) also reported some reduction in risk behaviour among attendees of syringe exchanges in
Amsterdam. According to their research only 17% of the 145 injecting drug users interviewed had used
borrowed needles in the month prior to interview, however 77% had lent needles to others during the
month. Hartgers et al concluded that subjects who used the syringe exchanges to get at least 90% of
their needles/syringes were significantly less likely to borrow used equipment than others but not less
likely to lend their injecting equipment.
There is however some evidence to suggest that syringe exchanges have not reduced the levels of
sharing among injecting drug users. Klee et al (1991) compared drug users who attended syringe
exchanges regularly with those who attended them rarely or not at all. The comparison revealed that the
former were significantly more likely to pass on their used injecting equipment to others. Fifty nine
percent of the syringe exchange attendees lent used injecting equipment compared with 42% of the non-
attendees in the two weeks prior to interview. The primary reason presented for passing on used
injecting equipment was pressure from non-attending friends. 
These findings were represented in Klee and Morris’s (1995a) study which assessed the contribution
that an increase in syringe availability made to injecting risk reduction. The data used came from three
studies conducted in the UK, between 1989 and 1993. However only the first study conducted in 1988
and 1989 (which comprised of the data originally presented in Klee et al’s 1991 study) revealed higher
levels of lending by syringe exchange attendees. Results from the second study conducted in 1990 and
1991 illustrated that regular attendees at a syringe exchange were significantly less likely to pass on
used equipment, and significantly less likely to borrow used injecting equipment. On the other hand, the
third study conducted in 1991 revealed no significant relationship between sharing and syringe
exchange attendance. These inconsistent findings lead Klee and Morris (1995a) to conclude that the
tendency to pass on needles and syringes to friends, revealed among regular attendees in the first study,
was as a consequence of demand outstripping supply. They stated that as a result of the large numbers
of injectors in the area the demand for equipment was high and this demand had not been met by the
relatively few syringe exchanges. This in turn resulted in the demand turning on those who attended the
exchanges, hence the high levels of lending by attendees. 
The literature reviewed above suggests that syringe exchanges have been effective in reducing injecting
risk behaviour among regular attendees. However, the influence of syringe exchanges upon the sharing
of injecting equipment is not simple and straightforward. It is likely to be affected by local conditions of
availability of equipment, the profile of injectors, educational strategies and the user-friendliness of
services (Friedman, et al 1992). Furthermore, HIV risk reduction among injecting drug users has proved
to be subject to peer influence (Magura et al 1989). For example, Friedman et al (1987) found that
among methadone maintained clients there was a strong association between subjects` reports that they
had attempted to reduce their drug related risk behaviour, and their reports that their friends had also
done so. On the other hand Donoghoe et al (1992) found that risk behaviour was associated with the
injecting of particular drugs; heroin, methadone and temazepam. Sharers were also less likely to be
receiving a prescription for methadone. Donoghoe et al concluded that other lifestyle factors which
were associated with syringe sharing were, living in unstable accommodation, living with other
injectors, being unemployed and recent involvement in crime.
Moreover, one cannot ignore the possibility that syringe exchange attendees are self-selecting, and have
lower rates of syringe sharing than other drug users. Some indication of self-selection was found in a
study that compared clients in contact with drug agencies against those not in contact. A study by Power
at al (1988) found that the proportion of non-agency clients (61%) located in the high risk category was
significantly higher than the corresponding proportion of agency clients. In other words, 65% of the
agency clients had substantially reduced their risk behaviour compared to 39% of the non-agency
group. Furthermore, only 24% of the agency group shared with people other than just their partners,
compared with 53% of the non-agency group. Nevertheless, the vast majority of research illustrates that
syringe exchanges reduce injecting risk behaviour. Because of the measurement difference in the
international research, it is difficult to estimate the specific level of risk reduction. However, the general
trend has been a reduction in risky injecting behaviour by 50%-80% (Paone, et al 1995). No study to
date has reported the total elimination of injecting risk behaviour.
2.3.3 Sexual Risk Behaviour
Although as outlined above there has been extensive research done on syringe exchanges and the
reduction of drug related risk behaviour, their impact on sexual risk behaviour has received less
attention. Many studies concur that changing sexual risk behaviour in drug injectors is more difficult
than changing injecting risk behaviour. Studies in the UK, the US and Amsterdam all reported higher
rate of risk reduction associated with equipment sharing and drug use than in sexual behaviour. Overall
the research carried out indicates that there has been little or no change in the reported condom use of
injecting drug users as a result of attending syringe exchanges. Hart (1989) believes that the emphasis
placed on needle and syringe sharing has led to the exclusion of other risk factors.
While it is often reported that drug users who take depressants (such as opiates) are less sexually active
than the norm, the WHO Collaborative Study Group (1993) found this not to be the case.  In terms of
reducing sexual risk behaviour, this study had ambiguous results. The WHO study of injecting drug
users in thirteen cities9, found that the majority of those who reported having a regular sexual partner
never used condoms. On the other hand, those who had sexual intercourse with casual partners were
more likely to use condoms. 
Rhodes et al (1994) examined the sexual risk behaviour of injecting drug users in London. They also
found that the majority of injecting drug users were sexually active. The levels of condom use were
very low, with two-thirds never using condoms with primary partners, and over a third never using
condoms with casual partners. Nonetheless, levels of condom use were highest among those engaging
in prostitution. The main concern emerging from Rhodes et al’s study is that those who reported having
sex most often were least  likely to report using  condoms. Moreover, a significant proportion of those
with non-injecting partners never used condoms, although they continue to share used injecting
equipment themselves.
In Frischer and Elliott’s (1993) study, approximately 30% of the syringe exchange attendees and non-
attendees reported having casual sexual partners. Only 16% used condoms every time they had sex with
their partner and 50% never used condoms. Although  it is worth  noting  that attendees reported greater
use of condoms with casual partners. In Keene et al’s (1993) study, non-attendees of syringe exchanges
were slightly more likely to be sexually active than attendees; 44% of the attendees and 61% of the non-
attendees reported ‘some’ condom use. Problems in question wording occurred, therefore the results
may not be accurate. Magura et al (1989) examined condom use among injecting drug users in the US.
Sixty eight percent of the sample did not use condoms in the previous month and only 11% used
condoms every time they had penetrative sex.  
                                                          
9 Athens, Bangkok, Berlin, Glasgow, London, Madrid, Naples, New York, Rome, Rio de Janeiro, Santos, Sydney
and Toronto.
McKeganey and Barnard’s (1990) in-depth study of injecting drug users in Glasgow found that
although the drug users were aware of the risks of HIV associated with the use of unsterile injecting
equipment, their understanding of the dynamics of sexual transmission were less clear. They found that
most of the injecting drug users interviewed interpreted the question relating to sexual transmission as
having to do with the risk of contracting the virus from their partners, rather than the risk that they
might themselves be the agent for transmitting the virus to their partner. It also became clear in
McKeganey and Barnard’s (1990) study that the majority of drug injectors interpreted sexual risk as
having to do with the issue of frequent partner change.
All of these results show high sexual risk taking among injecting drug users. This is particularly
important as there is evidence to suggest that the major route of HIV infection is shifting towards sexual
routes, as injecting drug users curtail their injecting risk taking behaviour but continue to have
unprotected sex (Schoenbaun et al 1989). There has been a great deal of promotion for condom use, as a
means of preventing HIV infection. However, for many the introduction of condom use into long-term
relationships causes problems. While there are difficulties in helping people change their sexual
behaviour, such changes are possible. Donoghoe (1992) points out that changing sexual behaviour
requires more than just the provision of condoms. More attention should be given to counselling, advice
about safer sex and based on McKeganey and Barnard’s (1990) study, increased awareness of the risks
of sexual transmission of HIV.
On the whole, the reviewed research illustrates that syringe exchanges are successful on a number of
measures. There is considerable evidence that those who attend syringe exchanges achieve and maintain
lower risk behaviour. They have also proved successful in reaching people who are not in contact with
conventional drug services (Stimson et al, 1991).
2.4 HARM REDUCTION: THE SITUATION IN IRELAND
Harm reduction practices, which aim to achieve ‘intermediate goals’ other than abstinence in drug
users, (O’Hare et al, 1992), are comparatively new in Ireland. The move from the traditional abstinence
orientated model of drug treatment to the more pragmatic harm reduction approach did not receive
official endorsement until the 1991 Government Strategy to Prevent Drug Misuse. To the author’s
knowledge there has been no published research on the effects of syringe exchanges on risk behaviour
in Ireland, since the implementation of the first exchange in 1989 (Butler, 1991). There has, however,
been a number of publications concerned specifically with the levels of risk behaviour among IV drug
users. For example, Williams et al (1990) investigated the extent of risk behaviour among drug users
known to be HIV positive, and measured the degree of positive change in this behaviour as a result of
being infected. They found a reduction in the number of drug users who reported sharing injecting
equipment, and also an increase in the numbers who reported using condoms. However, despite the
overall reduction in risk behaviour Williams et al discovered that 63% of those diagnosed as being HIV
positive had continued to share injecting equipment (although at a reduced level) and one-third of those
who remained sexually active did not use condoms. As all respondents in Williams et al’s study were
receiving methadone maintenance and the sample size was relatively small (n=69), it is not possible to
extrapolate on the basis of these findings.
Four Irish studies have been carried out which are concerned specifically with levels of risk behaviour
among attendees of syringe exchanges in Dublin. Firstly, Johnson et al (1994) measured the levels of
risk behaviour, and the prevalence of HIV infection among syringe exchange attendees (n=81). They
found high levels of both injecting and sexual risk behaviour among the syringe exchange attendees.
Although half of the respondents reported that they had not shared injecting equipment in the previous
28 days, a third had shared with multiple partners. As regards sexual risk behaviour, half of the
respondents reported that they had multiple sexual partners during the preceding year, and only a
quarter reported always using condoms. Johnson et al concluded that the high levels of unsafe injecting
and sexual activity indicates the need for more effective health promotion among drug users in Dublin. 
In a more recent study Dorman et al (1997) also illustrated high levels of risk behaviour among IV drug
users in Dublin. They found that over half of the participants (n=185) reported sharing injecting
equipment in the previous 6 months, and 62% reported lending others their used injecting equipment
within the same time period. Although the vast majority of respondents reported cleaning their injecting
equipment, less than half did so effectively. Levels of sexual risk behaviour were particularly high, with 
50% of the  male  respondents and 63% of the females  never using  condoms with their regular
partners. Moreover, one-third of the males never used condoms with their casual partners. 
In a third study Cassin et al (1998) compared the injecting and sexual risk behaviour of young injectors
with injectors over the age of 25. All respondents were first time presenters at the Health Promotion
Unit in the Merchant’s Quay Project between May 1st 1997 and February 28th 1998 (n=770)10. Analysis
revealed that young injectors were significantly more likely to report recent lending and borrowing of
used injecting equipment and the sharing of injecting paraphernalia. Young injectors were however
significantly more likely to report condom use. The authors suggest that the high levels of risk
behaviour among young recent injectors may be due to a lack of emphasis on harm reduction strategies
in recent years. Finally, Cox et al (1999) examined gender differences in first time attendees at the same
syringe exchange (n=934). They found no significant gender difference in the reported sharing (either
lending or borrowing) of injecting equipment or in condom use. However, the female clients were
significantly more likely to report recently sharing injecting paraphernalia, and sharing injecting
equipment with their sexual partner. This study highlighted the greater personal involvement of women
with other drug users and its impact in terms of depriving them of protective factors and exposing them
to high risk factors.
Unfortunately as Dorman et al (1997) point out it is not possible to compare the risk behaviour rates in
the aforementioned studies, as the time periods over which risk behaviour was measured were different.
Nonetheless, all the research is very informative in indicating levels of risk behaviour in injecting drug
users in Dublin. Another source of information on risk behaviour of drug users in Ireland, is the Health
Research Board’s publications which present data related to ‘problem drug users who present for
treatment’ in Ireland in 1995 (O’Higgins and Duff, 1997) and 1996 (Moran et al, 1997).  Although
there is a lot of valuable data contained in these reports, they do not provide any insight into the impact
of syringe-exchanges (or any other intervention) on changing drug users behaviour.
2.5 SUMMARY
The provision of sterile injecting equipment is an important part of any strategy which aims to reduce
risky drug use and HIV and Hepatitis transmission among injecting drug users. However increased
access to sterile syringes has been the subject of much debate. Notwithstanding, there is no evidence to
suggest that syringe exchanges increase either the amount or frequency of drug use, among attending
clients. Furthermore, none of the studies conducted to date have found that the increased availability of
injecting equipment as a consequence of syringe exchanges is associated with encouraging people to
begin injecting. As illustrated in this chapter, international research has highlighted the benefits of
syringe exchanges to attending drug injectors. It has been shown that syringe exchanges have proved
successful in a number of measures.  In short, they have proven to be effective in;
½ Reaching drug users who are not in contact with conventional drug services;
½ Delivering a basic service - distributing sterile syringes and collecting used injecting
equipment;
½ Improving access to sterile injecting equipment;
½ Reducing the risk of contracting infectious diseases in particular HIV;
½ Reducing levels of injecting risk behaviour;
½ Reducing levels of sharing (lending and borrowing) of injecting equipment and;
½ Accessing additional treatment services.
However there are limits to what syringe exchanges have achieved. The research indicates that they
have failed to reach younger injectors, newer injectors and women (McKeganey and Bernard, 1990).
Therefore, although sharing rates have reduced, and self-reported risk behaviour is lower than
                                                          
10 The data utilised in Cassin et al (1998) was collected in the first eight months of the evaluation of the Merchant’s
Quay Health Promotion Unit. The data collected from the 770 clients over this time period is included in the
analysis presented in this Report. 
previously, a substantial number of injecting drug users continue to share injecting equipment. There
may be multiple reasons associated with this continued level of risk behaviour. Firstly, the relationship
between syringe distribution and obstacles to risk reduction. The provision of clean injecting equipment
does not necessarily ensure that all sharing will cease. For example, studies have hypothesised that
injecting drug users whose lives are unstable because they are homeless, have greater difficulty
initiating and maintaining the desired behaviour change (Paone, et al 1995). Consequently, among
injecting drug users attending syringe exchanges, there are certain subgroups who may require services
beyond syringe exchanges (Hagan et al, 1993) i.e. those with psychiatric complaints and those who are
homeless.  Secondly there is the question of resources available to syringe exchanges, and the potential
demand for the service. In other words we must ask how adequate is the current distribution of
syringes? As the time and place of injecting are factors which have been proven to influence sharing
(Ross et al, 1994) wider and more accessible distribution of equipment is required. Finally, the staffing
and financial resources needed to meet this type of service may not be easily attainable. 
Syringe exchanges have not proved as successful in making an impact on sexual risk behaviour. Some
have argued that this is primarily due to the fact that such schemes tend to focus mainly on injecting risk
behaviour, with less emphasis on sexual behaviour, other than the provision of condoms. McKeganey
and Barnard, (1991) argue that greater success in promoting the widespread use of condoms might be
possible, if they were more clearly disassociated from’ promiscuity’. However, prior to any global
promotion of condom use, an awareness of the risks of sexual transmission needs to be developed.  
CHAPTER 3
RESEARCH 
METHODOLOGY
Appropriate research design and data collection are intrinsic to the research process. This chapter
outlines the research methods that were employed to achieve the objectives of the study. The first
section delineates the problems with the international research that has been carried out in the area. The
second section describes the research design employed in undertaking the evaluation of the Health
Promotion Unit. The different stages of development of the research instruments are summarised.
Thereafter, the final versions of the instruments are presented, and the limitations of the study are
outlined.
3.1 PROBLEMS WITH INTERNATIONAL RESEARCH
As illustrated in the previous chapter there has been a vast amount of research carried out on the
effectiveness of syringe exchanges. However, it is worth noting at this stage that there are important
methodological issues which must be considered when interpreting the results of this international
research. Methodological and moral constraints prevent the use of randomised controlled studies in this
area of research, and, as a result researchers use a wide variety of study designs (Elliott, 1998). As
illustrated in the previous chapter many studies have made comparisons between syringe exchange
attendees and non-attendees, sampled from drug services. These groups are used in either a snapshot or
in serial longitudinal comparisons, and in some instances followed up as cohorts over time. Conversely,
other studies have used no comparison groups, taking samples only from syringe exchanges. These are
used in either single cross-sectional or follow-up studies. Other researchers have used epidemiological
data to monitor the impact of syringe exchanges. For example, attempting to estimate the prevalence of
drug injecting in various drug using populations prior to and after the introduction of an exchange. The
problem with using any non-randomised research design is that arguments regarding the impact of
syringe exchanges rest on grounds of association rather than cause and effect. Regardless, as illustrated
in some detail, the large majority of studies in the field lend support to the idea that syringe exchanges
have worked. However, not all research studies in the field concur, and this is in part due to the
aforementioned methodological differences.
Apart from the methodological constraints, another problem with the international research reviewed in
the previous chapter is that most of the research on syringe exchanges has been conducted in the UK,
Australia and Amsterdam. This raises issues around the applicability of the findings to the Irish context,
where there are cultural, ideological, treatment and operational differences. Moreover, most of the
research has focused specifically on syringe exchanges as opposed to Health Promotion Units.
However, due to the lack of Irish research in the area and the very limited local evaluation data
available to date, the international research reviewed provides some valuable guidelines on empirically
derived approaches to evaluating syringe exchanges. This existing information is therefore useful
particularly in the process of formulating approaches to the evaluation of the Merchant’s Quay Project’s
Health Promotion Unit. Nonetheless, caution must be employed in interpreting such information.
3.2 RESEARCH METHOD
To reiterate, the aim of the study is to develop an on-going evaluation form that can be administered to
all new clients presenting at the Merchant’s Quay Health Promotion Unit. The research instruments are
intended to measure the impact of availability and access to the Health Promotion Unit in terms of client
outcomes. For the purpose of this research an outcome is defined as a change in the clients behaviour
over time (Burns, 1994:5). In designing the research instruments an appropriate balance had to be struck
between drafting an instrument which would be acceptable to clients in terms of content, clarity and
ease of completion, and designing a measure which would be sufficiently sensitive and comprehensive
to provide the required outcome information. At the same time, the research instruments needed to be
easy for the workers in the Health Promotion Unit to administer and not too time consuming, so as not
to detract from their work with the clients. Moreover, flexibility was required to account for the wide
range of client groups.
For the purpose of evaluating the Merchant’s Quay Health Promotion Unit, it was decided to employ a
before and after research design whereby all clients are interviewed by means of a highly structured
questionnaire at the point of intake or as soon as possible thereafter11 . The clients are asked for the
same pieces of core information, in the same way, at different points in time - in this instance three
months after the point of first contact, the results are then compared. 
Measuring changes in an individual’s behaviour is however fraught with difficulties. Any such change
is a result of the interaction of three factors: the person, the environment and the intervention. At least in
theory for a change to be due entirely to a particular intervention or treatment, all other variables to do
with the person and his/her environment would have to remain constant. This is never the case in the
real world.  Family and personal relationships have their ups and downs, as do many other factors in an
individual’s life, all of which in theory could contribute to a change, or outcome, over time.
Nevertheless it is possible to set up a basic evaluation system of the Health Promotion Unit without
dwelling too deeply on the issue of attributing outcomes. If the Health Promotion Unit is consistently
recording positive outcomes using the Intervention Sheets, it would be fair to assume that the Unit is
                                                          
11 From the onset, while the importance of evaluating the Health Promotion Unit was recognised by all Project staff,
it was secondary to ensuring the smooth running of the Unit. The provision of a quality service to all clients was of
the utmost importance. Although the Intervention Sheets are intrinsic to ensuring quality, it was inevitable that on
certain occasions effective management of the Unit would require that completing the questionnaires did not take
priority.
having a positive impact on client’s behaviour. The strengths and weaknesses of the before and after
research design employed to evaluate the Health Promotion Unit is examined in detail later in the
chapter. 
At the start of the evaluation, a review of the relevant literature was undertaken, and existing
instruments for the measurement of the effectiveness of syringe exchanges were examined. Previous
syringe exchange evaluation reports were also examined (Haydon and Stimson, 1994; Russell, 1991).
Since the international research reviewed has shown that syringe exchanges are associated with a range
of different outcomes, and the objectives of the Health Promotion Unit, as perceived by the staff are
multiple, the instruments had to be multi-dimensional in nature. Informal interviews and discussions
took place with the Health Promotion Team and other relevant staff members.  The outcome domains
identified were:
Table 3.1 Outcome Domains
• Drug use - including prescribed drugs and alcohol;
• Injecting Risk Behaviour;
• Sexual Risk Behaviour;
• Health and Well-being.
A potential list of items for each domain was drawn up. After discussions with the Health Promotion
Team the items to be included in the draft version of the research instrument were agreed upon. This
included some questions that were similar to instruments of known reliability and validity; such as the
Opium Treatment Index (Drake et al, 1991a) and some new items were developed specifically for the
Health Promotion Intervention Sheet.
3.3 PILOT STUDY
The first version of the questionnaire was piloted on 70 clients, with each member of the Health
Promotion Team administering a number of questionnaires. Clients were asked how they felt about
filling in the questionnaire, and their views on the content. Discussions were held with the Team around
the client’s feed back, and issues that arose during the administration of the Intervention Sheets. At this
stage questions which were poorly answered, or reported as being inappropriate were disregarded.
Some questions required varying degrees of modification. Those questions, which were answered well,
showed an even range of responses and, were not reported as causing any problems were left on the
Intervention Sheet. Some new items, which were agreed upon by the team were also added.
The main problem reported by the Health Promotion Team at this stage was the length of time it took to
complete the ‘First Visit Intervention Sheet’ with new clients. Filling in the questionnaire itself did not
take too long, however, the resulting issues that were brought up then had to be addressed by the
workers, which proved very time consuming. Consequently, first visits using the questionnaire took
between 20-30 minutes. While the team were not opposed to spending this time with the new clients, it
did however lead to increasing pressure in the reception areas, which was in turn passed on to the
Health Promotion Team. Nonetheless, at this stage it was decided not to shorten the questionnaire,
rather to wait and review the situation periodically.
The second pilot study was designed to run for six months. It was intended to test both the revised
version of the ‘First Visit Intervention Sheet’ and the ‘3 Month Follow-up Intervention Sheet’. The aim
of this pilot study was to test the viability of the new intervention sheets over time. For the purpose of
this pilot study the ‘Follow-up Intervention Sheets’ were administered three months after a client’s first
visit. At the end of the second pilot study no significant changes were made to either the First Visit, or
Follow-up Intervention Sheets12 .
3.4 RESEARCH INSTRUMENTS
In this section the final version of the Health Promotion Unit’s ‘Intervention Sheet’ is examined.
Three Demographic Characteristics were included: gender, age and postal code. 
International research suggests that syringe exchange programmes appeal primarily to drug users not in
contact with drug treatment services (Paone et al, 1995). However, there is evidence suggesting that as
a point of first contact, exchanges act as an effective source of referral into treatment (Stimson et al,
1991). A number of Treatment Measures were included in the Intervention Sheet primarily to examine
changes over time in clients self-reported contact with such services. To this end, clients are asked
whether they are currently using any other drug service and if so where. Another question concerned
with treatment was whether clients had previously undergone a detoxification, and if so how many.
Workers specified on the questionnaire whether the detoxification was supervised, or whether the
clients had self-detoxified. Clients were also asked whether they had ever stopped using drugs before
(for any period of time). Those who answered yes, were asked how long they were drug free, and what
they considered the primary reason for reusing drugs.
Although the treatment measures outlined above proved effective in highlighting whether first visit
clients were currently in contact with other services, in many instances one was only able to surmise as
to whether clients had previous treatment contacts. In order to address this notable omission, an
additional question was included; whether the client had ever had any previous contact with a drug
service. When appropriate the name and nature of the contact was also recorded. This permitted a more
accurate identification of first treatment contacts.
The Outcome Domains and the measures included within them are described below.
3.4.1 Drug Use
One of the aims of the Health Promotion Unit is to help people employ safer drug using practices. This
includes encouraging clients to use safer combinations of drugs and changing routes of administration;
it is not simply encouraging clients to reduce their drug use. Consequently, a method of estimating
recent drug(s)’ consumption was required. Despite the inherent problems of trying to gain estimates of
the frequency and type of drug use in face-to-face interviews, it was considered important to include
both measures. Clients were therefore asked to report on the frequency and route of administration of
their primary and secondary drug(s) over the 4 weeks prior to contact with the Health Promotion Unit.
Included in this were the use of prescribed drugs and alcohol.
A second measure included in this domain was how long the client had been injecting. Des Jarlais
(1992) and Paone et al, (1995) maintains that syringe-exchange programmes appeal primarily to people
with long histories of drug injecting and less to new injectors and young injectors. However, the Health
Promotion Unit would ideally aim to attract clients as soon as possible after initiating IV drug use, in
order to minimise risky drug using behaviour. Clients were also asked at what age they first initiated
intravenous drug use. This provided a method of validating the length of clients’ injecting careers. 
Clients were asked at what age they ‘first used drugs’. This was a relatively subjective measure as it was
left up to the clients to interpret the term ‘drug’, however it was stated that tobacco and alcohol were not
to be included. Other legal substances were however stated by clients and  included in the coding
system, such as cough bottle and solvents. The final two measures included in this domain were
whether clients smoked before they injected, and if so for how long were they smoking.
                                                          
12 The Intervention Sheet was reviewed again at a later date, and a number of modifications were made to it. This
primarily consisted of the inclusion of a number of variables previously omitted. The research instruments
employed in the Health Promotion Unit at the time of writing this report included these modifications. Where
appropriate, attention will be drawn to these recent changes. As a result of the inclusion of these additional
variables in May 1998, there will be some missing information in the data chapter. 
3.4.2 HIV Risk Behaviour
An accepted goal of the Health Promotion Unit is to minimise the transmission of HIV, Hepatitis B and
C and other sexually transmitted diseases, by reducing risk behaviour. Consequently, it was very
important to have baseline information on the risk behaviour of clients at the point of first contact with
the Health Promotion Unit, in order to enable a comparison at the follow-up stage. In the First Visit
Intervention Sheet there are two sections concerned with HIV risk behavior, one which deals with
injecting risk practices, and a second which deals with sexual risk behaviour.
Injecting practices are dealt with in some detail. Clients were asked about the frequency of use of both
needles and syringes and when pertinent how they cleaned their injecting equipment. There was a
general question on whether clients ever shared their injecting equipment, and more specifically
whether they had shared in the four weeks prior to contact with the Health Promotion Unit. Moreover, a
distinction was made between the recent lending and borrowing of used injecting equipment. This was
included primarily because the lending and borrowing of injecting equipment differs markedly in terms
of levels of personal risk, and risk of future transmission of HIV (McKeganey et al, 1988). 
There was also a separate question concerned with whether clients had ever shared injecting equipment
with their sexual partners. This question was included because members of the Health Promotion Team
had observed that many drug users do not consider the sharing of injecting equipment with their
partners as sharing per se. Consequently, it was felt that there was a need to remind clients of the
potential risks involved in such activities. The final question in this section is concerned with the
sharing of spoons and filters. It is important for the prevention of HIV and Hepatitis B and C that the
sharing of injecting paraphernalia be perceived by drug users as potentially risky (Hunter, et al 1995).
Moreover, the Health Promotion Unit must provide information on the possible HIV risks associated
with the sharing of such paraphernalia. Apart from sharing behaviour, clients were asked in some detail
about their injecting practices, this included details about injecting sites, and the preparation of the site
for injecting.
With regard to sexual risk behaviour, in earlier drafts of the questionnaire clients were asked the
number of sexual partners they had in the past year. This was considered very intrusive and the response
rate was low, consequently this question was omitted. In its place clients were asked whether they were
sexually active, and if so whether they had more than one sexual partner in the last three months.
Clients were also asked whether they had a regular sexual partner, and if so whether their partner was
an injecting drug user. Thereafter clients were asked the frequency of condom use. As illustrated in the
previous chapter, the international research on syringe exchanges, shows that few have had a positive
impact on sexual risk behaviour, in terms of increasing condom use among attendees (Donoghoe,
1992).
3.4.3 Health and Well Being
Given the well known medical problems associated with drug use and the fact that the primary aim of
the Health Promotion Unit is to maintain or improve the health and well-being and subsequent quality
of life13 of the clients, it was vital to have a number of measures in this domain. Moreover,
epidemiologists, clinicians, and researchers are well aware that for any medical and quasi medical
intervention, quality of life must in some way be measured. Increasingly within such interventions
individuals are being asked to report their own health status in a way that can be analysed quantitatively
(Jenkinson, 1994). In the Health Promotion Unit a health assessment was considered to have an
important clinical and research role both in order to ascertain the initial health status of the client (and
areas of concern) and to measure the impact of the service on the client’s health and well being.
Clearly in evaluating the Health Promotion Unit the health status of the client is an important variable.
A subjective health assessment was therefore incorporated into the Intervention Sheet which asked
respondents to report on their own physical and mental health. The aim was to provide a quick, and
effective measure of global health. Drake et al (1991b) developed a scale for estimating the health status
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(Albrecht, 1994).
of drug users, the Opium Treatment Index (OTI). The main problem with incorporating the OTI into
the evaluation of the Health Promotion Unit was that it is a very lengthy questionnaire. While the
benefits of the instrument are its known reliability and validity, in the end it was decided to employ a
similar symptom check-list to measure clients’ health and well-being, including some variables in the
OTI. Many of the illnesses included in the general health question, such as abscesses, septicemia and
overdoses are caused by drug use and indicative of unsafe injecting and drug using techniques. A global
measure of mental and physical health was also included - by employing a global rating scale. This
rating scale requires respondents to describe their state of health (physical and mental) through
answering just one question, for example “Would you describe your physical health as very good, good,
fair, poor or very poor”. There is evidence supporting the value of such uncomplicated global ratings in
terms of their simplicity and clarity (Ziebland, 1994).
In the Intervention Sheet there are also two questions concerned with Hepatitis. The first question is
whether the client has ever had hepatitis B, hepatitis C or jaundice. It was decided to include jaundice in
this section, as clients may be unaware of their hepatitis status, and whether they have had jaundice may
indicate hepatitis B or C. Clients were also asked whether they ever had a vaccination against hepatitis
B. Regarding HIV, clients were asked whether they ever had a HIV test, and if so the date of their last
test. The Health Promotion Team decided that it was inappropriate to ask clients their HIV status,
however some members of the team felt that it was important if such information is volunteered by a
client that it be recorded, for follow-up purposes. Consequently, space was provided for this
information to be recorded, and this is only done when the client consents.
The definition of health employed by the World Health Organisation “… is a state of complete physical,
mental and social well being and not merely the absence of disease or infirmity” (cited in Albrecht,
1994:13) highlights the importance of including social, cultural, subjective and social-psychological
variables that impact on independent living and perceived well-being in any measurement of health. In
order to strike a balance between designing a concise questionnaire and obtaining the detailed
information required to measure health, only those variables considered essential in determining the
social stability of clients were included. The variables included in this domain are employment status,
whether the client had any children and relevant details including care arrangements. Clients are also
asked whether they have ever been to prison, and their current legal status is ascertained. Finally, the
housing situation of the client is assessed.
3.4.4 Three Month Follow-up Intervention Sheet 
In order to measure any change in clients’ behaviour, a follow-up research instrument is required.  For
the purpose of this evaluation, it was decided that the Follow-Up Intervention Sheet was to be
completed three months after first contact with the Health Promotion Unit (or as soon as possible
thereafter). The follow-up questionnaire is largely the same as the first visit questionnaire outlined
above. In short, two methods were employed to measure changes in clients’ drug use, injecting and
sexual risk behaviour and health and well being, firstly by comparing clients’ self reported baseline
behaviour at the point of first contact, with their behaviour at follow-up.  Secondly, a more subjective
method was employed, whereby clients were asked whether they believed that their behaviour had
changed in any way since attending the Unit, and if so how.  It was felt that the use of these two
methods would allow for a more accurate measure of behaviour change.
3.5 LIMITATIONS OF THE STUDY
Demonstrating the impact of the Health Promotion Unit means that two key questions must be
answered. Firstly, is the intervention achieving its intended objectives? Secondly, can alternative
processes not associated with the service itself better explain the results of the evaluation? In other
words, there is a need to rule out rival interpretations and show, as Rossi and Freeman (1985) put it “in
a persuasive way that the changes are a function of the intervention and cannot be accounted for in
other ways”. For example, occasionally the changes in behaviour that occur may be so large that it is
improbable that they could have been caused by other factors. This is unlikely to happen with people
who inject drugs, where we would expect small changes in behaviour. In most cases however there will
be various extraneous factors operating at the same time as the intervention, which will have an impact
on behaviour change. Moreover, a wide variety of interventions will be operating in any given city, and
it will rarely be possible to identify the exact contribution of any one of them.  
Ideally, establishing the impact of such an intervention requires the selection of a control that represents
the condition that would have been obtained without the intervention. In short a rigorous evaluation of
the Merchant’s Quay Health Promotion Unit would require comparing large groups of injecting drug
users attending the Unit with a control group of non-attendees. As this approach was not possible14 the
evaluation employed a quasi-experimental design. This involved a before and after research method
with clients as their own reflexive control. The simplest form of a before and after design is indicated by
its name: a set of base-line measures are taken of a group of clients, who then experience the
intervention, and are then measured once more, or perhaps several times thereafter. The difference
between the post-test and pre-test results is said to be the ‘effect’ of the intervention, although this is
misleading. As respondents act as their own controls they provide the ‘all other things being equal’
conditions that enable the isolation of the effects of the intervention on clients so that valid causal
conclusions can be drawn. However, there are well documented weaknesses to employing such a
research design (Oppenheim, 1998: Elliott, 1998) and it is not feasible to attribute all the before–and–
after differences to the effects of the intervention. It is always possible that some changes in the
expected direction may have taken place even without the impact of the intervention. Moreover, there
are problems of sample bias, in that needle exchange attendees could be a self-selecting low risk or even
high-risk group (Elliott, 1998).
So at best, any differences in the behaviour of attendees before and after experiencing the intervention
can only be interpreted as possible indicators of syringe exchange performance and not directly caused
by the intervention. As Wodak (1995) points out
“…attributing benefit to any single intervention is impossible when multiple strategies
have been implemented at about the same time. The intensity of implementation is
difficult if not impossible to measure and the effect of the interventions is in all likelihood
synergistic. In a categorical sense, the methodological problems cannot be resolved
without a controlled trial of communities randomly allocated to a single intervention or
no intervention. The ethical, logistic, financial and public health problems of attempting
such a study are such that there is no alternative, especially in the urgency of the
epidemic, to making a judgment on the grounds of plausibility, feasibility, cost and
international experience. At issue is whether authorities in a particular country prefer to
be roughly right or precisely wrong..” (Wodak,1995).
Information collected for the purpose of the evaluation of the Health Promotion Unit was based on
clients’ self-reported risk behaviour. There is however a number of shortcomings associated with the
accuracy of self reported survey data. Inaccurate reports may either be false positive or false negative
(Skog, 1992). False positives occur when, for example, an individual erroneously claims to have used a
particular drug, either due to a misunderstanding of the question or by consciously lying. False
negatives on the other hand occur when respondents who have in fact used the drug in question state
that they have not done so. In short, it is possible that drug users may provide inaccurate information
about their past and current behaviours (Samuels et al, 1992). On the one hand, the respondents may be
unable to recall past behaviour. Patterns of drug use and sexual practices are complex and undergo
changes over time; consequently it may be very difficult for respondents to recall their behaviour
accurately (Bradburn et al, 1987). Conversely, the respondents may be able to remember their
behaviour but be unwilling to reveal sexual and drug using practices that may be stigmatized and even
illegal (Siegel and Bauman, 1986). Be it deliberate or unintentional, invalid self-reported information
about sensitive behaviour such as drug using practices and sexual behaviour can bias results.
Notwithstanding these concerns a variety of approaches have shown that intravenous drug users often
provide reasonably accurate self-reports of drug use (McElrath, et al 1994) and sexual behaviour (Kleyn
et al, 1993; Rhodes et al, 1996). However, the research suggests that the time frame should be kept as
short as possible so as to minimize recall bias. Consequently, in the questionnaires employed by the
Health Promotion Unit, respondents were asked to recall information primarily from two retrospective
                                                          
14 There are enormous difficulties in obtaining two identical groups, an experimental group and a control group, for
any matched-sample before-and-after research design (Oppenheim, 1998). In this instance these difficulties were
compounded by the fact that the individuals in question were drug users, and as such members of a ‘hard to reach’
population. Moreover, the time and finances necessary to secure the identification of a control group were not
available. 
periods: behaviour over the previous four weeks and over the previous three months (Bradburn et al,
1987). Some effort was also made to validate clients self reported drug use by comparing self-reports
with physical evidence of injecting.
Another drawback of employing the before and after research methodology is that it is difficult to
determine what can be considered a successful follow-up rate.  In general, a 1 in 4 rate of return at
follow-up would be a relatively optimistic estimate (Burns, 1994).  However the large numbers of
clients attending the Merchant’s Quay Health Promotion Unit on any given day, makes it extremely
difficult to estimate what percentage of clients present only once.  If it turns out that once off attendance
is common, it would inevitably effect the follow-up rates.  However, anecdotal evidence from the
Health Promotion Team suggested that it could be expected that at least 20% of the new clients would
attend on a regular basis. Despite the weaknesses of the before and after research design, this
methodology is considered appropriate, and it has been used in the evaluation of UK syringe exchanges
and proved very effective (Stimson et al, 1988).
3.6 DATA ANALYSIS
The data collected from the intervention sheets were entered into SPSS/PC. Two separate databases
were created, one for the First Visit Intervention Sheets, and the second for the Three Month Follow-up
Intervention Sheets. At the initial stage analysis was conducted on each database separately. However,
in order to compare clients’ behaviour change over time, a new database was formed, which consists of
the baseline and follow-up data of the 370 clients who represented for the three month follow-up.
Categorical variables were analysed using chi-square analysis to test differences between groups. As
will become apparent in Chapter Four the data are not normally distributed, consequently non-
parametric tests are employed when analysing continuous variables, such as age and length of time
injecting.  In order to examine differences in self reported behaviour for such continuous variables,
Mann Whitney Tests were employed to compare groups. Finally in Chapter Five when behavioiur
change is examined, variables were transformed into dichotomous variables when possible, and
McNemar Tests were employed to examine the behaviour change. As non-parametric tests are less
powerful than parametric tests, in the sense that the result is less likely to be statistically significant
when there is a relationship between two variables (Cramer, 1998) a 0.05 level of significance was
employed for the McNemar Tests.
3.7 SUMMARY
It has been illustrated in this chapter that in undertaking the evaluation of the Health Promotion Unit a
research instrument had to be designed which not only measured the changes in clients behaviour over
time, but which was compatible with, and caused the minimal interference to, the day to day working of
the Unit. It was decided that the only reliable way to actually measure an outcome or change among
clients attending the Unit, was to ask them the same core questions, in the same way, at different points
in time and compare results.  The core questions were concerned with the following; substance using,
risk behaviour, social circumstances, and health and wellbeing.  The research instrument was designed
to be completed by clients at first attendance, and then at 3 monthly intervals. Although there are
limitations to the methodology employed, it was considered to be the most appropriate and effective
method of measuring the changes in attending clients over time.
CHAPTER 4
PROFILE OF FIRST
VISIT CLIENTS
This chapter presents an analysis of baseline data collected from all clients at first-visit to the Health
Promotion Unit between May 1st 1997 to October 31st 1998. The data presents the total population of
new clients attending the Unit within this specified time period (n=1337). The data herein provides
comprehensive information on clients’ socio-demographic details including gender, age, and home
circumstances. Thereafter, data on each of the outcome domains; drug use, injecting risk behaviour,
sexual risk behaviour, and health and well-being will be conveyed. All percentages are based on valid
responses adjusted for missing data. Missing data includes information not collected by staff at the
Health Promotion Unit and non-responses by clients. It should however be noted that all clients agreed,
at least in part, to complete the questionnaires.
4.1 SOCIO-DEMOGRAPHIC DETAILS
This section presents demographic information on the first visit clients attending the Health Promotion
Unit. International research (Pearson, 1991) and to a certain extent national studies (O’Higgins 1998;
Cullen, 1997) illustrate that drug use, and in particular injecting drug use is not distributed randomly
across the population. The intention of this section is to provide some insight into the characteristics of
the injecting drug using population in Dublin. Throughout this Chapter, gender and age are considered
important variables. Consequently, when relevant, gender and age differences are presented.
4.1.1 Gender
Figure 4.1 illustrates that 23% of first visit clients were female (n=313). In Ireland data collected by the
Health Research Board for the Greater Dublin Area illustrates that 22% of the total treatment contacts in
1995 were female (O’Higgins and Duff, 1997) this increased slightly to 28% in 1996 (Moran et al,
1997). The problem with these figures is firstly that they represent non-opiate and opiate users.
Secondly they are based on drug users who actually present for treatment and it is generally recognised
that only a small proportion of drug users (Hartnoll et al, 1985) and in particular female drug users
(Anglin et al, 1987; Paone et al, 1995) are in contact with drug treatment services. Comiskey (1998) has
however attempted to estimate the prevalence of opiate use in Dublin. The estimated total number of
opiate users was put at 13,460 and the ratio of male to female opiate users was estimated to be 3:1. The
gender difference of first time attendees at the Health Promotion Unit is the same. This indicates that the
Health Promotion Unit is successful in attracting new female drug users (Cox et al, 1999).
Figure 4.1 Gender of Clients
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4.1.2  Age
Figure 4.2 graphically illustrates the age distribution of first visit clients attending the Health Promotion
Unit. The age range of new clients at the Unit is 14 to 52 years. The mean age of first visit clients is 24
years, and the mode is 18 years. 
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There were notable gender differences in the age of first visit clients at the Health Promotion Unit.
Analysis revealed female clients were significantly younger than their male counterparts (z = -5.98,
p<0.001). The mean age of male clients was 24.3 years old (median =23, range = 14-52), conversely female
clients were on average 22.2 years old (median=21, range =15-42). Figure 4.3 illustrates the gender
differences in the age of first visit clients. Moreover, it highlights the fact that female presenters are
proportionately more likely to be teenagers than their male counterparts. Conversely, male clients are
proportionately more likely to be over the age of 25 years.
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Figure 4.3 Age of First Visit Clients by Gender
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4.1.3 Area of Residence
Table 4.1 shows the area of residence of the new presenters at the Health Promotion Unit. It is
immediately apparent that the vast majority of clients (84%) attending the Unit are from the Greater
Dublin Area. These results are support other Irish data which illustrate that intravenous drug use is
primarily an urban problem, more specifically a Dublin phenomenon (O’Higgins, 1998; Moran, et al,
1997). At the same time however, one would expect the majority of attendees to be from the locality.
Table 4.1 Area of Residence
Area First Visit Clients
n
First Visit Clients
%
North Inner City (D1 & D7) 215 16
South Inner City (D2 & D8) 195 15
Remaining North Dublin 270 20
Remaining South Dublin 438 33
Remaining Counties 117 9
N. Ireland & U.K. 7 1
No Fixed Abode 87 6
Total 1329 100
*Missing Observations = 8
As illustrated in Table 4.1 this proved to be the case, in that the largest proportion of new clients
presenting at the Health Promotion Unit is from Dublin 8 (0.13) and Dublin 7 (0.9). These communities,
which are in the immediate vicinity of the Merchant’s Quay Project, are also disproportionately affected
by drug use. It is also worth noting that the vast majority of clients who reported having ‘no fixed
abode’ were staying in some form of emergency accommodation or sleeping rough in Dublin. 
4.1.4 Home Circumstances
Figure 4.4 illustrates the current accommodation of first visit clients (n=1325). Just under half of the first
visit clients reported living in their family home (n=645). There was no significant gender difference in
the percentage of male (50%) and female (43%) clients who reported this. 
Figure 4.4 Accommodation Type
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A significant minority of first visit clients reported being homeless15 . However, the percentage of
clients who reported being homeless when asked about their current accommodation (19%) does not
correspond with the percentage of clients who reported having no fixed abode (6%) as illustrated in
Table 4.1. This is primarily due to the fact that clients who reported staying in emergency
accommodation or staying with friends more often than not gave the postal code of this accommodation
as their area of residence. In short, it was rough sleepers who were most likely to report having no fixed
abode.
Of those clients who were considered homeless on the basis of their current accommodation, Figure 4.4
illustrates that 7% reported living in emergency accommodation (n=90) the majority of whom were
staying in hostels (n=83) and only a few in B&B’s. The remaining homeless clients as indicated in
Figure 4.4 by ‘Other’ reported staying in a squat (n=7), with friends/relatives (n=82), or sleeping rough
(n=67). This level of homelessness is cause for concern. Figure 4.4 illustrates that first visit clients are
more likely to report being homeless, than to report living in Local Authority accommodation.
Moreover, there was a gender difference, although not statistically significant, in the reported levels of
homelessness, in that 18% of male first visit clients reported being homeless, compared with 22% of the
female clients. Research undertaken within the Merchant’s Quay Project indicates that the issue of
homelessness among attending clients is a major problem16 .  
In order to attempt to estimate the extent to which clients are ‘at risk’ of becoming homeless all were
asked whether they regarded their current accommodation as temporary or permanent. Table 4.2
illustrates that female clients were significantly more likely than male clients to report living in
temporary accommodation (x2=6.66; df=1; p<0.01). Moreover, 39% of the total population of new presenters
reported currently living in what they regarded as temporary accommodation. This figure is
substantially larger than (yet includes) those who reported being currently homeless. 
Table 4.2 Accommodation Type by Gender
Accommodation Type Male
%
Female
%
Total
%
Temporary 37 45 39
Permanent 63 55 61
Percentage 100 100 100
Total 1022 311 1333
*Missing Observations = 4
                                                          
15 For the purpose of this research homeless clients are defined as those who reported living in a hostel, a B&B, a squat, staying
with friends or sleeping rough. In other words a fairly narrow definition of homelessness was employed, as those who reported
living in unsuitable temporary accommodation, or facing eviction are not included. Thus it is possible that such a definition will
underestimate the extent of homelessness among the client group.
16 Research has been undertaken by the Research Office on homelessness and drug use. The Report entitled “Where-Ever I Lay my
Hat: A Study of Out of Home Drug Users” is available from the Research Office.
An examination of those clients who were ‘housed’ revealed that many felt insecure in their current
accommodation. For example, 36% of those living in local authority accommodation viewed it as
temporary, 45% of those privately renting also regarded their accommodation as temporary, as did 17%
of those currently in the family home. 
Clients were also asked whether they were currently living with an injecting drug user. Table 4.3
illustrates that over a quarter of new attendees reported that they shared accommodation with an
injecting drug user. Moreover, female drug users were significantly more likely than their male
counterparts to report this (x2=6.66; df=1; p<0.01). Table 4.3 illustrates that 37% of new female presenters
reported living with an injecting drug user, compared with 25% of their male counterparts. The
importance of this data is grounded in the fact that international research has found that living with an
injecting drug user is related to the sharing of injecting equipment and paraphernalia, primarily because
it creates a social environment that leads to sharing (Donoghoe et al, 1992; Magura et al, 1989). 
Table 4.3 Living Status by Gender
Living with IVDU Male Female Total
% % %
Yes 25 37 28
No 75 63 72
Percentage 100 100 100
Total 1020 307 1327
*Missing Observations = 10
4.1.5 Legal Status
Over half of the first visit clients (51%) reported that they had been to prison at some point in time
(n=1329). Moreover, analysis revealed that there was a highly significant gender difference in having
previously experienced imprisonment (x2=136.08; df=1; p<0.001). Fifty nine percent of the male clients
reported having been to prison (n=604) compared with only 22% of the female clients (n=67). Figure 4.5
graphically illustrates that of those clients who report having been to prison, only 10% were female.
These figures must however be examined in terms of the prison population. In short the Irish prison
population is predominately male, and only 2% percent of the population are women. Moreover, it has
been estimated that at least 40% of the prison population have a history of serious drug use.
Figure 4.5 Imprisonment by Gender
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Clients were also asked about their drug use in prison. Unfortunately, this information was not included
in the First Visit Intervention Sheets at the outset of the evaluation. Therefore this data is not available
for the total population of first visit clients over the time period under investigation. From the valid data
(n=350) what is known is that 55% of those who have been to prison report using drugs therein (n=192).
Of these 44% reported that they injected drugs in prison (n=85) the majority of whom (70%) reported
sharing their injecting equipment (n=60).
Clients were also asked about their current legal status. Table 4.4 illustrates that 8% of first visit clients
reported being on temporary release. The percentage of clients serving any type of community based
sanction as an alternative to custody is very low, particularly when compared with the percentage who
have been to prison.
Table 4.4 Legal Status of Clients
Legal Status Temporary 
Release
Suspended 
Sentence
Community 
Service
Probation Bail
% % % % %
Yes 8 3 1 5 2
No 92 97 99 95 98
Percentage 100 100 100 100 100
Total 1286 1279 1276 1278 1328
4.2 TREATMENT STATUS
At first visit all clients were asked whether this was their first time in treatment. Just under half the
clients (48%) reported that they had never attended any other drug treatment service (n=1332). Female
clients were significantly more likely to report no previous treatment contact than males (x2=9.32; df=1;
p<0.01). Forty six percent of the male clients reported that this was their first time in treatment, compared
with 56% of their female counterparts. This is probably related to the fact that the clients who reported
no previous contact with drug treatment services were significantly younger than those who had
previous contact (Z = -9.37; p<0.001). Clients who reported no previous contact with treatment services
were on average 22.4 years old  (median = 21, range 14-52) compared with an average age of 25 years among
those reporting  previous treatment contact (median = 24, range 16-51).
Although over half of the new presenters at the Health Promotion Unit had at some point in their drug
using career attended a drug treatment service, only 21% reported being currently in contact with any
such service (n=1337). Table 4.5 shows the agencies with whom clients reported being in contact at the
time of presentation at the Unit.
Table 4.5 Other Drug Services Attended
Service Frequency
n
Percentage
%
Baggot Street 17 6
Trinity Court 61 22
Aisling Clinic 21 7
City Clinic 8 3
Anna Liffey 3 1
Other Exchange 27 10
Coolmine 17 6
CASP 11 4
Doctor (for physeptone) 27 10
Drug Addiction Counsellor 6 2
Other17 85 29
Total 283 100
Clients were also asked whether they had previously undergone a detoxification either supervised or
non-supervised, however this was not specified in the initial stages of utilising the Intervention Sheets.
Fifty four percent of the clients reported that they previously had a detoxification. Analysis revealed that
clients who reported having undergone a detoxification were significantly older than those who had not
                                                          
17 The organisations included under this category included Inchicore Health Centre, EHB Ballymun, the Methadone Bus,
Ballyfermot Health Centre, Cuan Mhuire, Castle Street Health Centre, Ruthland Centre, Finglas Health Centre, and Mountjoy
Clinic.
(z= -6.06, p< 0.001). Clients who reported having had a detoxification were on average 25 years (median =23,
range 16-50) while their counterparts were on average 23 years (median = 21; range 14-52).
Clients were also asked whether they had ever stopped using drugs. Sixty four percent of the clients
reported that they had stopped using drugs for a period of time. The number of clients who reported that
they had stopped using drugs for any period of time (n=860) was larger than the number who reported
having had a detoxification (n=721). This is probably due to the vagueness of the detoxification question,
in that clients who had self-detoxified did not necessarily consider it a detoxification per se. The time
periods in question ranged from one week to 20 years. Figure 4.6 graphically illustrates clients reported
‘time clean’. It is immediately apparent that the vast majority of clients relapsed within the first six
months of being drug free.
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In order to attempt to gain some understanding of the issues surrounding relapse clients were asked to
state what they felt was the main reason for their lapse. A variety of responses were given, however
some trends did emerge. Table 4.6 highlights the most common responses to the question. 
Table 4.6 Reasons for Lapse
Reasons for Lapse Frequency
n
Percentage
%
Peer Pressure 165 20
Boredom 164 20
Depression 72 9
Temptation too much 67 8
Personal Problems 46 6
Released from Prison 38 5
Family Problems 37 4
Methadone ran out 20 2
Partner still using 17 2
Other 199 24
Total 825 100
*Missing Observations=35
4.3 DRUG USE
Clients were asked in detail about their drug use, as it was considered vital to get a measure of new
presenters’ current drug use. To this end, all clients were asked about their recent drug use, four weeks
prior to contact with the Health Promotion Unit. However, a brief history of clients’ drug using career
was also required. In this section, the drug using history of clients is presented, followed by an analysis
of clients’ drug use at the time of presenting at the Health Promotion Unit.
4.3.1  Drug Using History
Clients were asked an open-ended question concerning the first drug they ever used. Both tobacco and
alcohol were excluded from this, however some legal substances were included, such as solvents. Table
4.7 presents the results.
Table 4.7 First Drug Used
First Drug Used Frequency
n
Percentage
%
Cannabis 669 51
Heroin 408 31
Ecstasy 73 5
Cocaine 58 4
Other opiates 25 2
Solvents 23 2
Benzodiazepines 22 2
Speed 22 2
Hallucinogens 20 1
Total 1320 100
*Missing Observations=17
Over half of the clients (51%) reported that cannabis was the first drug they used. A significant minority
of the clients (31%) reported commencing their drug using careers with heroin use. However, Figure
4.7 shows that the majority of the clients who initiated drug use with heroin, did not inject the drug.
Only 13% of the new attendees injected their first drug, all of whom reported using heroin as their first
drug, the remaining 18% of those who used heroin as their first drug smoked the drug.
Figure 4.7 Route of Administration of First Drug
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Clients were also asked at what age they first used drugs. Figure 4.8 illustrates that 79% of the new
attendees were teenagers when they first used drugs. The mean age for first drug use for the population
was 17 years and the mode age was 16. There was a very wide age range among the client population,
that is ranging from 7 to 42 years of age. Analysis revealed that there was no significant difference
between the age at which male (17.24 years) and female (17.5 years) clients initiated drug use.
< 15 Yrs 15-19 Yrs 20-24 Yrs 25-29 Yrs 30 + Yrs
23%
56%
15%
4%
2%
0
10
20
30
40
50
60
P
er
ce
nt
ag
e
Age
Figure 4.8 Age First Drug Use
Considering the nature of the service provided, it was not surprising that the vast majority of new
presenters (99%) reported that they had injected a drug at some point in their drug using careers. Ninety
five percent of those who had injected, reported heroin as being the first drug that they took
intravenously. The remaining clients reported first injecting with cocaine, N.A.P.S (morphine sulphate
tables) or amphetamines.
Figure 4.9 illustrates the age at which clients initiated intravenous drug use. Unlike age of first drug
use, almost half the clients were over the age of 20 years when they started injecting. The mean age of
first injecting was 20 years, and the mode age was 18. Again there was no significant gender difference
in age of first IV drug use, male clients were on average 20.3 years of age, while female clients were
19.6 years.
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Figure 4.9 Age First Injected 
4.3.2 Length of Time Injecting
All new presenters who reported having injected drugs were asked how long they had been intravenous
drug users (n=1320). Figure 4.10 shows that over half of the new presenters (55%) at the Health
Promotion Unit were injecting drugs for less than one year. Moreover, almost one third (30%) reported
that they were injecting for less than six months. 
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Figure 4.10 Length of Time Injecting
Analysis revealed that there was a significant gender difference in length of injecting careers. Male
clients had significantly longer injecting careers than their female counterparts (z= -5.9, p<0.001). They
reported having injected for an average of 3.4 years (median = 1 year, range 0-33 years) conversely female
clients had been injecting for an average of 1.7 years (median = 7 months, range 0-25 years). Analysis
supported the fact that length of time injecting is inextricably linked with age. When comparing recent
injectors (i.e. less than 6 months) with those more established in their injecting careers (i.e. in excess of
6 months) , analysis revealed that recent injectors were significantly younger (z= -8.88, p<0.001). Recent
injectors were on average 21.7 years of age (median = 21 years, range 15-42), while their counterparts were
however on average 24.7 years (median = 23, range 14-52).
The length of clients injecting careers was also related to previous treatment contact, in that clients who
reported no previous treatment contact had significantly shorter injecting careers than their treatment
counterparts (z= -16.81, p<0.001). The average length of time injecting for clients in treatment was 4.6 years
(median = 2 years, range 0-33 years) compared with an average of 1.2 years  (median = 6 months, range 0-25 years) for
clients reporting no previous contact with treatment services. Analysis also revealed unsurprisingly that
length of injecting career was related to having had a detoxification (z=-8.69, p< 0.001). Clients who
reported having had a detoxification injected for on average 3.7 years, (median=1.5 years, range 0-30 years),
compared with those who had no previous detoxification, who injected for an average of 2.1 years
(median = 8 months, range 0-33 years). 
4.3.3 Current Drug Use 
All clients were asked to detail their drug use over the four weeks prior to first contact with the Health
Promotion Unit. Table 4.8 illustrates the primary drug of choice of the new presenters at the Unit. The
majority of clients (92%) reported using heroin as their primary drug. Ninety two percent of the clients
reported injecting their primary drug (n=1324) the vast majority of whom also reported using heroin
and other opiates as their primary drug. The remaining clients reported that they either smoked (n=53),
injected (n=50) or sniffed their primary drug (n=5).
Table 4.8 Primary Drugs Used
Primary Drug
Used
Frequency
n
Percentage
%
Cannabis 12 1
Heroin 1219 92
Stimulants 23 2
Other opiates 15 1
Physeptone 58 4
Total 1327 100
*Missing Observations =10
Table 4.9 shows how often clients reported using their primary drug over the four weeks prior to
contact with the Unit. The majority of clients (83%) reported using their primary drug at least once a
day. Over a quarter of the new presenters reported levels of drug use in excess of 4 times a day. 
Table 4.9 Frequency of Use of Primary Drug
Frequency Frequency
n
Percentage
%
More than 4 times a day 358 27
Daily 743 56
4-6 times a week 80 6
1-3 times a week 106 8
Less than once a week 40 3
Total 1327 100
*Missing Observations = 10
Sixty four percent of new attendees at the Unit reported that they were poly drug users i.e. that they
regularly used other drugs apart from their primary drug of choice. Female first visit clients were as
likely as males to report poly drug use. There was no statistically significant relationship between age
and poly drug use, however it was related to length of time injecting (z =-3.58, p< 0.001). Poly drug users
were injecting for on average 3.2 years (median = 1 year, range 0-28) while clients who reported non poly
drug use were on average injecting for 2.7 years (median =10 months, range 0-33 years).
Table 4.10 Secondary Drugs Used
Secondary Drug
Used
Frequency
n
Percentage
%
Cannabis 249 30
Heroin 51 6
Stimulants 181 21
Other opiates 32 4
Benzodiazepines 204 24
Physeptone18 124 15
Total 841 100
Table 4.10 illustrates the secondary drugs that clients reported using. As heroin was largely the primary
drug of choice, levels of opiate use were much lower when secondary drug use was examined.
Conversely levels of cannabis use were higher. A significant minority of clients (n=138) reported using
cocaine as their secondary drug (included in Table 4.10 under stimulants) most of whom not only
reported injecting the drug but also reported using heroin as their primary drug.
Figure 4.11 Route of Administration of 
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18 There is space on the Intervention Sheet to indicate whether clients who reported using physeptone were getting a prescription
for the drug. Unfortunately this was not always filled in correctly. Thus there is some ambiguity around the numbers who were
taking street and/or prescribed physeptone. 
Figure 4.11 illustrates the route of administration of secondary drugs. As expected levels of intravenous
drug use were much lower than for primary drug, just over a quarter of new presenters injected their
secondary drug. As indicated previously, most of these clients also injected their primary drug. Table
4.11 shows the frequency of use of secondary drugs. Although secondary drugs were used less
frequently than primary drugs, 41% of clients reported using their secondary drug at least once a day. 
Table 4.11 Frequency of Use of Secondary Drug
Frequency Frequency
n
Percentage
%
More than 4 times a day 50 6
Daily 292 35
4-6 times a week 92 11
1-3 times a week 259 31
Less than once a week 142 17
Total 835 100
4.4 INJECTING RISK BEHAVIOUR
All clients who reported injecting drug use were asked for detailed information on their injecting
practices. This section presents the relevant data. Firstly, clients’ injecting techniques are addressed. At
the point of first contact an attempt is made to assess the injecting behaviour of all new presenters.
When necessary, advice is given on how to improve injecting techniques so as to minimise the risks to
the individual. Thereafter, the levels of sharing of injecting equipment and injecting paraphernalia is
examined.
4.4.1 Injecting Behaviour
Ninety seven percent (n=1299) of the clients reported that they were injecting drug users (i.e. they
injected either a primary or secondary drug). In the majority of cases, when permission was granted,
clients’ upper extremities were examined for evidence of needle marks to determine skin condition at
injecting sites. This information is recorded on the Intervention Sheets primarily as a means of
validating clients’ self reported drug use. Obviously this data relates only to clients who inject in their
arms. Table 4.12 illustrates the most common injecting sites reported by clients. The majority of clients
(85%) reported injecting in their arm. Table 4.12 shows that five percent of first visit clients reported
injecting into particularly dangerous sites, i.e. the groin and the neck. These clients are informed by
Health Promotion staff of the dangers of these practices, and are encouraged to either cease intravenous
drug use or when possible to change their injecting site. 
Table 4. 12 Injecting Sites
Injecting Site Frequency
n
Percentage
%
Arm 1098 85
Leg 28 2
Hands 80 6
Feet 19 1
Neck 13 1
Groin 48 4
Buttocks 13 1
Total 1299 100
*Missing Observations = 38
However, it should be noted that the majority of clients (83%) reported that they rotated their injecting
site (n=1300). Only 17% of new clients reported always injecting in the same site. Forty two percent of
clients reported that they always change sites, and the remaining 41% of new presenters stated that they
sometimes altered IV sites. As the skin contains bacteria, it is advisable for all injecting drug users to
clean the injecting site with a sterile swab before and after injecting. Table 4.13 illustrates that 60% of
new attendees at the Health Promotion Unit did not always clean their injecting site prior to drug use.
Clients are provided with sterile swabs to encourage them to employ more hygienic injecting practices.
Table 4.13 Cleaning Injecting Site Prior to Drug Use
Clean Injecting Site Frequency
n
Percentage
%
Always 521 40
Sometimes 299 23
Never 491 37
Total 1311 100
*Missing Observations = 26
Table 4.14 illustrates that female clients were significantly more likely to report having problems in
finding an injecting site than their male counterparts (x2=88.31; df=2; p<0.001). Almost one third of the
female clients reported that they always had problems in this regard, compared with only 13% of their
male counterparts. This may be due to the fact that women generally have smaller veins than men,
which not only leads to problems finding an injecting site, but  may also lead to a number of injecting
related complaints such as abscesses (Litt, 1981). This is probably compounded by the fact that female
clients are more likely to be recent injectors, and as such may have poor injecting techniques.
 
Table 4.14 Problems Finding Injecting Sites by Gender
Problems
Finding IV site
Male Female Total
% % %
Always 13 31 18
Sometimes 33 43 35
Never 54 26 47
Percent 100 100 100
Number 1003 304 1307
*Missing Observations=30
All clients were asked whether they injected themselves. Table 4.15 illustrates that female clients were
significantly less likely to report that they injected themselves (x2=63.33; df=2; p<0.001). Over one third of
the female clients reported that they had never injected themselves, compared with 16% of male first
visit clients. Analysis revealed that clients who reported always injecting themselves were significantly
older than those who did not (z=-5.56, p<0.001). Moreover, whether clients reported always injecting
themselves was also related to length of their injecting careers. Clients who reported always injecting
themselves were significantly more likely to have a more established injecting career i.e. injecting in
excess of 6 months (x2=70.51; df=1; p<0.001). Sixty percent of the recent injectors reported always injecting
themselves compared with 82% of the long-term injectors.
Table 4.15 Injecting Status by Gender
Inject Self Male Female Total
% % %
Always 81 58 76
Sometimes 3 8 4
Never 16 34 20
Percent 100 100 100
Number 998 300 1298
*Missing Observations=39
Clients were asked how often they normally used a needle and a syringe. Table 4.16 illustrates the
extent to which clients reported reusing needles and syringes. What is clear from the data presented in
this table is that the vast majority of clients employ some protective strategies to reduce the risk of
contracting infections, by either only using needles and syringes once, or in the majority of cases, by
cleaning the needles and syringes before reuse.
All clients who reported that they cleaned their needles (n=1004) and syringes (n=1089) before reuse
were asked for details on how they cleaned their equipment. Methods of cleaning were quite varied, and
were no doubt influenced by clients knowledge of cleaning methods and access to cleaning materials
such as bleach and sterile water.
Table 4.16 Reuse of Needles and Syringes
Frequency of Use Needles Syringes
n % n %
Once 234 18 143 11
> 1 but clean 1004 77 1089 83
> 1 but do not clean 68 5 78 6
Total 1306 100 1310 100
Table 4.17 illustrates the cleaning methods employed by first visit clients. At the point of first contact
all clients are told how to clean their injecting equipment. While this is not guaranteed to make injecting
with used injecting equipment safe - infections from bacteria and hepatitis are still possible - it is
recommended if and when clients re-use injecting equipment.  Clients are encouraged to use bleach and
(sterile) water when cleaning their equipment. If they do not have any bleach they are advised to use
washing-up liquid mixed with water, but are warned that it is not as effective as bleach.
Table 4.17 Cleaning of Injecting Equipment
Method of Cleaning Needles Syringes
n % n %
Bleaching 632 63 638 59
Cold Water 245 25 312 29
Boiling Water 95 10 93 9
Soapy Water 22 2 32 3
Total 994 100 1075 100
4.4.2 Sharing of Injecting Equipment
A number of questions on the Intervention Sheet were concerned with clients’ sharing of injecting
equipment. All clients who reported having injected (n=1323) were asked whether they ever shared, that
is either borrowed or lent, injecting equipment. They were also asked for information on the lending and
borrowing of injecting equipment over the four weeks prior to contact with the Health Promotion Unit.
Figure 4.12 illustrates that 41% of the new attendees reported that they never shared injecting
equipment (n=1309). Thus the remaining fifty nine percent of clients reported that they had shared
injecting equipment at some point in their injecting career. 
As regards this group of sharers, analysis revealed that there was no gender or age differences in
reported levels of sharing. However a number of variables, related to life style factors were associated
with the sharing of injecting equipment. Moreover, there was a highly significant relationship between
the length of a clients injecting career and reportedly having shared injecting equipment (z = -9.64; p<
0.001). Clients who reported having shared equipment were injecting for on average 3.7 years (median = 1.5
years, range 1-33 years) compared with an average of 1.9 years of injecting (median 6 months; range 0-30 years) for
the non-sharers.
Although not statistically significant homeless clients (0.64) were proportionately more likely than their
housed counterparts (0.57) to report having shared injecting equipment at some point in their injecting
careers. Analysis  revealed that living with an injecting drug user was related to the sharing of injecting
equipment (x2=13.62; df=1; p<0.001). Sixty seven percent of clients who reported living with an IV drug user
reported sharing injecting equipment, compared with 56% of clients not living with a drug injector. 
Clients who reported having had a HIV test were significantly more likely to report having shared
injecting equipment than those who were not tested (x2=22.2; df=1; p<0.001). Sixty six percent of clients
tested for HIV infection reported having shared equipment at some point in time, compared with 52% of
those not tested. This could suggest that clients who have shared injecting equipment in the past, were
concerned about their HIV status and consequently sought a HIV test. Conversely, it could indicate that
clients, having had a HIV test, did not consider themselves at risk of infection and so continued to share
injecting equipment. Due to the lack of time frame it is difficult to ascertain the nature of the
relationship between HIV testing and sharing of injecting equipment.
Figure 4.12 Sharing of Injecting Equipment
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Figure 4.12 shows that 29% of clients reported sharing injecting equipment recently, that is in the four
weeks prior to contact with the Health Promotion Unit.  Recent sharing behaviour can be broken down
into the lending and/or borrowing of used injecting equipment. As discussed in Chapter Three it is
important to make distinctions between these behaviours as they differ markedly in terms of levels of
personal risk, and risk of future transmission of HIV and hepatitis (McKeganey et al, 1998). 
Figure 4.13 shows that half of the clients who reported recent sharing (n=383) stated that they borrowed
used injecting equipment from others. This is hardly surprising in view of the fact that all clients are
new presenters at the Health Promotion Unit, and moreover 48% of these clients reported that contact
with the Unit was their first treatment contact in their drug using careers. Conversely, Figure 4.13
illustrates that 17% of those who recently shared, reported lending used injecting equipment to others.
The remaining 33% of this group reported both the lending and borrowing of used injecting equipment.
There was no gender difference in terms of recent sharing (either borrowing or lending) of injecting
equipment.
Figure 4.13 Recent Sharing Behaviour
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As the greatest risk is associated with the borrowing of others’ used injecting equipment, and a
significant proportion of clients engage in this behaviour, it is therefore examined in some detail.
Analysis revealed that there was no gender difference in the reported borrowing of used injecting
equipment. However, those clients who reported borrowing used injecting equipment in the four weeks
prior to contact with the Health Promotion Unit were significantly younger than those who reported not
borrowing (z=-4.27, p< 0.001). Those who reported borrowing equipment were on average 22.4 years of
age (median 21 years, range 15-46 years) compared with non-borrowing counterparts who were on average 24
years of age (median 23 years, range 15-52 years).
Further analysis illustrated that various life style factors of the first visit clients proved to be related to
the borrowing of injecting equipment. Firstly, homeless clients were significantly more likely than their
housed counterparts to report the recent borrowing of used injecting equipment (x2=5.81; df=1; p<0.05).
Twenty three percent of the housed population reported this behaviour, compared with 31% of the
homeless population. The findings of this study supported international research (Donoghoe et al, 1992)
which states that close proximity with other injecting drug users leads to the sharing of injecting
equipment. First visit clients who reported living with an injecting drug user (x2 =7.44; df=1; p<0.01) and
having a sexual partner who was an injecting drug user (x2=6.77; df=1;p<0.01) were significantly more
likely to report recently borrowing injecting equipment. 
Clients were also specifically asked whether they shared their injecting equipment with their sexual
partner. This was included, as anecdotal evidence suggests that many do not consider such behaviour as
sharing per se. Table 4.18 illustrates that female clients were significantly more likely to report sharing
injecting equipment with their sexual partner (x2=89.73; df=1; p<0.001). This gender difference is related to
the sexual behaviour of female clients, which will be discussed in detail in the next section. However,
there is no evidence to suggest that clients who reported sharing with their sexual partner where less
likely to view such behaviour as sharing,  in that only 8 clients who reported sharing with their partner,
stated that they never shared works.
Table 4.18 Sharing of Injecting Equipment with Partner by Gender
Share IV Equipment
with Partner.
Male Female Total
% % %
Yes 13 37 18
No 87 63 82
Percent 100 100 100
Number 1000 304 1304
*Missing Observations=33
Finally, the sharing of injecting paraphernalia was also examined. More specifically, all clients were
asked whether they had shared spoons and/or filters in the four weeks prior to contact with the Health
Promotion Unit. Table 4.19 shows that female clients were significantly more likely to report having
shared injecting paraphernalia in the four weeks prior to contact with the Unit (x2=9.19; df=1; p<0.01). Sixty
three percent of the female new presenters reported having shared spoons and filters in the month prior
to contact with the Unit, compared with 53% of the male clients.
Table 4.19 Sharing of Injecting Paraphernalia by Gender
Share Injecting
Paraphernalia
Male Female Total
% % %
Yes 53 63 55
No 47 37 45
Percentage 100 100 100
Total 999 305 1304
*Missing Observations=33
Analysis revealed that the sharing of injecting paraphernalia was related to age (z=-6.24, p<0.001), in that
those who reported sharing were significantly younger than those who reported not having done so.
Sharers were on average 23 years of age (median 22 years, 15-42 years)  and non sharers were on average 25
years (median 24 years, 15-51 years).
As with the borrowing of used injecting equipment, analysis revealed that the sharing of injecting
equipment was similarly related to proximity with other drug users. Those who reported sharing
injecting paraphernalia were significantly more likely to report both living with an injecting drug user
(x2=14.89; df= 1; p<0.001) and having a drug user as a sexual partner (x2= 11.34; df=1; <0.001). Furthermore, the
data illustrates that clients who reported sharing injecting paraphernalia were significantly more likely
to report having shared injecting equipment at some point in time (x2=150.38; df=1; p<0.001) and the recent
borrowing of injecting equipment (x2=174.34; df=1; p<0.001). 
4.5 SEXUAL RISK BEHAVIOUR
Information is collected on clients’ sexual behaviour. One quarter of first visit clients reported that they
were not sexually active (n=1322).  Of the remaining clients Figure 4.14 illustrates that 12% reported
having no regular sexual partner, 39% had a regular partner who was not an injecting drug user and one
quarter reported having a regular partner who injected drugs.
Figure 4.14 Sexual Behaviour of Clients
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While there was no significant difference between male and female clients in terms of having a regular
partner, Table 4.20 shows that of those clients who were sexually active, female clients were
significantly more likely than their male counterparts to report having a regular sexual partner who is an
injecting drug user (x2=152.87; df=1; p<0.001). Of those clients who were sexually active, sixty eight percent
of the female clients reported having a regular partner who was an injecting drug user, compared with
only 24% of the male clients. 
Table 4.20 IVDU Sexual Partner by Gender
Injecting Sexual Partner Male Female Total
% % %
Yes 24 68 34
No 76 32 66
Percentage 100 100 100
Total 744 229 973
*Missing Observations =31
Clients were asked how often they used condoms. Figure 4.15 shows that only 35% of clients reported
using condoms all the time. Moreover, just over one third of the first visit clients reported never using
condoms. 
Figure 4.15 Condom Use
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Analysis revealed that there was no significant gender difference in reported condom use. However,
forty one percent of the female clients reported never using a condom, compared with 34% of the male
clients. There was however a significant relationship between condom use and age (x2=13.9; df=2; p<0.001).
Clients over the age of 25 were significantly more likely than those under 25 to report never using a
condom. Thirty one percent of clients under 25 years reported never using condoms, compared with
43% of those over 25 years.
Further analysis revealed that clients who reported having regular sexual partner were significantly
more likely to report never using a condom  (x2=32.22; df=2; p<0.001). Table 4.21 illustrates  that 41% of
clients with regular sexual partners never use condoms, compared with 25% of the clients who reported
having no regular sexual partner. This may be due to the fact that clients find it difficult to introduce the
use of condoms into a long-term relationship. 
Table 4.21 Condom Use by Sexual Status
Condom Use Regular
Partner
No Regular
Partner
n % n %
Always 278 32 177 40
Sometimes 236 27 157 35
Never 351 41 110 25
Total 865 100 444 100
*Missing Observations = 28 
4.6 HEALTH AND WELL- BEING
On the Intervention Sheets clients are asked a number of questions concerning their health and well-
being. The data gathered from these questions are presented in this section. The extent to which clients
have been in contact with medical services is also examined. It will be seen that there are some
significant gender differences in terms of both health complaints and medical contact.
4.6.1  Health Complaints
All clients were asked whether they ever had a HIV test. Just under half of the new clients (49%)
reported that they had a HIV test in the past (n=1299). Analysis revealed that having had a HIV test is
related to both clients’ age and the length of injecting careers. Clients who reported having had a HIV
test were on average significantly older than clients who had not been tested  (z= -9.54; p<0.001). Those
who had been tested for the virus were on average 24.3 years (median 23, range 14-52 years), compared with
an average of 22 years for those who had not been tested (median 21 years, range  15-42 years). Clients who
were tested also had a significantly longer injecting career (z= -9.53; p<0.001). Those tested injected for an
average of 4.6 years (median 2 years, range 0-30 years) while those who reported not having been
tested injected for on average 1.5 years (median 6 months, range 0-33 years). These results suggest that young
recent injectors, while engaging in risk behaviour, are not getting tested for HIV infection. 
Clients were also asked whether they ever had jaundice, hepatitis B and/or C. Table 4.22 illustrates the
extent to which clients reported being aware of having these infections. Whether clients reported having
any of these infections, was no doubt largely influenced by whether they had received a medical
diagnosis from a doctor. As levels of medical contact are relatively low among injecting drug users, the
percentage of clients who reported having jaundice, hepatitis B and C in Table 4.22 is probably
underestimated. There were no significant gender differences in the reported experiences of jaundice
and/or hepatitis infection. 
Table 4.22 Hepatitis (B and C) and Jaundice
Medical Complaint Jaundice Hepatitis B Hepatitis C
n % n % n %
Yes 105 8 88 7 239 19
No 1066 85 1063 84 905 71
Don’t Know 91 7 114 9 122 10
Total 1262 100 1265 100 1266 100
In view of the risk of hepatitis B infection to injecting drug users, all clients were asked whether they
had received a vaccination against hepatitis B. Table 4.23 illustrates that there was a highly significant
relationship between having had a hepatitis B vaccination and gender. Male clients were significantly
more likely to report having had a vaccination for hepatitis B than their female counterparts (x2=17.34;
df=1;p<0.001). Only eleven percent of the female clients reported having had the vaccination, compared
to 22% of the male clients.
Table 4.23 Vaccination for Hepatitis B by Gender
Vaccination Hepatitis B Male Female Total
% % %
Yes 22 11 19
No 75 86 78
Don’t Know 3 3 3
Percentage 100 100 100
Total 1002 306 1308
*Missing Observations=29
Analysis revealed that having had the hepatitis B vaccination was also related to having been to prison
(x2=96.13; df=2; p<0.001). Table 4.24 illustrates that thirty percent of the clients who reported having been
to prison reported having had a vaccination against hepatitis B, compared with only 8% of the clients
who have never been to prison. 
Table 4.24 Vaccination for Hepatitis B by Experience of Prison
Vaccination Hepatitis B Been in
Prison
Never in
Prison
Total
% % %
Yes 30 8 19
No 68 88 78
Don’t Know 2 4 3
Percentage 100 100 100
Total 661 639 1300
*Missing Observations=37
As discussed in Chapter Three a symptoms check list was employed to determine the extent to which
clients suffered from a number of complaints associated with drug use. Table 4.25  shows that seventy
two percent of the clients reported that they were suffering from insomnia. Sixty two percent of the new
presenters reported that they had been suffering from weight loss over the previous three months. On
the other hand, the numbers of clients who reported suffering from abscesses and septicemia were
relatively low. 
Table 4.25 Physical Health Complaints
Medical Complaint Abscesses Septicemia Weight Loss Insomnia
% % % %
Yes 16 1 62 72
No 84 99 38 28
Percentage 100 100 100 100
Total 1279 1272 1279 1283
There was no significant gender difference in the reported physical complaints of clients. However, as
illustrated by Figure 4.16 female clients were significantly more likely to report suffering from a
number of mental health complaints. It is difficult to know whether this is due to the fact that women
are more likely to admit experiencing these problems, or because they are in fact more likely to actually
experience such symptoms.
Regardless, Figure 4.16 illustrates that female clients are significantly more likely than their male
counterparts to report suffering from depression (x2=30.16; df=1; p< 0.001). Over three quarters of the
female clients (78%) reported suffering from depression over the three months prior to first contact with
the Unit, compared to 60% of the male clients. Likewise, female clients were significantly more likely
than male clients to report being unable to cope (x2=16.38; df=1; p<0.001). Sixty three percent of the female
clients reported not being able to cope, whereas only 49% of the male clients reported this. Significant
gender differences were also found in the extent to which clients reported feeling isolated (x2=7.86; df=1;
p<0.01). Moreover, Figure 4.16 illustrates that female clients were more likely to report having
deliberately overdosed in the three months prior to contact with the Health Promotion Unit. 
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A global measure of mental and physical health was included on the Intervention Sheets. All clients
were asked to rate their physical health and mood on a five point scale ranging from very bad to very
good. Table 4.26 illustrates that over one third of the clients (36%) reported that their physical health
was O.K., while 33% reported that their health was bad. Although the difference was not statistically
significant female clients were more likely than male clients to report that their physical health was bad.
 
Table 4.26 Physical Health by Gender
Rate Health Male Female Total
n % n % %
Very Bad 97 10 33 11 10
Bad 317 33 109 37 33
O.K. 352 36 103 35 36
Good 185 19 41 14 19
Very Good 24 2 9 3 2
Total 975 100 295 100 100
*Missing Observations = 67
Table 4.27 shows how clients rated their mood on a similar five point scale. Forty one percent of the
male clients rated their mood as ‘bad’ compared with 45% of the female clients.  Conversely, female
clients were less likely to rate their mood as being ‘good’, only 5% of the female clients reported this,
compared with 11% of the male clients.
Table 4.27 Mood by Gender
 Rate Mood Male Female Total
n % n % %
Very Bad 80 8 21 7 8
Bad 401 41 132 45 41
O.K. 375 39 125 43 39
Good 104 11 14 5 11
Very Good 14 1 0 0 1
Total 974 100 292 100 100
*Missing Observations = 71
4.6.2 Medical Contact
Fifty two percent of the clients reported that they had a medical card (n=1314). All clients who report
having no medical card and are entitled to one, are given an application form when they visit the Health
Promotion Unit. Table 4.28 illustrates that women were significantly more likely to report having a
medical card than their male counterparts (xx=40.94; df=1; p<0.001). Less than half of the male clients
reported having a medical card, compared with 68% of the female clients.
 
Table 4.28 Medical Card by Gender
Medical Card Male Female Total
% % %
Yes 47 68 52
No 53 32 48
Percentage 100 100 100
Total 1009 305 1314
*Missing Observations=23
Clients were asked in some detail about their contact with medical services over the three months prior
to presenting at the Health Promotion Unit. Forty two percent of the clients reported that they had no
contact with medical services over the time period under investigation. The remaining 58% of clients
reported some form of medical contact. Table 4.29 illustrates that the female clients were significantly
more likely than their male counterparts to report having had some medical contact in the three months
prior to attending the Health Promotion Unit (x2=23.96;df=1;p<0.001).
Table 4.29 Medical Contact by Gender
Medical Contact Male Female Total
% % %
Yes 55 70 58
No 45 30 42
Percentage 100 100 100
Total 1014 307 1321
*Missing Observations=16
Further analysis revealed that there is a relationship between previous drug treatment contact and
reporting contact with medical services (x2=19.53; df=1; p<0.001). This is highlighted by the fact that clients
who reported previous drug treatment were significantly more likely to report having medical contact in
the previous three months. Similarly, clients who reported being currently in treatment were
significantly more likely to report recent medical contact than their non treatment counterparts (x2= 17.59;
df=1; p<0.001).
Table 4.30  illustrates the nature of the medical contact for the total population of first visit clients.
Forty three percent of the population reported that they had been in contact with their G.P within the
previous three months. Just under a quarter of the new presenters (22%) had been to A+E , and 13%
had been to a dentist. Levels of contact with the GUM clinic and other specialist medical services were
very low, at 4% and 6% respectively.  
Table 4.30 Type of Medical Contact
Medical
Contact
Gum Clinic A+E Dentist G.P Other
Services
% % % % %
Yes 4 22 13 43 6
No 96 78 87 57 94
Percent 100 100 100 100 100
Total 1315 1316 1315 1317 1310
Figure 4.17 illustrates the gender differences in reported medical contacts. It is immediately apparent
that female clients are more likely to report all types of medical contact. Analysis revealed that women
were significantly more likely to report having been to their GP (x2=48.75; df=1; p<0.001). Sixty percent of
female clients reported such medical contact compared with only 38% of their male counterparts.
Similarly female clients were significantly more likely to report having been in contact with ‘other
medical services’ (x2=7.87; df=1; p<0.01). Ten percent of female clients reported this compared to 5% of the
male clients. Finally, female clients were also significantly more likely to report having been to the
GUM clinic in the previous three months (x2=8.24; df=1; p<0.01).
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4.7 DISCUSSION
This chapter has presented a comprehensive profile of the 1337 new clients who attended the
Merchant’s Quay Project’s Health Promotion Unit over the 18 months under investigation. Some
important issues emerged from the analysis undertaken, and this section will discuss these main areas of
concern in relation to other research findings. It will also be seen from the baseline data collected at first
visit, that it is possible to conclude that the Health Promotion Unit is effective in three regards; firstly,
in making initial contact with female injecting drug users; secondly, in attracting recent injectors to the
service and; finally in initiating contact with a large proportion of young injectors.
4.7.1 Gender 
Twenty three percent of new presenters at the Health Promotion Unit were female. A number of studies
have identified barriers to women entering treatment. These include women’s lack of economic
resources (Hodgins et al, 1997) child care concerns (Cuskey, 1982) and the perceived insensitivity of
the treatment setting to women’s problems (Reed, 1987). However, the male to female gender ratio of
3:1 indicates that the Health Promotion Unit is successful in attracting and initiating contact with female
drug users. Moreover, the time interval between first IV drug use and presentation at the Unit was
significantly shorter for women.  First visit female clients were injecting for on average 1.7 years, while
their male counterparts reported injecting for on average 3.4 years. If women were deterred from
attending the Unit, the delay between onset of intravenous drug use and first presentation should be
greater (Cox et al, 1999). 
The earlier presentation at the Health Promotion Unit by female drug users may in part be due to the
fact that the rate of physical deterioration is, as other research indicates, more rapid among injecting
women so they quickly reach the state of requiring treatment (Cox et al, 1999; Gossop et al, 1994).
Despite their shorter injecting careers, new female presenters were significantly more likely to report
injecting related problems, such as difficulty finding an IV site. They were also significantly more likely
to report suffering from a range of physical and mental health complaints. Yet they were more likely to
report being in contact with medical services. Seventy percent of the female clients reported contact
with medical services in the previous three months, compared with only 55% of the male clients.
International research suggests that more often than not health related problems precipitate women’s
entrance into drug treatment (Rosenbaum and Murphy, 1987). This may in part explain the earlier
presentation at the Health Promotion Unit by female clients. Moreover, female clients were significantly
more likely to report that presentation at the Health Promotion Unit was their first treatment contact.
Fifty six percent of women reported that they had never attended any other drug treatment service
compared with 46% of their male counterparts. 
In addition this study highlights important gender differences in terms of the extent of personal
involvement with other drug users. Female first visit clients were significantly more likely to report
living with an injecting drug user. In addition, they were also significantly more likely to report being
involved in a sexual relationship with an injecting drug user, and to share injecting equipment with their
sexual partner. This greater personal involvement of women with other drug users has consequences in
terms of health related problems, and risk behaviour. International research indicates that such life style
factors are predictors of risk behaviour. For example Darke et al, (1994) found that having a regular
sexual partner who is an injecting drug user increases the likelihood of engaging in risk behaviour.
Furthermore, living with an injecting drug user is related to increased risk behaviour (Klee et al, 1990).
In short, the social opportunities created by living in close proximity with other injecting drug users
creates an environment in which risk behaviour flourishes.  
This study supports the above findings. Female clients, in particular those with injecting partners, were
also more likely to report the sharing of injecting equipment and injecting paraphernalia. The norm of
sharing within injecting couples is particularly problematic, and difficult to change. Some injectors will
be unaware that their partners have shared or are sharing with others (Klee et al, 1991a). On the other
hand changing such behaviour patterns may threaten the relationship (Klee et al, 1990). In sum, the
greater personal involvement of women with other drug users could have considerable impact on the
prognosis and clinical intervention by simultaneously depriving them of protective factors and exposing
them to high risk factors (Cox et al, 1999). This in turn has implications for service providers. 
This study has also highlighted important gender differences in terms of male presenters at the Health
Promotion Unit. It has been shown that 90% of the first visit clients who reported having been to prison
were male. While it is recognised that these figures when viewed in context are representative of the
prison population as a whole, they are still cause for concern. The importance is in determining the role
imprisonment plays in initiating and maintaining drug use. Prisons are now well recognised as having
significant levels of drug availability and individuals within prison are at risk of contracting HIV and
both hepatitis B and C as a result of increased risk behaviour (O’Higgins, 1998). Moreover, the valid
data in this Report illustrates that of the 55% of clients who reported using drugs in prison, 70%
reported sharing their injecting equipment. 
The links between drugs and crime are complex and it is not possible to assume a causal relationship. In
fact research in the UK suggests that many drug users were involved in crime before they commenced
drug use (Auld et al, 1986). Findings in this study suggest that ‘criminal/deviant lifestyles’ can lead to
heroin and other drug use. Nonetheless, according to Keogh (1997) 43% of individuals apprehended for
indictable offenses in the Dublin Metropolitan (Garda) Area were known drug users, and they were in
turn responsible for 66% of all detected crime in the area. Unfortunately, based on the data collected
from first visit clients it is not possible to determine whether clients were active drug users prior to their
experience of imprisonment. However based on drug availability in prisons, it is feasible that in some
instances drug use, in particular IV drug use, may be initiated in prisons. 
However one advantage of prior imprisonment is that a large proportion (0.30) of those who were in
prison reported having had a vaccination against hepatitis B. Moreover, they were significantly more
likely than their non-prison counterparts to report having had the vaccination. The suggestion is that as
a captive group of injecting drug users it is easier for them to receive their vaccination (3 timed interval
dose) for hepatitis B within the prison environment. However, the overall low reported levels of
vaccinations (19%) among the population of new presenters at the Health Promotion Unit is cause for
concern.
4.7.2 Age
According to the 1996 Annual Report for the European Monitoring Centre for Drugs and Drug
Addiction, Ireland is among a handful of countries consistently reporting increases in heroin use by new
groups of young people. This is highlighted by the fact that the average age of drug users in treatment in
Ireland is the lowest in Europe (23.6 years). Just over 65% of individuals treated for drug problems in
Ireland were under the age of 25 compared with 43% in the UK (EMCDDA, 1997). Due to the fact that
recent injectors are likely to be younger, there exists a complex relationship between age and length of
injecting career. In this study recent injectors (i.e. less than 6 months) were significantly younger than
clients who were more established in their injecting career (i.e. injecting in excess of 6 months). Recent
injectors were on average 21.7 years of age, their counterparts were however on average 24.7 years of
age. 
The mean age of  new clients at the Health Promotion Unit is 24 years. As the age range is vast (14-52
years) this figure is deceptive. When alternatively viewed, over one quarter of new presenters at the
Unit (28%) were under 19 years of age; and a further 36% of new presenters were under the age of 24.
The mean age of new clients attending the Unit is higher than the mean age of first treatment contacts
for the Greater Dublin Area in 1995 and 1996 (O’Higgins and Duff, 1997; Moran et al, 1997).
Moreover, in both of these years almost half of the new presenters were teenagers, compared with only
28% of the new attendees at the Health Promotion Unit. This is primarily due to the fact that the vast
majority of new presenters at the Unit are injecting drug users (99%) compared with only a quarter of
the new treatment contacts recorded by the Health Research Board (Moran et al, 1997). Analysis
revealed that there was a gender difference in age of first visit clients. Female clients were significantly
younger than male clients. Female clients were on average 22.2 years, and the male clients were on
average 24.3 years. 
There are two main areas of concern which both national (Cassin et al, 1998) and international research
(Fennema et al, 1997) have associated with age, firstly, the relationship between age and treatment
contact, and secondly the relationship between age and risk behaviour. Research has illustrated that age
is related to previous treatment contact, in that young injectors are less likely to attend drug treatment
services, including needle-exchanges (Paone et al, 1995). Findings of this study support this, in that
clients who reported no previous treatment contact were significantly younger than those in contact with
other services. The average age of clients who reported no previous treatment contact was 22.4 years,
compared with 25 years among those who reported previous contact.
In relation to risk behaviour, research has shown that younger injectors report higher levels of HIV risk
behaviour when compared with older injecting drug users (Cassin et al, 1998; Battjes et al, 1992). This
is compounded by the fact that drug users who have recently initiated injecting have also been shown to
be more likely to engage in risk behaviour (Fennema et al, 1997). Analysis revealed that age is related
to injecting risk behaviour. Clients who reported the recent borrowing of used injecting equipment were
significantly younger than those who reported not borrowing injecting equipment. Borrowers were on
average 22.4 years, while their non-borrowing counterparts were on average 24 years of age. Similarly,
clients who reported sharing injecting paraphernalia were significantly younger than non-sharers. Age
was also related to injecting practices, in that younger clients were less likely to inject themselves. This
is also related to the fact that younger clients have a significantly shorter injecting career. Regarding
sexual risk behaviour clients over the age of 25 years were significantly more likely to report never
using a condom. Thirty one percent of clients under 25 years reported never using condoms compared
with 43% of those over the age of 25 years.
The findings of this study point to high levels of risk behaviour amongst young injectors. This is
compounded by the fact that young injectors were significantly less likely to report having had a HIV
test; consequently they are less likely to be aware of their HIV status. These findings suggest that the
harm reduction message has not reached young recent injectors (Cassin et al, 1999). However the fact
that such a large proportion of the population of first visit clients attending the Health Promotion Unit
were young injectors with no previous treatment contact is a positive outcome. The challenge is to
maintain contact with this vulnerable group of young injectors. 
4.7.3 Housing
Throughout this discussion it is being argued that HIV risk behaviour is complex and related to, and
influenced by, various extraneous factors. One life-style factor that international research has associated
with injecting risk behaviour, is the quality of drug users’ housing circumstances, in particular unstable
accommodation (Donoghoe et al, 1992). 
In this study 48% of the total population of new presenters at the Health Promotion Unit reported living
in the ‘family home’. Furthermore, 33% reported living in local authority or private rented housing.
Analysis revealed that a significant minority of clients reported being homeless (19%). Due to the
relatively narrow definition of homelessness employed (those at risk of being homeless were not
included) and the transient nature of homelessness this figure no doubt underestimates the extent of
homelessness among the population of new presenters at the Unit. Evidence for this lies in the fact that
39% of the total population reported that they were currently living in ‘temporary accommodation’.
Viewed another way 26% of the clients who reported living in what may be considered stable
accommodation (i.e. local authority, private rented and family home) reported this accommodation as
being temporary.19 
The problem of homelessness among this population is compounded by the fact that analysis revealed
that  homeless clients were significantly more likely than their housed counterparts to report having
shared injecting equipment at some point in their drug taking career (Cox and Lawless, 2000).
Moreover, they were significantly more likely to state that they borrowed used injecting equipment in
the four weeks prior to contact with the Unit. Finally, while not statistically significant, homeless clients
were proportionately more likely to report having recently shared injecting paraphernalia.
Access to adequate housing is a major social problem, particularly in urban areas where the majority of
drug injectors are located. The link between lack of adequate housing and sharing risk behaviour may
be further compounded when injectors, out of necessity, share accommodation with other drug injectors
(Donoghoe et al, 1992). Research in the UK illustrates that drug users who live with other people,
particularly other injectors, are more likely to engage in injecting risk behaviour (Crisp et al, 1994).
Very little research has been carried out at a national or international level. This is primarily due to the
fact that homelessness among the age group predominantly engaging in illicit drug use (those under 25)
is a relatively recent phenomenon (McCarty et al, 1991). Moreover, most of the research that has been
carried out has concentrated on drug use among the homeless, as opposed to homelessness among drug
users. The research that has been conducted both nationally (Cox and Lawless, 1999) and
internationally (Flemen,1997) suggests that homelessness is a growing problem among drug users and
                                                          
19 It is worth noting that since the introduction of the Housing (Miscellaneous Provisions) Act 1997, there has been
an increase in the number of individuals evicted for ‘drug related anti-social behaviour’ this in turn may increase
the likelihood of a drug user perceiving such accommodation as being temporary.
can influence their drug using patterns and risk behaviour. The findings of this study highlight the need
for a thorough analysis of the relationship between drug use and homelessness.
4.7.4 Injecting Risk Behaviour 
In this study HIV risk behaviour was divided into two categories, injecting risk behaviour and sexual
risk behaviour. Injecting risk behaviour is primarily concerned with the sharing of injecting equipment
and paraphernalia i.e. spoons and filters. Thirty percent of the new presenters at the Health Promotion
Unit reported having shared injecting equipment in the past. A further twenty nine percent of the clients
reported having shared injecting equipment in the four weeks prior to contact with the Unit. The term
‘sharing’ involves two activities, the lending and borrowing of injecting equipment, which differ
markedly in terms of levels of risk. Of those new presenters who reported recently sharing (n=383),
50% reported borrowing used injecting equipment, 17% reported lending their injecting equipment to
others, and the remaining 33% reported both the recent lending and borrowing of injecting equipment.
The lending of injecting equipment occurs when an individual is asked to make his/her injecting
equipment available to another person. Thus, the practice carries with it little personal risk to the lender.
This form of sharing according to Klee et al (1990) is due to either a lack of concern for the welfare of
others or the motivation may be to ‘help out’ when another drug user is in distress. Although lending is
low risk to the lender, it is high risk to others, as the person who lends the equipment may have HIV or
hepatitis. Thus, borrowing used injecting equipment is an activity which involves high levels of
personal risk . 
The levels of borrowing exhibited by the new presenters at the Health Promotion Unit are high.
Research has indicated that there are a number of reasons why injecting equipment is borrowed (Ross et
al, 1994). The primary reason being difficulty in obtaining new injecting equipment. However, it is not
solely due to the lack of ‘general availability’ of injecting equipment but as Ross et al (1994) argue, to
the availability at the time and place of injecting, in other words ‘situational availability’. The high
levels of borrowing by new clients at the Unit may in part be due to the fact that levels of current
contact with other treatment services were so low (21%).
A number of barriers to safer injecting practices have been identified apart from availability of injecting
equipment. Factors such as poly drug use (Klee et al, 1991), high frequency drug use and cocaine use
(Darke et al, 1994) increase the likelihood of injecting risk behaviour. As stated previously the social
environment also plays a vital role. For example, homelessness (Klee et al, 1990; Donoghoe et al, 1992)
and imprisonment (Crisp et al, 1994) have been shown to be predictors of risk behaviour. However, one
cannot ignore the fact that sharing is a social behaviour, which Barnard (1993) argues is expressive of
social ties between people and is also attributed with social meaning. As illustrated previously among
the population of first visit clients, sharing is something that is primarily undertaken with injecting
sexual partners. The problem is that sharing in such circumstances is generally not regarded as a risky
practice by those involved, but rather as a normal part of an intimate relationship (Burt and Stimson,
1993). It is worth noting that the fact that sharing occurs is not always indicative of unsafe injecting
practices. The vast majority of new presenters reported cleaning their injecting equipment prior to use.
However, it was illustrated that not all cleaning methods used were effective.
Another area of concern in terms of injecting risk behaviour was the fact that over half (55%) of the
population of first visit clients reported sharing injecting paraphernalia. The sharing of spoons and
filters is likely to be a major cause of the spread of HIV infection and hepatitis (Rhodes et al, 1994).
Filters collect infections, they are moist, warm and provide the perfect breeding ground for bacteria.
The high levels of sharing of injecting paraphernalia highlighted in this study suggest a need to focus on
informing new attendees of the risks involved.
Finally, preliminary analysis of the data collected from first visit clients indicates the presence of a
group of injecting drug users who engage in multiple risk behaviours. The evidence for this lies in the
fact that clients who reported sharing injecting equipment were significantly more likely to report both
the sharing of injecting paraphernalia (x2=150.38; df=1; p<0.001) and infrequent condom use (x2=26.04; df=2;
p<0.001).
4.7.5 Sexual Risk Behaviour
Many harm reduction strategies, in particular syringe-exchange programmes have been accused of
ignoring sexual risk behaviour and concentrating primarily on injecting risk behaviour (Paone et al,
1995). Yet the potential harms associated with ‘unsafe’ or unprotected sex are immense. As drug users
continue to reduce the risks directly associated with drug use, sexual transmission is increasingly
becoming the primary route of HIV infection (Des Jarlais and Friedman, 1987; McKeganey and
Barnard, 1991). Moreover, Rhodes et al (1994) argue that the next stage of the HIV epidemic among
drug injectors is likely to be significantly associated with whether or not, and with whom, sex is safe.
Despite evidence that drugs, in particular opiates, impair sexual functioning and lower the levels of
sexual activity (Mirim et al, 1980) 76% of new presenters at the Health Promotion Unit reported being
sexually active. Analysis revealed that levels of reported condom use were very low, with only 35% of
the new presenters reportedly always using condoms. 
A number of issues for concern emerged from the data presented in this chapter. Firstly, 39% of the
population reported having a non-drug using partner, and these clients were significantly more likely to
be male. International research supports the fact that male drug injectors are less likely than their female
counterparts to have injecting sexual partners. For example, in Klee et al’s (1990) study male
respondents reported a preference for non-drug using female sexual partners. The low levels of condom
use and the high degree of sexual mixing between injecting drug users and non drug users are cause for
concern. The potential for the spread of HIV into the non-drug using population would, therefore seem
considerable, particularly when one considers that that over half the population of new attendees have
never been tested for HIV and are therefore unaware of their status. This is particularly worrying in
view of the fact that research has identified an increased sexual risk of HIV infection to the female non-
injecting sexual partner of male drug users (Klee et al, 1990: McKeganey and Barnard, 1991).
Moreover, research from the United States reports that the majority of documented cases of women
with AIDS are among injecting drug users or the partners of male drug injectors (Cohen et al, 1989). 
Analysis revealed that 64% percent of the population reported having a regular sexual partner.
Moreover, one quarter of the population reported having a regular sexual partner who was an injecting
drug user. As discussed previously women were significantly more likely than men to report this. In this
study it was revealed that clients who have a regular sexual partner were significantly more likely to
report never using condoms. The difficulties of introducing condom use into a long-term relationship
and the possible consequences, may lead an individual to view unprotected sex as being the easier
option. McKeganey and Barnard (1991) argue that one approach to promoting condom use within a
relationship may be through encouraging a sense of responsibility among drug injectors, not only for
their own health, but also for that of their sexual partner.
International research suggests that the reported levels of condom use among drug injectors are almost
identical to those among the heterosexual population in general (McKeganey et al, 1988). Rhodes et al
(1994) argue that the perception of unprotected sex as ‘normal’ in heterosexual relationships is upheld
by drug users and non drug users alike. This illustrates the extent of social change necessary to make
any impact on reported levels of condom use among drug users. Consequently it is not surprising that
international research has consistently shown that changing sexual risk behaviour is more difficult than
changing injecting risk behaviour (Donoghoe, 1992). The success of harm reduction strategies is
inextricably linked with the social, cultural and political context in which such strategies operate.
Moreover, in order for individual behaviour changes to be possible, changes in social norms and social
contexts are required. It is essential to recognise the importance of sexual norms in influencing whether
or not unsafe sex occurs. In short, sexual norms cut across drug-using and non-using population. 
One final issue worth mentioning is the well established association between the sex industry and drug
use (Plant et al, 1989). Although this issue is not examined in this study, it still has implications for the
adoption of safer sex practices among injecting drug users. In short, research argues that prostitution is
one way in which HIV may spread to the general heterosexual population (Plant et al, 1989). However,
increased condom use has been reported among injecting prostitutes in Amsterdam (Van den Hoek et
al, 1990) and among prostitutes in general in London (Day et al, 1988). Thus, although it is only one
possible route of transmission, there is a need to be aware of the implications of using sex workers as
scapegoats thus marginalising them further.
CHAPTER 5
OUTCOME
MEASURES
This chapter examines the effectiveness of the Health Promotion Unit in terms of reported changes in
clients’ behaviour over the time period under investigation. Although the primary objective of the
Health Promotion Unit is to dispense sterile injecting equipment and maintain acceptable return rates, it
nevertheless recognises the importance of all behaviour changes, however gradual or minor, among
injecting drug users. To this end clients’ self reported changes in drug use, injecting risk behaviour,
sexual risk behaviour and health and well-being are investigated.
5.1 CLIENT FOLLOW-UP RATES
As presented in the previous chapter 1,337 new clients attended the Health Promotion Unit within the
specified 18 month time period, and of those a total of 370 clients represented three months after initial
contact with the Unit. In other words, 28% of first visit clients represented at follow-up. It is difficult to
determine whether this is a satisfactory follow-up rate as previous evaluations of syringe exchanges, as
discussed in Chapter Three, have employed different methodologies. For example, Robertson et al
(1988) when measuring changes in risk behaviour initially interviewed 986 drug users, and follow-ups
were completed on the first 50 consecutive drug users to represent. Stimson et al (1988) in evaluating
the impact of a syringe-exchange on attendees’ risk behaviour, required that all new clients complete a
brief Intake Sheet at first attendance. A First Client [Evaluation] Questionnaire concerned with client’s
risk behaviour was completed during the first month of attendance. Only 16% of the 2,449 new clients
who filled in the Intake Sheet completed the questionnaire. Moreover, only 34% of the clients attended
the syringe-exchange through to five visits. Conversely, Stephens et al (1991) in evaluating the impact
of an intervention programme on risk behaviour actively followed up on the sample of clients initially
interviewed. Consequently, their follow-up rate was much higher. In short there is no yardstick to
determine an acceptable follow-up rate of attendance. However, given the relatively lengthy follow-up
period employed in this study and the chaotic lifestyle of attending clients, a 28% follow-up rate is
reasonable. Notwithstanding, the Health Promotion Unit strives to achieve a higher retention rate. 
                 Table 5.1 Frequency of Presentation of Follow-Up Clients
Attendance Number of 
Clients
Percentage of
 Clients
Attended twice 70 20
Attended 3 times 72 21
Attended 4 times 44 12
Attended 5 times 33 9
Attended 6 times 43 12
Attended 7 times 28 8
Attended 8 times 17 5
Attended 9 times 12 3
Attended 10 or more times 37 10
Total 356 100
*Missing Observations = 14
The follow-up clients (n=370) reported a total of 1,930 visits between their first visit and follow-up
interventions. The average number of visits per client was 5 (range 2-29) over the three month time
period. Table 5.1 presents the frequency of presentation of follow-up clients. It illustrates that 21% of
clients attended the Unit 3 times between first visit and follow-up. On the other hand, 10% of the clients
attended the Unit ten times or more over the three month follow-up period.
Conversely, Figure 5.1 graphically illustrates clients’ visits over the follow-up time period. It shows the
gradual decline in the number of clients representing at the Unit. A total of 80% of the clients presented
twice at the Health Promotion Unit between first visit and follow-up. Fifty nine percent of the clients
attended the Unit three times, and this dropped to less than half (47%) of the clients who attended the
Unit four or more times.
Figure 5.1 Number of Visits over Three Month Follow-up
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In the 1,930 visits a total of 7,738 syringes were distributed among the follow-up clients. Each client
therefore received on average 22 syringes (range 0-229) or 4 syringes per visit. However it is worth
noting that the number of syringes given per client varied, depending on prior return rates, and places of
residence. For example, if a presenting client resided outside County Dublin  it is at the discretion of the
worker to decide how many syringes to dispense to that individual, within reason. A total of 3,386
syringes were returned to the Health Promotion Unit. In other words, 44% of the syringes distributed by
the Unit were returned. At the time of writing this report the Health Promotion Unit had introduced the
use of personal ‘sharps bins’ for safer, improved return rates.
5.2 PROFILE OF FOLLOW-UP CLIENTS
The baseline data collected from the 370 follow-up clients was examined in order to determine whether
the profile of these clients differed significantly from the profile of the total population of first visit
clients. Analysis revealed that there were no significant differences. However, there were some
differences in the characteristics of the follow-up clients compared with the total population that are
worth highlighting. Eighty percent of the follow-up group were male, the remaining 20% were female.
At first visit the ratio of male to female first visit clients was 3:1, and at follow-up the male to female
ratio was 4:1. This suggests that female clients were less likely to represent at the Unit. 
There were also some changes in the area of residence of the follow-up clients. At follow-up 19% of
clients were from the south inner city compared with 15% of the first visit clients. This suggests that the
proximity of the service to clients may have some influence on maintaining further contact with this
client group. Moreover, clients from the remaining North and South Dublin area were less likely to
represent at follow-up. This may be due to the emergence of treatment facilities within these localities. 
Finally, when the current accommodation of the 370 follow-up clients was compared with the total
population some notable differences emerged. Follow-up clients were more likely to report living in the
family home. Fifty six percent of follow-up clients reported this compared with 48% of first visit
clients. This may indicate that the family environment provides the necessary support for the clients,
which in turn increases their likelihood of representing. At the same time, follow-up clients were
proportionately more likely to report living in emergency accommodation. Fourteen percent of the
follow-up clients reported this, compared with 7% of the first visit clients. 
5.3 BEHAVIOUR CHANGES OVER TIME
This section examines the effectiveness of the Health Promotion Unit in terms of client outcomes. In
other words, it looks at how effective the Unit is in impacting on clients’ drug use, injecting and sexual
risk behaviour, and promoting contact with other treatment and medical services. As discussed
previously two methods of measuring clients’ behaviour change were included in the study. One
method was by comparing clients’ self reported baseline behaviour at the point of first contact with their
behaviour at follow-up. Secondly, a more subjective method was employed whereby clients were asked
whether they believed their behaviour had changed as a result of attending the Health Promotion Unit.
In this section the baseline and follow-up data for the 370 follow-up clients is presented.
In looking at data collected from clients on their self reported behaviour, at first visit and follow-up
intervention, they can be presented in two different ways. Firstly, the data can be used to illustrate the
frequency of occurrence of the behaviour at the two time periods under investigation; for example, the
number of clients who reported the use of various primary drugs at both first visit and follow-up. When
presented in this fashion the data permits an examination of the two groups over the two time periods.
Conversely, the data can be used to illustrate the changes in the proportion of clients reporting
behaviour changes over the time period under investigation. In this instance, analysis is concerned with
the number of clients who have reported a behaviour change from one occasion to the next, and the
nature and direction of such change, for example, the numbers of clients who reported a change in
primary drug use, either to or from heroin use.
5.3.1 Drug Use
Table 5.2 illustrates the primary drugs used by clients at the point of first contact with the Unit and at
the three month follow-up stage. It shows that at follow-up less clients reported using heroin as their
primary drug, than at first visit. At first visit 94% of clients reported using heroin, compared with 87%
of the clients at follow-up. Table 5.2 also illustrates that there was an increase in the number of clients
at follow-up who reported using physeptone as their primary drug. The number of clients who reported
the use of ‘Other’20 as their primary drug of choice at both first visit and follow-up was very low.
 
Table 5.2 Primary Drug Used
Primary Drug First Visit Follow-Up
n % n %
Heroin 346 94 321 87
Physeptone 15 4 31 8
Other 8 2 17 5
Total 369 100 369 100
Missing Observations = 1
Table 5.2 does not accurately show the changes in the number of clients who reported using either
heroin or physeptone at follow-up. However, Table 5.3 illustrates the nature of the changes in reported
use of heroin as a primary drug. For the purpose of this table all primary drugs with the exception of
heroin were combined to form one category, ‘Other’. In Table 5.3 the changes are highlighted by the
numbers in italics. It illustrates that a total of 41 clients, or 15% of those who reported using heroin as
their primary drug at first visit (n=345) had changed to using another primary drug at follow-up.
Conversely, 16 clients or 70% of those who reported using a primary drug other than heroin at first visit
(n=23) changed to utilising heroin as a primary drug at follow-up. Analysis revealed that the difference
                                                          
20 At first visit the drugs included under the category other were cannabis, benzodiazepines, speed, cocaine, N.A.P.S (morphine
sulphate tables) and crack. The same drugs were included in the ‘Other’ category at follow-up along with ecstasy. 
in the proportion of clients who reported the use of heroin as their primary drug at follow-up compared
with first visit was statistically significant (McNemar x2=10.1; p<0.01).
   Table 5.3 Changes in Primary Drug Use: Heroin
First Visit Follow-Up Visit
Heroin Other
Heroin (345, 94%) (304,83%) (41,11%)
Other (23, 6%) (16,4%) (7,2%)
Missing Observations = 2.
Similarly analysis revealed that there was a significant change in reported physeptone use over the two
time periods under investigation (McNemar x2=6.25; p<0.05). Table 5.4 illustrates the changes in the reported
use of physeptone as a primary drug at first visit and follow-up. A total of 26 clients, or 7% of those
who reported the use of ‘Other’ drug at first visit (n=353), reported changing to physeptone as a
primary drug at follow-up. Furthermore, all of these clients reported heroin as their primary drug at first
visit. However, Table 5.4 also shows that a further 10 clients changed their primary drug from using
physeptone at first visit, to ‘Other’ - more specifically heroin - at follow-up.
     Table 5.4 Change in Primary Drug Use: Physeptone
First Visit Follow-Up Visit
Physeptone Other
Physeptone (15,4%) (5,1%) (10,3%)
Other (353,96%) (26,7%) (327,89%)
Missing Observations = 2
Regarding routes of administration of primary drugs, Table 5.5 illustrates the reported routes by clients
at first visit and follow-up. This table shows that by follow-up a substantial number of clients had
relinquished injecting drug use as the route of administration of their primary drug. There was a
corresponding increase in the number of clients reporting oral routes of administration. These changes
in behaviour are related to the change in preference in primary drug use, outlined above, in that the
reduction in reported heroin use explains the accompanying decline in reported intravenous drug use.
Conversely, the increase in reported use of physeptone at follow-up, explains the increase in the
numbers of clients ingesting their primary drug, as illustrated in Table 5.5
 
  Table 5.5 Route of Administration of Primary Drug
Route First Visit Follow-Up
n % n %
Inject 342 93 325 88
Smoke 12 3 15 4
Ingest 14 4 29 8
Total 368 100 369 100
In order to examine whether the Health Promotion Unit was effective in promoting the adoption of safer
routes of drug use, the changes in the number of clients reporting injecting their primary drug was
examined in detail. Analysis revealed a significant change in the proportion of clients reporting this
behaviour at follow-up as illustrated in Table 5.6 (McNemar x2=5.35; p<0.05). Thirty six of the clients, or
11% of those who reported injecting their primary drug at first visit (n=341), had changed their route of
administration by follow-up, to a safer means of administration. On the other hand, 18 clients reported
changing from an alternative route to injecting their primary drug at follow-up.
Table 5.6 Changes in Injecting
First Visit Follow-Up Visit
 Non-IV IV
IV (341,93%) (36,10%) (305,83%)
Non-IV (26,7%) (8,2%) (18,5%)
Missing Observations=3.
Table 5.7 illustrates the overall reduction in the percentage of clients who used their primary drug 4 or
more times a day at follow-up, from 30% to 24%. There was however, an increase in the number of
clients who reported using their primary drug once a day. At first visit 52% of clients reported this,
while 56% of clients reported daily drug use at follow-up. Analysis revealed that the changes in
reported frequency of use in excess of four times a day, were statistically significant (McNemar x2=4.13;
p<0.05). Table 5.8 illustrates that 70 clients or 67% of those who reported using their primary drug in
excess of 4 times a day (n=104), had reduced their frequency of use by follow-up.
Table 5.7 Frequency of Use of Primary Drug
Route First Visit Follow-Up
n % n %
More than 4 times a day 105 30 86 24
Daily 183 52 202 56
4-6 times a week 26 7 19 5
1-3 times a week 29 8 43 12
Less than once a week 9 3 9 3
Total 352 100 359 100
Table 5.8 Changes in Frequency of Primary Drug Use
First Visit Follow-Up Visit
 < 4 times a day > 4 times a day
> 4 times a day (104,30%) (70,20%) (34,10%)
< 4 times a day (238,70%) (191,56%) (47,14%)
Missing Observations=28
Regarding poly drug use analysis revealed that that there was no significant change in the number of
clients reporting using more than one drug, between first visit and follow-up. However Figure 5.2
illustrates that 42% of follow-up clients reported poly drug use at both first visit and follow-up (n=154).
A further 19% of clients reported non-poly drug use at first visit and at follow-up (n=68). Furthermore,
Figure 5.2 shows the changes in reported poly drug use. Twenty percent of the clients (n=72) who
reported non-poly drug use at first visit, were poly drug users at follow-up. Conversely, 19% of the
clients changed from poly drug use at first visit, to not using any secondary drugs at follow-up.
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5.3.2 Injecting Risk Behaviour
One of the primary aims of any needle-exchange is to enable clients to reduce both the borrowing and
lending of used injecting equipment, and to promote safer injecting practices.  In this section changes in
the  injecting behaviour of the 370 clients who represented at the three month follow-up period are
examined. The Unit is also concerned with promoting more hygienic injecting practices, particularly in
terms of improving injecting techniques. To this end, Table 5.9 illustrates the number of clients who
reported injecting themselves at first visit and follow-up. At first visit 24% of clients reported that they
did not inject themselves, this decreased to 16% at follow-up.
Table 5.9 Injecting Status
Inject Self First Visit Follow-Up
n % n %
Yes 274 76 310 84
No 87 24 60 16
Total 361 100 370 100
Analysis revealed that there were significant changes in the proportion of clients reporting  injecting
themselves over the time period under investigation (McNemar x2=10.25; p<0.01). Table 5.10 illustrates that
56 clients, or 64% of those who reported not injecting themselves at first visit (n=87) were injecting
themselves by follow-up.
Table 5.10 Changes in Injecting Status
First Visit Follow-Up Visit
Not Inject Self Inject Self
Inject Self (273,76%) (26,7%) (247,69%)
Not Inject Self (87,24%) (31,9%) (56,15%)
Missing Observations=10
One of the main safer injecting techniques promoted by the Unit is the cleaning of the injection site
prior to injecting. Table 5.11 illustrates the number of clients who reported cleaning their injection site
prior to injecting at first visit and at follow-up. At first visit 64% of the clients reported cleaning their
injection site, this increased to 84% at follow-up.
Table 5.11 Clean Injecting Site
Clean Skin First Visit Follow-Up
n % n %
Yes 147 40 206 56
No 219 60 163 44
Total 366 100 370 100
Table 5.12 illustrates that there were significant changes in the number of clients who reported such
behaviour (McNemar x2=23.2; p<0.001). Ninety six clients, or 44% of those who reported that they did not
clean their injecting site at first visit (n=132), reported that they always did so at follow-up.
 
Table 5.12 Changes in Cleaning Injecting Site
First Visit Follow-Up Visit
Don`t Clean Site Clean Site
Clean Site (147,40%) (39,11%) (108,29%)
Don’t Clean Site(219,60%) (123,34%) (96,26%)
Missing Observations=4
As discussed in detail in the previous chapter the lending and borrowing of used injecting equipment
differs markedly in terms of personal risk. The Health Promotion Unit aims to eliminate, as far as
possible, both of these risky behaviours. Table 5.13 illustrates that at follow-up there was a reduction in
the percentage of clients who reported the recent borrowing of injecting equipment. At first visit 23% of
clients reported borrowing used injecting equipment in the previous four weeks, while only 15% of the
follow-up clients reported such borrowing.
Table 5.13 Borrowed Injecting Equipment
Borrowed Equipment First Visit Follow-Up
n % n %
Yes 85 23 55 15
No 278 77 312 85
Total 363 100 367 100
Analysis revealed that there was a significant change in the number of clients who reported borrowing
injecting equipment at follow-up, compared with rates of borrowing among first visit clients (McNemar
x2=10.11; p<0.01). Table 5.14 illustrates that 60 clients, or 71% of those who reported borrowing used
injecting equipment at first visit (n=85), did not engage in this activity in the four weeks prior to follow-
up. However, 29 clients or 11% of those who did not borrow used injecting equipment at first visit
(n=275), reported  doing so at follow-up. As discussed in detail in Chapter Four the sharing of injecting
equipment is a complex behaviour, not inevitably eliminated by increased availability of injecting
equipment.
Table 5.14 Changes in Borrowing Behaviour
First Visit Follow-Up Visit
No Borrowing Borrowing
Borrowing (85,24%) (60,17%) (25,7%)
No Borrowing (275,76%) (246,68%) (29,8%)
Missing Observations =10
Table 5.15 shows the percentage of clients who reported lending their used injecting equipment at first
visit and at follow-up. It illustrates that 15% of clients reported lending used injecting equipment at first
visit and this dropped to 9% at follow-up. As the lending rates exhibited by the population as a whole at
first visit were less than the borrowing rates, a less dramatic change in this activity occurred at follow-
up.
            Table 5.15 Lending Injecting Equipment
Lent Equipment First Visit Follow-Up
n % n %
Yes 56 15 33 9
No 309 85 335 91
Total 365 100 368 100
Nonetheless, Table 5.16 shows that there was a significant change in the numbers of clients reporting
the recent lending of used injecting equipment (McNemar x2=7.93; p<0.01). Forty two clients, or 76% of
those who reported lending used injecting equipment at first visit (n=55), had ceased engaging in this
activity by follow-up. Alternatively, 19 clients or 6% of those who reported not lending at first visit, had
lent injecting equipment in the four weeks prior to follow-up.
 
   Table 5.16 Changes in Lending Behaviour
First Visit Follow-Up Visit
 No Lending Lending
Lending (55,15%) (42,12%) (13,3%)
No Lending (308,85%) (289,80%) (19,5%)
Missing Observations=7.
At first visit and follow-up, clients were also asked about the sharing of injecting paraphernalia  (i.e.
spoons and filters), in the four weeks prior to contact with the Unit. Table 5.17 illustrates that at first
visit 54% of the clients reported sharing injecting paraphernalia, at follow-up 53% of the clients
reported such behaviour. Analysis revealed that there was no significant change in the percentage of
clients reporting the sharing of injecting paraphernalia at first visit and follow-up. Nevertheless, 36% of
those who reported sharing paraphernalia at first visit (n=194) had ceased by follow-up and 41% of
those who reported not engaging in such activity at first visit (n=165) did so at follow-up.
Table 5.17 Sharing Injecting Paraphernalia
Injecting Paraphernalia First Visit Follow-Up
n % n %
Yes 197 54 194 53
No 166 46 172 47
Total 363 100 366 100
5.3.3 Sexual Risk Behaviour
The Health Promotion Unit aims to promote safer sexual behaviour. To this end it advocates the use of
condoms among all clients attending the Unit. As illustrated in the previous chapter this is particularly,
though not exclusively, an issue among clients who have sexual partners who are injecting drug users.
In this section the sexual activity of the 370 clients who represented at the three month follow-up period
is examined, and a comparison made between their behaviour at first and follow-up. Analysis revealed
that there was no significant change in the number of clients who reported being sexually active at first
visit and follow-up. At first visit 73% of the sample reported being sexually active this increased
slightly to 79% at follow-up.
Table 5.18 illustrates that the percentage of clients who reported having a regular sexual partner did not
change much over the three month time period. At first visit 61% of clients reported having a regular
sexual partner, this increased slightly to 64% at follow-up. Further analysis revealed that there was no
significant difference in the proportion of clients reporting changes in whether they have a regular
sexual partner. However, 50 clients, or 23% of those who reported having a regular sexual partner at
first visit (n=223), did not at follow-up. On the other hand, 61 clients or 44% of those who did not have
a regular sexual partner at first visit (n=140), reported having a regular partner at follow-up. 
Table 5.18 Regular Sexual Partners
Regular Sexual Partner First Visit Follow-Up
n % n %
Yes 223 61 235 64
No 140 39 133 36
Total 363 100 368 100
Clients were asked whether they had a regular sexual partner who was an injecting drug user. There was
no difference in the percentage of clients (32%) who reported this at first visit and follow up. However,
analysis revealed that there were individual changes which were statistically significant (McNemar x2=5.19;
p< 0.05). Table 5.19 shows that 49 clients, or 45% of those who reported having an IV partner at first
visit (n=109), did not at follow-up. On the other hand 28 clients, or 12% of those who reported not
having an IV partner at first visit, reported having an IV partner at follow-up.
Table 5.19 Changes in Injecting Sexual Partner
First Visit Follow-Up Visit
 No IV Partner IV Partner
IV Partner (109,32%) (49,14%) (60,18%)
No IV Partner (227,68%) (199,59%) (28,9%)
Missing Observations = 34.
Table 5.20 illustrates the percentage of clients who reported using condoms at first visit and at follow-
up. Sixty two percent of clients reported that they never used condoms at first visit, this dropped to 57%
at follow-up21. Further analysis reveals that the changes in reported condom use were not statistically
significant (McNemar x2=2.25; p<0.13). Table 5.21 illustrates that 73 clients, or 33% of those who reported
never using condoms at first visit (n=222), reported using them at follow-up. However Table 5.21 also
shows that in addition condom use changed in the other direction, in that 55 clients, or 40% of those
who reported using condom at first visit (n=138) reported not using them at follow-up. 
Table 5.20 Condom Use
Condom Use First Visit Follow-Up
n % n %
Uses Condoms 139 38 159 43
Never 224 62 208 57
Total 363 100 367 100
Table 5.21 Changes in Condom Use
First Visit Follow-Up Visit
 Never Uses Condoms
Uses Condoms(138,38%) (55,15%) (83,23%)
Never (222,62%) (149,42%) (73,20%)
Missing Observations=10
In the previous chapter it was illustrated that clients who had a regular sexual partner were significantly
more likely to report never using a condom. Analysis was carried out on the data in an effort to
determine whether clients who had regular partners changed their condom use. Table 5.22 illustrates
that changes in reported condom use among this sub-section of the population were not statistically
significant (McNemar x2=2.08; p<0.14). However, 41 clients, or 29% of those who reported not using
condoms at first visit (n=143), reported using them at follow-up.
                                                          
21 The variable condom use was recoded to form a dichotomous variable for the McNemar analysis. Accordingly, if
an individual reported using a condom sometimes or never, due to the continued level of risk behaviour, they were
classified as not using condoms.
Table 5.22 Changes in Condom Use with Regular Sexual Partner
First Visit Follow-Up Visit
 Never Uses Condoms
Use Condom (77,35%) (28,13%) (49,22%)
Never  (143,65%) (102,46%) (41,19%)
5.3.4 Treatment and Medical Contact
As illustrated in the previous chapter only 21% of all first visit clients (n=1337) reported being currently
in contact with any other drug treatment service. Reported levels of contact with medical services were
substantially higher among first visit clients (58%). The Health Promotion Unit aims to increase clients’
contact with both drug treatment and medical services. To this end clients are often referred on to other
services. In this section, clients’ reported contact with other services are examined, and changes in such
contacts, over the time period of investigation, analysed.
Table 5.23 illustrates the percentage of clients who reported being in contact with other drug treatment
services at first visit and at follow-up. At the point of first contact 20% of the clients reported being in
contact with other drug treatment services, this increased to 26% at the three month follow-up period.
Analysis revealed that the change in the proportion of clients reporting contact with other drug
treatment services between first visit and follow-up were not statistically significant. Nevertheless, 67
clients, or 23% of those who reported no contact with any other drug treatment service at first visit
(n=294), reported such contact at follow-up.
Table 5.23 Contact with Other Drug Treatment Services
Treatment Contact First Visit Follow-Up
n % n %
Yes 75 20 95 26
No 295 80 274 74
Total 370 100 369 100
At both first visit and follow-up all clients are asked whether they have undergone a detoxification in
the previous three months. Table 5.24 shows that over half of the clients (55%) reported at first visit
having undergone a detoxification in the previous three months, compared with 25% of the clients at
follow-up. Analysis revealed that there was a significant change in the number of clients reporting
having had a detoxification at follow-up visit (McNemar x2=66.96;p<0.01). This is due to the fact that as
illustrated in Table 5.25 the 148 clients who reported having undergone a detoxification in the three
months prior to their first visit (n=204), had not undergone another detoxification by follow-up.
However, it is worth noting that 36 clients, or 22% of those who reported not having undergone a
detoxification at first visit (n=165), reported having had one prior to their follow-up visit. This result is
not surprising, as in order for clients to attend the Health Promotion Unit it is generally accepted that
they must be active drug users. In short, one would expect that if clients were detoxifying they would
not be attending the Unit. The suggestion is that the group of follow-up clients are self selecting, in that
clients who have detoxified between first visit and follow-up are less likely to represent at the Unit. 
Table 5.24 Previous Detoxification
Detoxification First Visit Follow-Up
n % n %
Yes 205 55 92 25
No 165 45 277 75
Total 370 100 369 100
Table 5.25 Changes in Detoxification
First Visit Follow-Up Visit
 No Detoxification Detoxification
Detoxification (204,55%) (148,40%) (56,15%)
No Detoxification (165,45%) (129,35%) (36,10%)
Missing Observations=1
In order to promote contact with medical services, all clients who do not have a medical card and are
entitled to one, receive the appropriate application form at the Health Promotion Unit. Table 5.26
shows that at first visit 51% of the clients reported having a medical card, this increased to 54% at
follow-up. Although the changes in the proportion of clients reporting having a medical card at follow-
up were not statistically significant, 48 clients, or 27% of those who had no medical card at first visit
(n=178), reported having one by follow-up.
Table 5.26 Medical Card Holders
Medical Card First Visit Follow-Up
n % n %
Yes 187 51 200 54
No 178 49 166 46
Total 365 100 366 100
Table 5.27 illustrates the number of clients who reported having had some type of medical contact in
the three months prior to first visit and follow-up. At first visit 56% of the clients reported contact with
medical services; this increased slightly to 57% at follow-up. On the other hand Table 5.28 shows the
nature of these changes in reported medical contact. Although these changes were not statistically
significant, this table illustrates that 77 clients, or 48% of those who did not report any medical contact
at first visit (n=161), reported such contact at follow-up.
Table 5.27 Medical Contact
Medical Contact First Visit Follow-Up
n % n %
Yes 206 56 212 57
No 161 44 158 43
Total 367 100 370 100
Table 5.28 Changes in Medical Contact
First Visit Follow-Up Visit
 No Medical Contact Medical Contact
Med. Contact (206,56%) (74,20%) (132,36%)
No Med. Contact (161,44%) (84,23%) (77,21%)
Missing Observations=3
Promoting medical contact also entails encouraging clients to engage in specialist contact such as
having a HIV test, and receiving the hepatitis B vaccination. Table 5.29 illustrates that at first visit 42%
of clients reported having had a HIV test in the previous three months. At follow-up 24% of the clients
reported having had the test. Table 5.30 shows the nature of the changes in clients’ reporting having
had the test. Thirty six clients, or 18% of those who reported not being tested in the three months prior
to their first visit (n=203), had done so by follow-up. The majority of clients who reported having had a
HIV test in the three months prior to first visit, were not tested again in the three months prior to follow-
up.
Table 5.29 HIV Test
HIV Test First Visit Follow-Up
n % n %
Yes 151 42 89 24
No 206 58 277 76
Total 357 100 366 100
Table 5.30 Changes in Reported HIV Test
First Visit Follow-Up Visit
 No HIV Test HIV Test
HIV Test (150,42%) (100,28%) (50,14%)
No HIV Test (203,58%) (167,48%) (36,10%)
Missing Observations=17
Regarding the hepatitis B vaccination Table 5.31 illustrates that 16% of the first visit clients reported
having had the vaccination in the three months prior to their first visit. At follow-up 18% of the clients
reported having had the vaccination prior to follow-up. Although the changes in reportedly having had a
vaccination were not statistically significant 31 clients, or 10% of those who reported not having had a
vaccination at first visit (n=301), reported having had one at follow-up. Moreover, 32 clients or 55% of
those who reported having had a vaccination at first visit (n=58), also reported having had the
vaccination in the three months prior to follow-up. This is primarily due to the fact that the vaccination
against hepatitis B consists of a course of three injections over a six month time period.
Table 5.31 Vaccination Against Hepatitis B.
Vaccination Hep B. First Visit Follow-Up
n % n %
Yes 58 16 66 18
No 303 84 302 82
Total 361 100 368 100
5.3.5 Health and Well Being
As discussed in Chapter Three a subjective health assessment was included in the first visit and follow-
up intervention sheets. In this section changes in clients’ physical and mental health are explored.
Analysis revealed that there were no significant changes in the number of clients who reported having
hepatitis B, hepatitis C or jaundice between first visit and follow-up. However, a number of clients at
follow-up did report being affected by the aforementioned conditions, who did not at first visit. For
example 11 clients, or 3% of those who reported not having hepatitis B at first visit (n=319) reported
having it at the three month follow-up. Similarly, 24 clients or 8% of those who reported not having
hepatitis C at first visit (n=285) reported the symptoms of hepatitis C at follow-up. 
Table 5.32 illustrates the changes in reported physical health complaints over the time period under
investigation. This table shows that there was a significant change in the number of clients reporting
weight loss over the three month follow-up period. Eighty six clients or 40% who reported weight loss
at first visit (n=215) did not report this at follow-up. Moreover, 68 clients or 56% of those who did not
report weight loss at first visit (n=121), did not report any deterioration in the weight at follow-up. 
Table 5.32 Changes in Physical Health Complaints
Physical Complaint First Visit
% (n)
Follow-Up
% (n)
x2 p Value
Weight Loss 64(221) 54(195) 7.36 <0.01*
Abscesses 16(56) 17(62) 0.22 <0.6
Insomnia 70(245) 69(250) 0.01 <0.9
Overdose 16(46) 13(46) 0.91 <0.34
There were a number of changes in clients’ mental health complaints over the time period under
investigation. Table 5.33 illustrates that there was a drop in the number of clients who reported
suffering from all mental health complaints, between first visit and follow-up. For example Table 5.33
shows that 65% of clients at first visit reported suffering from depression, this dropped to 58% at
follow-up. Moreover, 70 clients or 31% of those who reported suffering from depression at first visit
(n=224), did not report this at follow-up. Table 5.33 illustrates that there was a 9% drop in reported
rates of anxiety at follow-up. Further analysis revealed that 77 clients or 44% of those who reported
suffering from anxiety at first visit (n=177), did not at follow-up. Not only was there a decrease in the
percentage of clients reporting this mental health complaint, Table 5.33 also shows that there was a
sizable drop in the percentage of clients reporting suicidal tendencies at follow-up. Forty nine clients or
68% of those who reported feeling suicidal at first visit (n=72), were not at follow-up.
Table 5.33 Changes in Mental Health Complaints
Health Complaint First Visit
% (n)
Follow-Up
%(n)
x2 p Value
Depression 65(228) 58(210) 5.48 <0.01*
Anxiety 53(182) 44(158) 4.46 <0.05*
Unable to Cope 52(182) 47(170) 3.67 <0.05*
Isolated 49(168) 43(155) 2.4 <0.12
Suicidal 27(76) 15(50) 7.14 <0.01*
5.3.6 Advice and Information
In order to encourage behaviour change in clients it is essential that the Health Promotion Unit provide
clients with the necessary advice and information to enable them to make the appropriate changes. To
this end, the Unit aims to provide all clients with information on safer drug use, safer injecting
techniques and safer sex. All follow-up clients were asked whether they received this information over
the three months they had been attending the Health Promotion Unit. Figure 5.3 illustrates that the
majority of clients (70%) reported that the Unit provided them with information on safer injecting
techniques.  
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Likewise, Figure 5.4 shows that 71% of the follow-up clients reported that they had received
information on safer drug use. While Figure 5.5 illustrates that the majority of clients reported
receiving information specifically on safer sex. Unsurprisingly analysis revealed that there was a
relationship between a clients’ reported receiving information on safer drug injecting techniques and
safer drug use. In short, clients who reported receiving information on safer drug use were significantly
more likely to report receiving information on safer injecting techniques (x2=112.15; df=2; p<0.001). Equally
clients who reported receiving information on safer drug use were significantly more likely to report
that they received information on safer sex. The suggestion is that the majority of follow-up clients were
satisfied with the advice and information provided by the Health Promotion Unit. However, there exists
a small minority of clients who were not satisfied with the information provided by the Unit, and these
clients were proportionally more likely to  report that the Unit could be improved upon, as will be
discussed later.
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5.4 SELF REPORTED CHANGES IN BEHAVIOUR
As discussed previously two methods of measuring clients’ behaviour changes over the three month
follow-up period were employed. One method, as presented above, was by comparing clients self
reported baseline behaviour at the point of first contact with their behaviour at follow-up. The second
method permitted a more subjective analysis of behaviour change, by asking clients whether they
believed that their behaviour had changed since first attending the Unit. In this section clients’ self
reported behaviour changes are examined.
 
5.4.1 Drug Use
All follow-up clients were asked whether they believed that their drug use had changed in any way
since they first attended the Health Promotion Unit. Figure 5.6 below illustrates that fifty six percent of
the follow-up clients (n=207) reported changes in their drug use since attending the Health Promotion
Unit. 
Figure 5.6 Self-Reported Changes in Drug Use
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The majority of the 207 clients who reported changes in their drug use, reported positive changes.
These self reported changes in drug use can be broken down into the categories outlined in Table 5.34;
Table 5.34 Categories of Behaviour Change: Drug Use 
½ 58% reported a reduction in their drug use
½ 23% reported an increase in their drug use
½ 7% reported cessation of drug use for a period of time
½ 3% reported using safer methods of drug use
½ 5% reported changing their primary drug to physeptone
½ 4% reported an increase in knowledge re: safer drug use
Table 5.34 illustrates that over half of the clients (58%) reported that they felt that their drug use had
reduced since first attending the Health Promotion Unit. Moreover, 7% of clients reported that they had
stopped using drugs for a period of time, between first visit and follow-up. On the other had 23% of the
clients reported that there had been an increase in their drug use over the three month follow-up period.
Finally Table 5.34 confirms the previously identified changes to physeptone use illustrated in Table 5.4.
On the follow-up questionnaire a section was provided which enabled clients to state in their own words
how they felt their drug using behaviour had changed over the three month follow-up period. Figure
5.7 presents some of the comments made by clients. This figure illustrates the diversity of behaviour
changes reported by clients. The selection of comments from clients presented in Figure 5.7 illustrates
that behaviour changes ranged from changes in choice of primary drug to period of being drug free. The
information provided in Figure 5.7 highlights how important minor behaviour changes are in promoting
harm reduction among the client group.
Figure 5.7 Clients’ Reported Changes in Drug Use
“I’ve stopped using coke since coming here”-21 yr-old male student
“I’ve cut down a lot, I was on three or four bags of heroin a day now I’m only on one bag a
day”-Male drug user staying in a hostel in Dublin 8
‘Now I’m on phy and not injecting anymore”-Male client who had been injecting heroin for 17 years
“I’m not using regularly anymore’-Mother of three from the North Inner City
“I stopped using for a while to clear my head”-24-yr-old male seeking methadone programme
“I’m smoking more but injecting less”-Male poly drug user
“My heroin habit has dropped, I have only had about six turn on’s in the last month and
I’m now on phy”-Male drug user who at first visit injected 4 or more times a day
“Now I’m only dabbling”-39-yr-old male from Co. Wicklow
“I have been drug free for the last 6 weeks”-26-yr-old female now on physeptone
“I’m using less heroin than when I came here first- I’m not strung out now”-Street worker
who has been injecting for the last six months
‘’I’ve gone back to smoking and cut down on my habit”-44-yr-old male who has been injecting
on/off for 25 years
5.4.2 Injecting Behaviour
In addition, all follow-up clients were asked whether they believed that their injecting practices had
changed in any way since they first attended the Health Promotion Unit. Figure 5.8 illustrates that 47%
(n=174) of clients did report that their injecting practices had changed.
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As with the changes in drug use, the majority of clients who reported changes in their injecting
practices, reported positive changes. Table 5.35 illustrates the categories of behaviour change
Table 5.35 Categories of Behaviour Change: Injecting Practices
½ 38% reported employing more ‘hygienic’ injecting practices
½ 24% reported being more ‘careful’ when injecting
½ 19% reported having learnt how to inject correctly
½ 9% reported increased awareness of safer practices
½ 6% reported rotating their injecting site
½ 4% reported no longer sharing injecting equipment
Table 5.35 illustrates that thirty eight percent of the clients reported that their injecting behaviour had
changed, in that as a result of attending the Health Promotion Unit they employed more hygienic
injecting methods. This included for example using swabs prior to injecting and cleaning injecting
equipment. A further 19% of the clients reported that they had learnt how to inject properly. As
illustrated in Chapter Four a number of clients did not know how to inject themselves. As a learnt
behaviour, novices often use inappropriate techniques, or as illustrated previously get other people to
inject them. In terms of safer injecting techniques it is better for drug users to be in control of the
situation and inject themselves. Finally, Figure 5.9presents some of the statements made by clients
regarding changes in their injecting practices, since first visit.
Figure 5.9 Clients’ Reported Changes in Injecting Practices
“I’ve learnt how to inject myself now”-19-yr-old female who at first visit was being injected by her
partner
 “I’m not sharing works anymore”-Rough sleeper in Dublin Inner City
“I am now more aware of viruses such as Hep B and Hep C”-Female Client who engages 
in high risk sexual behaviour
“Since I have been coming here I have always used citric”-35-yr-old client who has been
injecting for 9 years
“I now understand the risks of sharing”-20-yr-old male who uses with others in a squat
“I’ve found advice on safer injecting practices very good”-27-yr-old female who reported having
never attended any drug service at first visit
“I won’t share spoons and filters now”-32-yr-old male who has recently commenced injecting following
a drug free period of 5 years 
 “Before I used to blow my veins, now I know how to inject safely”-26-yr-old male who at first
visit reported the problem of abscesses
“I’ve stopped injecting for a while so I can clean up my arms”-Male drug user who has recently
initiated IV drug use
“I use swabs now and I’m more aware of cleaning before injecting”-22-yr-old drug user who
reported at first visit not cleaning site before injecting 
“I use clean ‘works’ all the time and always clean my injecting site with swabs ”-32-yr-old
male staying with friends and relatives
“I take more care of myself”-23-yr-old female from Dublin 8
5.5 DISCUSSION
In this chapter, clients’ baseline self reported risk behaviour was compared with their behaviour at
follow-up. The ultimate aim was to evaluate the effectiveness of the Merchant’s Quay Project’s Health
Promotion Unit in terms of client outcomes - or changes in clients’ behaviour over time. As discussed
previously in this Report, measuring behaviour change in individuals is fraught with difficulties. To
summarise, any behaviour change is a result of the interaction of three factors; the person, the
environment and the intervention. In theory for an identified behaviour change to be due entirely to an
intervention, all other variables to do with the person and his/her environment would have to remain
constant. This is of course never the case; various extraneous factors operate at the same time as any
given intervention, which will invariably have an impact on behaviour change. Moreover, a wide
variety of interventions will be in operation in any given city, and it will rarely be possible to identify
the exact contribution of any one of them. 
Over the two years, while the evaluation of the Merchant’s Quay Health Promotion Unit was being
conducted a number of changes were occurring in Dublin, as regards drug treatment. For example, the
last few years have seen an increase in community based responses, largely funded by Local Drug Task
Forces. This in turn has lead to an increase in the availability of prescribed physeptone. No doubt these
changes have had an impact on the behaviour of injecting drug users in Dublin, and the impact of such
interventions is largely inseparable from that of the Health Promotion Unit. The positive behaviour
changes identified in this Chapter are no doubt a result of a combination of factors, many external to the
Health Promotion Unit. However the fact that follow-up clients consistently reported positive outcomes,
suggests that the Health Promotion Unit contributed to these changes. In short, while all behaviour
changes cannot be solely attributed to attending the Health Promotion Unit, international research has
consistently shown that attending a syringe exchange impacts on drug injectors’ risk behaviour. What
follows is a summary of the key outcomes identified in this Chapter.
5.5.1 Drug Use
Many of the objectives of the Health Promotion Unit are directed at changing clients’ drug using
behaviour. This includes reducing the use of risky combinations of drugs, changing routes of
administration, and reducing the frequency of use of drugs. In short, although the ultimate aim of the
Unit may be the cessation of intravenous drug use, all behaviour changes in this direction, no matter
how insignificant they may seem, are beneficial. The analysis in this chapter illustrated that the Health
Promotion Unit has been effective in impacting on clients’ drug use.
It was shown that at follow-up there was a significant reduction in the percentage of clients reporting
the use of heroin as their primary drug.  At first visit 94% of clients reported the use of heroin, this
dropped to 87% at follow-up. Moreover, there was a corresponding increase in the number of clients
who reported the use of physeptone as their primary drug at follow-up. Analysis also revealed a
significant change in the number of clients who reported injecting their primary drug at first visit. Thirty
six clients or 11% of those who reported IV drug use at first visit, had ceased to administer their
primary drug intravenously at follow-up. This change in IV drug use at follow-up is no doubt related to
changes in choice of primary drug. 
As the aforementioned changes in drug use are relatively dramatic, the suggestion is that they are
largely due to external factors, in particular, the increase in the number community based treatment
programmes prescribing physeptone. However, the suggestion is that, as the level of treatment contact
was so low at first visit (21%), the Health Promotion Unit played a significant role in referring clients
on to other treatment services where prescribed physeptone is available.
5.5.2 Injecting Practices 
As illustrated previously the Health Promotion Unit aims at impacting upon clients’ injecting practices.
To this end, the Unit strives not only to reduce the sharing of injecting equipment and paraphernalia, but
also to encourage the adoption of safer injecting practices among the client group. The analysis
presented in this chapter illustrates that the Unit has proved largely effective in this regard. Moreover,
the quantitative data presented in this Chapter supported the comparative analysis of baseline and
follow-up data collected from clients. 
Firstly, the analysis in this chapter illustrated that over the three month follow-up period there were
significant changes in clients’ injecting practices. More specifically, at follow-up there was a substantial
reduction in the percentage of clients who reported that they did not inject themselves. At first visit 24%
of clients reported that they did not inject themselves, this decreased to 16% at follow-up. Injecting is a
learnt behaviour. As many of the first visit clients attending the Health Promotion Unit were young,
recent injectors, they were not yet accomplished at administering an injection. At follow-up clients
reported being more hygienic in their injecting practices. For example, there was an increase in the
number of clients who reported cleaning their injecting site prior to IV drug use. At first visit 40% of
clients reported this, compared with 56% at follow-up.
It has been shown that there was a significant reduction in the proportion of clients who reported the
recent borrowing of injecting equipment at follow-up. At first visit 23% of the client group reported
borrowing used injecting equipment; this dropped to 15% at follow-up. More detailed analysis
demonstrated that 60 clients who reported borrowing used injecting equipment at first visit, reported not
engaging in this behaviour in the month prior to follow-up. In other words, 71% of those who reported
borrowing used injecting equipment at first visit had eliminated this behaviour by follow-up. There
were also significant changes in the proportion of clients who reported the recent lending of used
injecting equipment. At first visit 15% of the client group reported lending others their used injecting
equipment; this dropped to 9% at the three month follow-up intervention. Put another way, 76% of the
clients who reported lending other their used injecting equipment at first visit (n=42), did not engage in
this behaviour in the four weeks prior to follow-up. However, the follow-up clients did not report
similar changes in the sharing of injecting paraphernalia. Over half the client  group reported the
sharing of spoons and filters at first visit (54%) and at their three month follow-up visit (53%). This
suggests that there is a need to stress  the risk of viral infection as a result of the sharing of injecting
paraphernalia such as spoons and filters with the clients attending the Unit. 
5.5.3 Sexual Behaviour
As discussed in Chapter Two, traditionally syringe exchanges have concentrated on injecting risk
behaviour, less attention has been paid to sexual risk behaviour. Moreover, international research
suggests that changing sexual behaviour is more difficult. A combination of these two factors has
resulted in little or no changes in the sexual behaviour of drug users attending syringe exchanges.
Nonetheless, the Health Promotion Unit aims to change clients’ sexual behaviour, more specifically to
promote the use of condoms. At first visit 62% of clients reported never using condoms; this decreased
by 5% at the three month follow-up. The data presented in this chapter illustrated that there was also an
increase in condom use among those least likely to use them, that is individuals with a regular sexual
partner. Forty one clients or 29% of those who reported never using condoms at first visit, reported
using them at follow-up. One issue of concern to emerge from this research is the high level of
movement in and out of ‘regular sexual relationships’. Fifty clients, or 23% of those who reported
having a regular sexual partner at first visit did not at follow-up. While, 61 clients or 44% of those who
did not have a regular sexual partner at first visit reported having a regular partner by follow-up. This
has implications in terms of condom use and transmission of HIV and hepatitis. As illustrated in
Chapter Four, individuals who were in a regular sexual relationship were significantly more likely than
their counterparts to report never using condoms. Thus the large number of clients moving in and out of
such relationship, while not using condoms increases the likelihood of transmission of HIV and
hepatitis.
5.6 SUMMARY
In this chapter, it has been highlighted that the Health Promotion Unit was effective in not only providing
an appropriate service to attendees but also in producing the desired outcomes. It illustrates that the Health
Promotion Unit was successful in initiating contact with ‘hard to reach’ injecting drug users such as;
women, young injectors and recent injectors. Features of the Health Promotion Unit such as, the inner city
geographical location, high staff ratio and the provision of refreshments, allow for the drop in nature of the
service, in which high levels of social interaction occurs among attendees. This no doubt has a major
impact on the effectiveness of the Unit, as to what extent it remains unknown. It is also worth noting that
the evaluation process did not interfere with the daily activities of the Unit and it not only produced
positive outcomes but also a profile of attendees. 
In summary, the Unit has the ability to reduce the frequency of injecting, the incidence of sharing and to
promote cleaner injecting practices and behaviour. To a lesser extent, it has the ability to increase condom
use and more importantly to increase use among those who reported having a regular sexual partner. In
summary, there were notable changes in the behaviour of follow-up clients according to each of the various
outcome domains; drug use, injecting risk behaviour, sexual risk behaviour, contact with services and
health and well-being. However, there were less significant changes in regard to the sharing of injecting
paraphernalia. While it is recognised that any behaviour change is as a result of the interaction of three
factors: the person, the environment, and the intervention, the fact that the Health Promotion Unit is
consistently recording favourable outcomes would lead one to assume that the Unit is having a positive
impact on clients’ behaviour. The main outcomes are summarised in Table 5.36 below;
Table 5.36 Main Outcomes
12% reduction in nos. using heroin
7% increase in nos. using physeptone
Drug Use and 11% reduction in nos. injecting
Injecting Practices 67% reduction in nos. injecting four or more times a day 
64% increase in nos. self injecting
44% increase in nos. employing cleaning practices
71% reduction in nos. borrowing injecting equipment
76% reduction in nos. lending injecting equipment
33% increase in nos. using condoms
29% increase in nos. using condoms with their partner
23% increase in nos. contacting other drug services
27% increase in nos. having a medical card
48% increase in nos. contacting medical services
Health and 18% increase in nos. having a H.I.V test
Well Being 10% increase in nos. having a hepatitis B vaccination 
22% increase in nos. having a detox
72% reduction in nos. overdosing
44% reduction in nos. feeling anxious
42% reduction in nos. feeling isolated
62% reduction in nos. reporting abscesses
40% reduction in nos. reporting weight loss
CHAPTER 6  
SUMMARY AND 
RECOMMENDATIONS
The Merchant’s Quay Project commenced the evaluation of it’s Health Promotion Unit in 1997 in order
to determine the effectiveness of the service provided to its clients.  To date, no similar evaluation has
been undertaken in Ireland. The data gathered over the 18 months of the evaluation process, not only
provided the desired outcome measures but also permitted a detailed profile of injecting drug users in
Dublin. In this section a summary of the main findings and their implications are located within a
broader social context. 
6.1 SUMMARY 
Harm Reduction
1. Harm reduction has proved successful as a public health response to drug use because it
emphasises practical and achievable objectives. Moreover, it is neutral about the long term goals
of an intervention. 
The principle feature of harm reduction is the acceptance of the fact that all drug users cannot be
expected to cease their drug use at the present time (Single,1995). It presupposes that the dynamics of
every day drug use are capable of modification (Burt and Stimson, 1993), and that any change no matter
how small, is significant. This study has shown that harm reduction strategies, more specifically syringe
exchange programmes, are an effective means of reducing the levels of risk behaviour among those not
prepared to cease using drugs. The fact that 1,337 new attendees presented at the Health Promotion Unit
over an 18 month period,  illustrates the demand for such a service.  Moreover, the appeal of such a
service lies primarily in the fact that it aims to reduce risk behaviour without necessarily reducing drug
use.
Syringe Exchanges: A Model of Behaviour Change
2. Presentation at a syringe exchange provides drug injectors with the knowledge and means
necessary to reduce risk behaviour. 
Syringe exchanges operate on a knowledge and means model of behaviour change. This is based on the
assumption that in order to change behaviour, people need to know the reasons why such changes are
necessary and be provided with the means to make these changes. This study illustrates that syringe
exchanges can provide the knowledge (information on safer injecting) and means (i.e. sterile syringes)
necessary to promote and sustain behaviour change among injecting drug users.
International research shows high levels of accurate knowledge about HIV transmission among
injecting drug users (Burt and Stimson, 1993). However, the findings of this study indicate that levels of
knowledge vary according to routes of transmission. The suggestion is that individuals are very aware
of the risks of transmission via sharing of injecting equipment but lack accurate knowledge on other
routes (ie. paraphernalia and sexual transmission). While syringe exchanges provide the means to
change behaviour by increasing the ‘general availability’ of clean injecting equipment, ‘situational
availability’ is not addressed by the majority of syringe exchanges. For example, injecting drug users do
not have access to clean injecting equipment in the evenings3 or at weekends in Dublin. Consequently,
forward planning is required by injecting drug users, in order to prevent any possible need to share.
However research has shown that there is a gap between knowledge of HIV transmission and the
continuation of high risk behaviour, suggesting that even with the knowledge and means to change,
there may be further obstacles to risk reduction. These include for example, social situations between
friends and acquaintances, other situational contexts and lifestyle factors (Donoghoe et al, 1992).
Injecting Risk Behaviour
3. Syringe/needle sharing proved to be an exceptional rather than a normal occurrence.
Moreover, the Health Promotion Unit was effective in reducing the levels of such behaviour. On
the other hand, the reported levels of sharing injecting paraphernalia was high, and did not
reduce over time.  
This study has illustrated that the provision of sterile injecting equipment can have a positive impact on
levels of sharing. At follow-up, clients were proportionately less likely to report the recent borrowing of
used injecting equipment. Moreover, a reduction was also seen in the number of clients who reported
recently lending used injecting equipment to others. Although the ultimate aim of any syringe exchange
is to eliminate sharing, this is not possible without identifying the social, environmental and cultural
context within which this behaviour occurs. For example, international research has shown that living
with an injecting drug user (Darke et al, 1994), homelessness (Flemen 1987; Cox and Lawless, 2000),
poly-drug use (Donoghoe et al,1992) and cocaine use (Klee et al, 1990) are all predictors of injecting
risk behaviour. Due to cultural differences there is a need to identify such predictors within an Irish
                                                          
3 One Health Centre in Dublin (Ballymun) is open between 6.00pm and 8.30pm one day a week.
setting. Once this has been achieved, it would be possible through a syringe exchange intervention to
equip drug users with the protective factors necessary to reduce their vulnerability in such
circumstances.    
This study showed very high levels of sharing of injecting paraphernalia in Dublin. Over half the clients
reported such behaviour. Unfortunately, the Health Promotion Unit was not successful in significantly
reducing levels of reported sharing of injecting paraphernalia. Although the Unit provides the means to
reduce such sharing behaviour, the suggestion is that there is a lack of knowledge among injecting drug
users around the risks of such behaviour. Greater emphasis needs to be placed on the sharing of spoons
and filters, and on the fact that they are identified routes of transmission of HIV and hepatitis.
Sexual Risk Behaviour
4. Most injecting drug users are sexually active and accompanying levels of risk behaviour are
high. While syringe exchanges have the potential to increase levels of condom use, sustained
behaviour change requires a societal response.
This research supports international studies (WHO,1993) which illustrate that the majority of drug users
(75%) are sexually active. Thirty nine percent of first visit clients reported having a regular sexual
partner who was not an injecting drug user and a further 25% of clients had an injecting drug using
partner. Moreover, clients with regular sexual partners were significantly more likely to report never
using condoms. This is compounded by the fact that this study suggests that there are high levels of
movement in and out of ‘regular’ sexual relationships. Thirty percent of follow-up clients had moved
either in or out of a regular sexual relationship within the three-month follow-up period. These findings
highlight the importance of  advising drug injectors about sexual risk behaviour in addition to injecting
risk behaviour.
International research has shown that levels and patterns of condom use among drug users does not
differ substantially among the general heterosexual population (McKeganey et al 1988; Donoghoe,
1992). Research has also demonstrated that syringe exchanges have failed to impact significantly on
levels of condom use largely due to lack of emphasis on sexual routes of HIV transmission (Hart,1989).
If knowledge, attitudes and practices regarding sexual risk behaviour were put higher on the agenda for
both drug workers and drug users, more noticeable behaviour changes might be possible. However, in
order to sustain such behaviour changes, changes in sexual norms and cultural contexts are required. It
is essential that sexual norms cut across the drug using and non-drug using population.
 
Treatment Contact
5. Contact with syringe exchanges promotes contact with other services, and operates as a
potential gateway into drug treatment. 
The Health Promotion Unit proved successful in attracting drug users who were not currently in contact
with other drug treatment services. International research has shown that those in contact with drug
treatment services are more likely to adopt and sustain harm reduction strategies (Paone et al, 1995).
The majority of clients (80%) reported that they were not attending any other service at first visit. The
evaluation revealed that there was a 23% increase in the number of attendees reporting contact with
other drug treatment services by follow-up. The fact that a high proportion (0.3) of clients were recent
injectors may explain why levels of first treatment contact were so low. International research illustrates
that syringe exchanges appeal primarily to older individuals (Paone et al, 1995), who are more
established in their injecting careers (Battjes et al, 1992). However, the Health Promotion Unit proved
successful in attracting young drug users, who have recently initiated intravenous drug use (Cassin et
al,1998). 
Health and Well Being
6. Syringe exchanges have the ability to alleviate the isolation experienced by many injecting drug
users. This in turn can have a positive effect on their health and well-being.
The Health Promotion Unit offers a holistic approach to its clients, and is therefore not only concerned
with risk behaviour. It is accepted that an individual’s drug use will impact on his/her overall health and
well-being. To this end, the Unit aims, in as far as possible, to address the physical and emotional health
problems of attendees. However, as health and well-being are intertwined with quality of life, the Unit
recognises that addressing such issues is gradual and takes time. The short follow-up time period
employed in this study, means that dramatic changes in health and well-being were not expected.
There were no significant changes in clients reported physical health, however, it should be noted that at
the same time there was no deterioration. There were more notable changes in clients emotional well-
being. At follow-up clients were significantly less likely to report being depressed, suffering from
anxiety and feeling unable to cope, among other complaints. This research illustrates that a syringe
exchange can, by simply providing a safe place where there is somebody to talk to, improve clients
well-being and overall quality of life. 
6.2 RECOMMENDATIONS
  
This study has clearly demonstrated the effectiveness of needle exchanges as a public health initiative,
while at the same time highlighting a number of deficits in service provision and policy. The process of
evaluating the Health Promotion Unit contributes to, not only the daily operational issues of the service
provided by the Merchant’s Quay Project, but also to similar exchange programmes operating in
Ireland. 
Syringe exchange programmes should be conceptualised as an integral part of public health efforts to
reduce HIV and hepatitis C infection among injecting drug users. They should also be part of a
comprehensive approach to drug use that will improve access to drug treatment. This section presents
general recommendations on improving the efficiency, effectiveness and future development of syringe
exchanges as a harm reduction strategy.
Improving Access to Injecting Equipment in the Greater Dublin Area
Ensuring adequate and easy access to the supply of sterile injecting equipment is essential. There is a
clear need to increase the number of syringe exchanges operating in the Greater Dublin Area as it is
unrealistic to expect the existing services to cope with the potential demand. The diversity of responses
in the UK, and the development of syringe exchange schemes outside drug services, may strengthen a
public health campaign to prevent the spread of HIV and hepatitis infection among injecting drug users
in Dublin. To this end, the following strategies which aim to supplement existing services are outlined.
They have the potential to ensure 24 access and non restrictive availability of sterile injecting equipment
for all injecting drug users.
• Greater access to needle exchange services at a local and community level.
• The provision of strategically placed vending machines to increase the availability of injecting
equipment.   
• Increased availability of sharps bins, in publicly accessible places to ensure safe means of
disposal of injecting equipment.  
• Syringe exchanges to be extended to services other than drug agencies (i.e. Community Health
Centres, Services for the Homeless). 
• Pharmacies to be involved in the distribution of sterile injecting equipment. 
• Mobile Services to provide needle exchanges in the evenings and at week-ends. 
• Detached services to promote harm reduction to injecting drug users who fail to initiate
and/or maintain contact with drug services.
Service Development
In order to maximise the effectiveness of low threshold services, a more holistic approach to the needs
of drug injectors must be adopted. This research highlights the diverse range of issues with which drug
injectors present at a Health Promotion Unit. This is further compounded by the fact that drug injectors
frequently report low levels of contact with other services. Recognising the fact that not all drug users
maintain contact with syringe exchanges there is a need to develop the services available at the point of
first contact. To this end the following developments in service provision are recommended;
• Primary health care including hepatitis vaccinations, HIV and TB screening, available as an
integrated part of drug service provision throughout the city. 
• Workshops to be provided at needle exchanges and drop-in centres for injecting drug users, as
a means of promoting safer injecting techniques. 
• Development of more flexible prescribing options, to include graduated prescribing services
from injectable to oral methadone.
• Introduction of dedicated services for the vulnerable and hard to reach injecting drug users,
i.e. women and young injectors.
• Implementation of peer based users groups, whereby active injecting drug users utilise their
knowledge and expertise in an attempt to influence current social norms and the rituals within
the drug using culture.
• Employment of active drug users to act as health agents in the promotion of drug related
harm.
• Provision of legal advice to form an integral part of drug service provision.
• Greater integration and coordination of services for marginalised groups.
• The provision of specialist training to all drug workers on hepatitis C transmission and safe
sex practices, to ensure a more effective intervention. 
Publicity, Promotion and Information
A comprehensive public health campaign is needed to place HIV and hepatitis C on the forefront of the
public health agenda. Such a campaign must include the provision of accessible, informative and
relevant harm reduction material, to the general population and more specifically to injecting drug
users. To help achieve this, the recommendations are;
• Wider publicising and co-ordination of existing services. 
• Culturally appropriate health promotion leaflets and posters aimed at injecting drug users
widely distributed in targeted areas (e.g. in drug services, homeless services, GP clinics, public
toilets, pubs and clubs). 
• National awareness campaigns to promote safer sexual practices among the general
heterosexual population is urgently required. 
• Health promotion campaigns to offer positive images of drug users, rather than negative
stereotypes. 
Future Research
In Ireland, there is as dearth of research on drug use and related issues. Moreover, all the research that
has been carried out to date has concentrated specifically on drug users in contact with drug services. To
promote harm reduction, there is a need to develop a greater understanding of the social circumstances
in which such risk behaviour occurs. Furthermore, research also plays an important legitimating role in
service provision and development. To this end research in the following areas needs to be undertaken;
• Utilising control group methodology to further evaluate the effectiveness of syringe exchanges.
• An assessment of the effects of design features of needle exchanges (e.g. geographical location,
site characteristics, opening hours, staffing levels) on the effectiveness of the service.  
• An examination of the effectiveness of harm reduction strategies in sustaining behaviour
change. 
• An investigation into the sexual behaviour of injecting drug users. 
• An ethnographic examination of the sharing practices and culture of injecting drug users in
Dublin.
Policy Issues
It is clear that drug use is a problem of public health, rather than a question of individual pathology.
Throughout this Report harm reduction, as a public health response to injecting drug uses, has been
recognised as providing a short term intervention, with long term value. It is just one approach across a
continuum, which caters for the needs of drug users. At its most basic, it operates at the level of current
drug using practices. It seeks within this limited context to tackle the consequences of the drug using
behaviour, rather then the issue of drug use itself. 
All services, whether statutory or voluntary, which deal primarily with injecting drug users must be
subject to regular and reflective review. The services provided must begin and end with a vision of a
comprehensive, integrated and coherent policy. To this end, the following are recommended;
• The reduction of drug related harm explicitly stated as a primary objective of a national drug
policy. 
• Any legal restrictions in Ireland on the adoption of extensive harm reduction strategies need to
be addressed.
• In light of the increasing numbers of under age injecting drug user, harm reduction strategies
must be extended to youth services.
• Development of needle exchanges in prisons.
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